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ABSTRACT OF THE DISSERTATION
Developing New Methodologies for Crosslinked Polymeric Nanostructure Syntheses,
Chemoselective Modifications, and Applications as Imaging and Delivery Agents

By
Guorong Sun
Doctor of Philosophy in Chemistry
Washington University in Saint Louis, 2009
Professor Karen L. Wooley, Chairperson

The overall emphasis of this dissertation research includes the syntheses of
amphiphilic block copolymers bearing functional groups through controlled radical
polymerization techniques, followed by the aqueous assembly of these block copolymer
precursors to construct polymeric nanostructures with different sizes and morphologies.
Further chemical modification of the nanostructures afforded functional crosslinked
nano-objects with reporting probes for imaging and biocompatible “stealth” materials for
tuning the in vivo fate of nanostructures.
Amphiphilic block copolymers poly(acrylic acid)-block-polystyrene (PAA-b-PS)
with well-defined structures were prepared through nitroxide-mediated radical
polymerization (NMP).

Using novel pre-functionalization strategies, these block

copolymer precursors were functionalized with DOTA for chelating 64Cu and were then
assembled into micelles and crosslinked throughout the micelle shell domain to afford the
shell crosslinked nanoparticles (SCKs), containing large numbers of effective DOTAs per

ii

particle for 64Cu radiolabeling These 64Cu–complexed nanoparticles showed impressive
specific activities (ca. 400 μCi μg-1), which suggest that they will serve as highly
sensitive in vivo positron emission tomography (PET) tracers at low administering doses.
The “pre-grafting” strategy was further extended to accomplish SCKs with
variable biodistributions. PAA-b-PS amphiphilic block copolymers were modified with
varying numbers of poly(ethylene oxide) (PEO) chains, together with DOTA, before
assembling into block copolymer micelles and crosslinking throughout the micellar shell
regions.

After chelation of

64

Cu tracers, the in vivo fate of PEGylated SCKs was

evaluated by means of biodistribution experiments and PET imaging.

The blood

retention of PEGylated-SCKs exhibited tunabilities, depending on the mPEG grafting
density and the nanoparticle surface properties.
Various bi-functional pyrazine-based chromophores were used as crosslinkers to
probe directly their incorporation efficiencies into the shells of block copolymer micelles,
which further determined the actual crosslinking extents ─ a critical factor for developing
SCKs as PET imaging agents.

The micelles were made to carry poly(N-

acryloxysuccinimide) (PNAS) as pre-installed amine-reactive functionalities along
amphiphilic triblock copolymer precursors (PEO-b-PNAS-b-PS) prepared through
reversible addition-fragmentation chain transfer (RAFT) radical polymerizations. The
incorporation/crosslinking efficiencies were dependent upon the type of crosslinker and
the applied stoichiometries.
The intrinsic reactivity of aldehyde motivated the developments of well-defined
polymers having reactive carbonyl side chain substituents.

Amphiphilic block

copolymers bearing poly(4-vinyl benzaldehyde) (PVBA) block segments with controlled

iii

molecular

weights

and

low

polydispersities

were

obtained

through

RAFT

polymerizations and assembled into polymeric vesicles and micelles. The vesicles were
crosslinked and functionalized with fluorescent molecules through chemoselectivelyreductive amination and were shown to display interesting in vitro cell association
behaviors.

The micelles were modified with near-infrared fluorescent dyes and

crosslinked with diamino crosslinkers, each via reductive amination, to prepare robust
nanoparticles with optimized luminescent characteristics for in vivo optical imaging.
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Chapter 1

Introduction

The groundbreaking lecture by Richard Feynman in 1959,1 “There’s Plenty of
Room at the Bottom”, triggered the campaign to study and manipulate matters over
atomic and/or molecular scale and opened the “Nano-window” to natural scientists.
Different from conventional science and technology, in which the size of objects usually
are below 0.1 nm, the targets of nanoscience and technology are focused onto the
“things” from molecular-based assemblies and/or objects with size scales between 0.1 nm
to 100 nm, as well as single atoms and molecules. During the past 50 years, through the
efforts and devotions from several generations of scientific researchers, nanoscience and
technology have achieved significant innovations in academic and industrial laboratories,
across disciplines, and become a robust and well-accepted scientific field.2, 3 Meanwhile,
profound impacts of nanoscience and technology have been growing explosively
worldwide in the manufacturing and R&D areas such as miniaturization of electronic and
memory devices, design and synthesis of more robust and efficient catalysts,
development of more accurate and effective diagnostic procedures, and exploration of
more potent drugs with “smart” abilities to recognize and attack only the diseased sites.
In modern nanotechnology, there are two basic approaches to realize the
syntheses of nanostructures, the Top-down and Bottom-up approaches. The Top-down
approach is based on physics and lithography techniques,4-10 while the Bottom-up is
mainly influenced by chemical principles.11-18
1

Both approaches provide specific

capacities that can be implemented by the other.19-23 However, the relatively broader
substrate scope and more precise tuning of chemical binding strength and orientations
offer extra driving forces for the Bottom-up approach to evolve and advance
nanotechnology.
The self assembly of amphiphilic polypeptides into proteins with intricate
supramolecular structures and variety of functionalities represents one of the elegant
manners in constructing complex assembles by Nature.

This phenomenon inspired

scientists to exploit nano-scale material mimics having unique optical, electric, catalytic,
and biological properties.24, 25 Utilizing synthetic amphiphiles as assembly components,
many nanostructures ranging from atomic to supramolecular dimensions have been
assembled through weak non-covalent interactions, which included van der Waals,
electrostatic, hydrophobic interactions, hydrogen and coordination bonds,26-30 via a
balanced reversible process.31-33 These nano-assembles exhibited diverse non-spherical
morphologies, such as belt,34 cylinder,35 fiber,36-39 helix40-42, lamella43, and vesicle,44-46
depending upon the intrinsic compositions and physical properties of the amphiphiles and
the assembly conditions.
Among the synthetic amphiphiles, amphiphilic block copolymers have gained
significant attentions recently by both academic and industry investigators.47-49

In

contrast to small surfactants, the amphiphilic block copolymer systems exhibit the
following advantages: the facile tuning of dimensions, compositions, and components;
the easier introduction of functionalities; the much larger phase segregation tendency;50, 51
the significantly slower assembly kinetics;52 and the enhanced robustness and
morphological variation of resulting structures.

2

Amphiphilic block copolymers can

construct a wide range of supramacromolecular assemblies including conventional
morphologies like spheres (the most common morphology), cylinders/worms53-59 and
vesicles,60-70 and many other novel morphologies such as bamboos,71 bowls,72 discs,73
helices,74 and toroids.75
segregation

in

inter-

Moreover, the spherical micelles can undergo higher-order
and/or

intra-micellar

multicompartment,79-81 and onion82,

83

micelles.

fashion

to

create

Janus,76-78

The versatility in composition and

assembly behaviors offer a rich selection of building blocks for the construction of
nanostructured materials as well as their use in biomedical and catalytic applications.
Advances in living polymerization techniques, especially in the development of
controlled radical polymerizations (CRP)84 have dramatically improved the availability of
well-defined block polymers, thereby facilitating the numbers and types of
nanoassemblies that can be prepared and studied. Using different CRP techniques, atom
transfer radical polymerization (ATRP),85, 86 nitroxide-mediated radical polymerization
(NMP),87,

88

and

reversible

addition-fragmentation

chain

transfer

(RAFT)

polymerization,89-91 various kinds of polymers having narrow molecular weight
distributions, controlled architectures, and low polydispersities can be produced.
Moreover, CRP realizes better tolerance of functionalities during the polymerization
process, which enables the facile preparation of functional polymers allowing for postmodifications.92
The heightened impact of nanotechnology in healthcare generates a specific filed
─ Nanomedicine,93-100 the medical applications of nanotechnology to improve the
properties of existing therapeutic and diagnostic modalities and to establish novel
modalities for diagnostics, treatment, and therapy of diseases.

3

Block copolymer

micelles101-105 and vesicles104, 106-109 have already been widely applied in nanomedicine
and found promising applications in both therapeutic agent delivery and diagnostics.
However, both self-assembled entities are equilibrium products formed in solution and
under diluted conditions (concentrations below the critical micelle/vesicle concentrations,
which usually at the order of 10-7 M), their ordered structures will collapse and reorganization of the unimer (amphiphilic block copolymer precursor) will occur.
Covalent110-115 and non-covalent116 crosslinkings have been introduced to micellar
assemblies to enforce the structural stability of and obviate the self correction. Several
new classes of materials termed shell crosslinked (SCK) nanoparticles and core
crosslinked (CCK) nanoparticles have been constructed, depending upon the location
inside the micellar structure where the crosslinking reaction is conducted. The same
strategy has also been applied to vesicular structures where the crosslinking was confined
into the wall domains.70, 117-119
The advantage of crosslinking is not limited only for providing robust
nanostructures. Recent reports highlighted that core crosslinking could enhance the cargo
“holding” ability of nanostructures120 and the increasing of shell crosslinking extents
prolonged the blood retention time of nanoparticles.121

Moreover, functionalized

nanostructures can be directly derived by using crosslinkers bearing diverse
functionalities,122, 123 in addition to their structural roles. This dissertation is focused on
the design, synthesis, and characterization of functionalizable crosslinked nanostructures
(micelles and vesicles) bearing characteristics allowed for chemoselective modification
and their utilizations as nanoplatforms for molecular imagings.

4

Previous studies on shell crosslinked knedel-like nanoparticle (SCKs) suggest that
these materials can serve as good templates for biomedical applications.124 To render the
SCKs functional, post-modification of pre-established SCKs with functionalities stands a
versatile and straightforward method that allows for multiple numbers and types of
ligands to be attached onto a well-defined scaffold.125-127

However, the reaction

efficiency usually suffers a variety of factors, especially the steric and electrostatic
factors, due to the fact that most of the SCK modification reactions are conducted in
aqueous media. As found during the study of post-functionalization of SCKs with DOTA
(1,4,7,10-tetraazocyclododecane-N,N′,N′′,N′′′-tetraacetic

acid)

derivatives

having

different features, even a “tiny” structural difference (one carboxylate and 4 atoms)
caused ca. 7- to 10-fold of reaction efficiency variations.128

Chapter 2 of this

dissertation is focus on the development of new synthetic strategy for preparation of SCK
nanoparticles having “high-dense” functionalities as potential positron emission
tomography (PET) imaging129-132 contrast agents through Bottom-up pathway.

The

DOTA-functionalized SCKs in chapter 2 were constructed through a “pre-grafting”
approach, which involved coupling the functionalities to amphiphilic block copolymer
precursor before assembly into nanostructures, in order to reduce the complexity of
nanostructure functionalization.

This strategy provided easier quantification of

functionalities per nanostructure, but also was demonstrated as a facile and effective
methodology for incorporation of highly sensitive in vivo PET tracers into nanoscale
frameworks to allow for administration of low doses in vivo.
The determination of the in vivo distribution of nanoparticulate carriers following
systemic administration and the development of imaging modalities for visualizing the

5

biodistribution over time take top priority in nanomedicine.133

In chapter 3,

monomethoxy-terminated poly(ethylene glycol) (mPEG) and radionuclide

64

Cu chelator

were sequentially installed onto the block copolymer precursor prior to assembly and
crosslinking to afford SCK nanoparticles with different surface characteristics. The in
vivo fates of these SCKs were then evaluated through the combination of biodistribution
and PET imaging techniques. This study represented extension of applying the “pregrafting” strategy for construction of multifarious nanostructures having quantifiable
functionalities, but also demonstrated the biodistributions of nanovectors can be
manipulated in tunable fashion. A semi-quantitative model of the density of mPEG
surface coverage as a function of in vivo behavior was applied to enhance the
understanding of this system.

The distance between exposed mPEG molecules on

nanoparticle surface was found to determine the blood retention time of the
corresponding SCK nanoparticles through opposing blood protein absorption mechanism
and the calculated results were consistent with the theoretical predictions proposed by de
Gennes and co-workers.134, 135
Because the general methodology for the preparation of SCKs involves
crosslinking reactions between polymer chain segments that constitute the corona of
block copolymer micelles, the nature of the crosslinking agent and the degree to which
crosslinking is conducted allows for tuning of the SCK surface characteristics and the
shell permeability. In fact, the phenomena that higher crosslinking extent caused a
reduction of the radiolabeling efficiency (chapter 2), but benefited the in vivo fate
(chapter 3) have already been noticed. Therefore, a precise balance between the above
issues needs to be managed for developing SCK nanoparticles as potential imaging

6

agents. Research presented in chapter 4 describes the fundamental investigations for
exploring the incorporation efficiencies of crosslinkers into the shells of block copolymer
micelles, which further determines the actual crosslinking extents, by utilizing pyrazinebased crosslinkers as reporting probes. In order to minimize other factors related with the
carbodiimide-mediated amidation, the block copolymer micelles were made to carry preinstalled reactive functionalities (N-acryloxysuccinimide, NAS) along the central block of
amphiphilic triblock copolymer as amidation sites.

It was revealed that the

incorporation/crosslinking efficiencies were dependent upon the intrinsic properties of
crosslinker, the conditions used for crosslinking, and the applied stoichiometries. In the
meantime, unique photo-physical properties of the optical-active SCKs at lower
crosslinking extents (13% to 20%) were observed. Compared with the crosslinkers as
small molecules, the maximum absorption peaks of SCKs exhibited blue-shifts of ca. 35
to 40 nm. More interestingly, SCKs showed dual emissions of the fluorescence (498 nm
and 555 nm, respectively) while the fluorogenic probes only afforded single emissions at
555 nm without the internal nanostructure environment.
Chapter 5 depicts the development of well-defined homopolymer and block
copolymer systems bearing pendant benzaldehyde functionalities through RAFT
polymerizations. The motivation of this work comes from the intrinsic reactivity of
benzaldehyde, one of the most reactive and diverse electrophiles that undergoes reaction
under mild conditions. By taking advantage of the higher functional group tolerance in
RAFT polymerization, poly(4-vinyl benzaldehyde)s (PVBA) with controlled numberaverage molecular weight (Mn) and low polydispersity (PDI < 1.17) were obtained. The
controlled characteristic of the RAFT polymerization process was confirmed by the

7

linearity between the Mn values of PVBA and monomer conversions. Well-defined
PVBA was further used as a macromolecular chain transfer agent (macro-CTA) in RAFT
polymerization of styrene (St), and a block copolymer PVBA-b-PSt with relatively low
polydispersity (PDI = 1.20) was successfully synthesized.
Work towards biological applications of nanoscale objects with PVBA as reactive
hydrophobic block segments continues in chapter 6 and chapter 7.

Chapter 6

illustrates the aqueous describe assembly of block copolymer poly(ethylene oxide)-blockpoly(4-vinyl benzaldehyde) precursors into polymeric vesicles with tunable sizes and the
following chemoselctive post-modifications through the reductive amination chemistry.
Different from most literature reported60-70 AB diblock copolymer precursors (A
represents for the hydrophilic block segment while B for the hydrophobic segment) for
preparing vesicular nanostructures, in which a longer hydrophobic B block segment was
required, the unimer used in this study, PEO45-b-PVBA26, had a relative shorter B block.
The morphology transformation during vesiculation process was investigated and
variations from traditional trend (sphere-rod-vesicle), including the forming of vesicles at
lower water contents and the “absence” of rods, were noticed from the transmission
electron microscopy (TEM) measurements. It was also found that small vesicles could be
obtained from the same block copolymer precursor through a “kinetic trapping” protocol,
as characterized through a combination of TEM and dynamic light scattering (DLS). The
reactivity of the benzaldehyde functionalities was verified by crosslinking the vesicles,
and also by a one-pot sequential functionalization and crosslinking approach to further
render the vesicles fluorescent, each via reductive amination. In vitro studies found these
labelled vesicles underwent cell membrane associations, as indicated by the confocal
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microscopy, which might be related with the interactions between the membrane proteins
and the leftover aldehydes.
The last research part of this dissertation (chapter 7) introduces the modelpredictable optimizations of luminescence efficiency (quantum yield, QY) of fluorescent
nanomaterials for the core crosslinked micelles, prepared from PEO-b-PVBA through the
established one-pot sequential functionalization and crosslinking protocol.

Both the

experimental and model-predicted data revealed that the nanoparticle QY was related
with the dye “loading” stoichiometry and the size of core domain. These two factors
determined the distance between adjacent fluorophores, which further decided the extent
of non-radiatively transferred energy.
This introduction has encompassed the successes and complications in attempting
to develop functionalized crosslinked nanostructures which exhibit selective biological
activities, interesting optical properties and other physicochemical properties that are
being exploited for tissue selective imaging applications in vivo.

Moreover, the

fundamental strategy behind this dissertation, i.e., synthesizing well-defined amphiphilic
block copolymers bearing diverse functionalities; following by assembly the resulting
precursors into polymeric nanoscopic objects with various morphologies; and
subsequently exerting internal and/or external functionalization/crosslinking through
varying methodologies to achieve discrete functional nanomaterials with improved
robustness and stability, will remain on the forefront of nanotechnology field.
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Chapter 2

Strategies for Optimized Radiolabelling of Nanoparticles for in vivo
PET Imaging
[Portions of this work have been published previously as Guorong Sun, Jinqi Xu, Aviv
Hagooly, Raffaella Rossin, Zicheng Li, Dennis A. Moore, Craig J. Hawker, Michael J.
Welch and Karen L. Wooley Adv. Mater. 2007, 19(20), 3157-3162.]

Abstract
Driven by the motivation for optimizing

64

Cu radiolabelling efficiency of

nanoparticles for in vivo PET imaging, a new strategy has been developed. This strategy
involved a complete redesign of the nanoparticle system, utilizing macromolecular
precursors that were pre-loaded with labelling sites and programmed for supramolecular
assembly into discrete, functional nanoscale objects.

A series of shell crosslinked

nanoparticles (SCKs) have been constructed by grafting a copper chelating agent
(DOTAlysine) onto amphiphilic block copolymers (PAA-b-PS), self assembling the
functionalized block copolymer precursors into micelles, and crosslinking the micellar
corona to afford the expected nanoobjects.

These pre-DOTAlysine-SCKs showed

impressive results on 64Cu radiolabelling (~ 400 copper atoms per spherical nanoparticle).
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Introduction
Among the molecular imaging modalities, positron emission tomography (PET) is
widely used as a powerful diagnostic tool by clinicians and scientists.1-3 Compared with
other imaging methods, it bears the advantages of high sensitivity (the level of detection
approaches 10-11 M of tracer) and isotropism (i.e., ability to detect expression accurately,
regardless of tissue depth), which provide reliability for quantitative imaging analyses of
in vivo abnormalities. As the pharmaceutical industry began applying PET imaging for
assisting drug discovery,4-10 small animal PET scanners with spatial resolution up to 1
mm were developed and have been considered to be one of the major achievements for
PET technology during the past two decades.11

64

Cu is an attractive radionuclide for PET

imaging because of its suitable half-life (t1/2 = 12.7 h) and positron emission energy (0.65
MeV), as well as the relatively convenient radiolabelling via coordination with specially
designed ligands (chelators).12-15

The formation of thermodynamically-stable metal

complexes reduces the copper binding with plasma proteins which minimizes its nonspecific background activity and its accumulation and resultant toxicity in the liver and
kidney.16 Under the present instrumental conditions, optimizations and improvements of
the specific activity of radiopharmaceuticals are of special interest to
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Cu-based PET

systems for achieving high quality images even at low doses, especially when the targets
can be readily saturated in vivo. One practical resolution is to encapsulate or conjugate
the chelating agents with nanocarriers, which have already been utilized by many
27

research groups17-21 including ourselves22,

23

and have been found to exhibit exciting

potential in both high loading capacities and re-direction of the bio-distributions of small
molecule ligands (e.g. for tissue targeting) or guests (e.g. for pharmaceutical effect).24
Our research has focused upon shell crosslinked knedel-like nanoparticles
(SCKs)25 as the nanoscale framework for the attachment of macrocyclic chelators and
labelling by 64Cu radionuclides. SCKs have been established from the self assembly of
amphiphilic block copolymers to afford micelles with core-shell morphology that are
then covalently crosslinked throughout the shell domain. Recently, it was confirmed that
by tuning the nanoparticle properties, especially the size and rigidity, increased in vivo
circulation times and improved bio-distributions could be reached for
conjugates.23
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Cu-TETA SCK

Although these preliminary results are promising, several challenges

require further investigations. Among them, efficient radiolabelling takes the highest
priority. Previously, the direct conjugation of macrocyclic chelators onto pre-established
SCKs afforded limited coupling and radiolabelling yields, due to steric and electrostatic
factors.23,
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As part of our ongoing efforts, we now report an alternative strategy to

construct chelator-SCK conjugates with high radiolabelling efficiencies, which is
expected to lead to nanoscale objects that can be administered in small quantities for
ultra-sensitive PET imaging.
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Results and Discussion
SCKs used in this study were comprised of polystyrene (PS) and poly(acrylic
acid) (PAA), a particle composition previously demonstrated to have long blood
circulation times23 and characteristic low cytotoxicity and low immunogenicity when
crosslinked with 2,2’-(ethylenedioxy)-bis(ethylamine).27

The particle sizes were

controlled by the relative balance of hydrophobic PS block length vs. the hydrophilic
PAA segment.28,
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The amphiphilic block copolymer precursors (PAA-b-PS) were

acquired via sequential living radical polymerization of tert-butyl acrylate and styrene,
followed by acidolysis of the tert-butyl ester protecting groups. In all cases, the block
copolymers had well-defined structures and narrow polydispersities (PDI < 1.20).
As shown in Scheme 2.1, a lysine derivative of 1,4,7,10-tetraazocyclododecaneN,N′,N″,N′″-tetraacetic acid (DOTA), DOTAlysine, was grafted onto the amphiphilic
PAA-b-PS block polymer precursors, with a fixed hydrophilic PAA segment length (DPn
= 60) and varied hydrophobic PS segment lengths (DPn = 30, 60, 140). Conventional
amidation chemistry was employed in organic solvent to afford ca. 65 to 75% isolated
yield, for which the coupling yields were > 85%. After purification by dialysis against
water and lyophilization, the numbers of DOTAlysines per polymer chain were
determined by 1H NMR spectroscopy analyses. For PAA60-b-PS30 and PAA60-b-PS60
block copolymers, the grafting numbers were 2, 4, and 7, for three different samples.
Grafting more DOTAlysines (> 10 DOTAlysines/chain) was also attempted, but the
29

resulting DOTAlysine-g-copolymers suffered from poor solubility in organic solvents
and generated nanoparticles with broad size distributions.

The same problem was

encountered for the PAA60-b-PS140 after coupling 7 DOTAlysines, so only 2 and 4
DOTAlysines/chain were studied.

Scheme 2.1. A two-step synthetic route was developed for the preparation of preDOTAlysine-SCKs: (1) labelling of three different amphiphilic block copolymers,
PAA60-b-PSp, with three different levels of DOTAlysine; (2) their self assembly into
micelles in water and shell crosslinking to two different extents. Overall, eight micelles
and sixteen SCKs resulted from this scheme (see also Table 2.1).
30

Each amphiphilic block copolymer was assembled into micelles in aqueous
solution by a standard micellization protocol30,

31

and crosslinked throughout the shell

layer to differing degrees (20% and 50%, according to the chemical stoichiometry). A
series of micelles and SCKs having different dimensions and shell properties
(electrostatic character, permeability, and residual carboxylic acid concentrations) was
obtained and characterized by dynamic light scattering (DLS) and transmission electron
microscopy (TEM) (Table 2.1 and Figure 2.1).

31

Table 2.1. Characterization data for pre-DOTAlysine-SCKs and control SCK samples
(lacking DOTA functionalities).
Samplea
(Extents of
Crosslinking)

(Dh)nb
(nm)

Davc
(nm)

SCK1 (20%)

21 ± 3

SCK2 (20%)

(DOTAlysinem-g-PAAn)-b-PSp

Nagge

m

n

p

11 ± 1

2

58

30

125

21 ± 3

16 ± 2

2

58

60

240

SCK3 (20%)

21 ± 6

11 ± 2

2

58

140

40

SCK4 (20%)

21 ± 3

12 ± 2d

4

56

30

160d

SCK5 (20%)

47 ± 7

19 ± 2d

4

56

60

340d

SCK6 (20%)

17 ± 2

11 ± 2

4

56

140

40

SCK7 (20%)

26 ± 6

11 ± 2

7

53

30

125

SCK8 (20%)

25 ± 6

19 ± 2

7

53

60

400

SCK9 (50%)

21 ± 3

11 ± 1

2

58

30

125

SCK10 (50%)

24 ± 3

16 ± 2

2

58

60

240

SCK11 (50%)

13 ± 4

12 ± 2

2

58

140

40

SCK12 (50%)

22 ± 4

15 ± 2d

4

56

30

160d

SCK13 (50%)

43 ± 5

18 ± 3d

4

56

60

340d

SCK14 (50%)

17 ± 4

13 ± 2

4

56

140

40

SCK15 (50%)

24 ± 5

11 ± 2

7

53

30

125

SCK16 (50%)

28 ± 4

19 ± 2

7

53

60

400

Control1 (50%)

18 ± 2

11 ± 1

0

60

30

125

Control2 (50%)

22 ± 1

17 ± 1

0

60

60

240

Control3 (50%)

34 ± 4

25 ± 1

0

60

140

330

a

All samples were dispersed in 5.0 mM pH 7.3 PBS (with 5.0 mM NaCl) buffer
solutions. b The number-averaged hydrodynamic diameters ((Dh)n) were determined by
DLS. Samples were passed through PVDF filters with 220 nm average pore size before
conducting DLS measurements. c The TEM average diameter (Dav) values were
measured for the nanoparticle cores. d Only spherical nanoparticles were counted. e The
aggregation numbers (Nagg) were calculated based upon TEM micrographs.
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Figure 2.1. TEM micrographs of 50% crosslinked SCKs prepared from DOTAlysinemg-PAAn-b-PSp block copolymer precursors: (a), (b), (c), and (i) are images of SCK9,
SCK12, SCK15, and Control1, prepared from PAA60-b-PS30 with 2, 4, 7, and 0
DOTAlysine grafts, respectively; (d), (e), (f), and (j) are images of SCK10, SCK13,
SCK16, and Control2, prepared from PAA60-b-PA60 with 2, 4, 7, and 0 DOTAlysine
grafts, respectively; (g), (h), and (k) are images of SCK11, SCK14, and Control3,
prepared from PAA60-b-PA140 with 2, 4, and 0 DOTAlysine grafts, respectively. Scale
bars in (i), (j), and (k): 100 nm.
Based upon the TEM image analysis, the number of grafting DOTAlysines
greatly influenced the morphologies of the nanoparticles. All pre-DOTAlysine-SCKs
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constructed from the three different amphiphilic block copolymers, each having 2
DOTAlysines/polymer chain (SCK1-3 having undergone 20% crosslinking, and SCK911, with 50% crosslinking) exhibited spherical morphologies with relatively narrow
particle size distributions. This similarity could be attributed to the fact that the small
percentage of modification (< 4%) across the PAA backbone did not generate significant
variation over the entire block copolymer properties, i.e. the balance between the
hydrophilic and hydrophobic blocks remained little affected. When p = 30 or 60, the preDOTAlysine2-g-PAA58-b-PSp polymers gave uniform assembly (SCK1, SCK2, SCK9,
and SCK10) to afford SCK dimensions that were in agreement with control SCKs
(Figure 2.1i and 2.1j), prepared from PAA60-b-PS30 and PAA60-b-PS60, respectively. In
these cases, the loss of hydrophilicity (i.e., transformation of carboxylic acid to amide
linkage) and the increased steric repulsion caused by the rigid macrocyclic moiety of
DOTAlysine could be partially compensated by the ca. 10% increase of carboxylic acid
residues (from DOTAlysine) over the length of the PAA60 segments. In contrast, the
DOTAlysine-functionalized amphiphilic block copolymers with the longest PS chain
segment, DOTAlysine2-g-PAA58-b-PS140 underwent assembly into unusually small
micelles to afford SCK3 and SCK11 that were significantly smaller in size and
aggregation number than was the control assembly from PAA60-b-PS140 (Figure 2.1k)
We are still investigating the reasons for the atypical assembly for these block
copolymers.
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For pre-DOTAlysine-SCKs with ca. 4 DOTAlysines/chain (20% crosslinking for
SCK4-6 and 50% crosslinking for SCK12-14), their morphologies became much more
complex. As the DOTAlysine4-g-PAA56-b-PS30 was assembled, in addition to the major
spherical morphology (> 80%), small rod-like structures appeared with ca. 60 nm length
(Figure 2.1b).

Such unusual observation became extreme for SCKs prepared from

DOTAlysine4-g-PAA56-b-PS60, in which half of the nanoobjects were rods with average
lengths of ca. 100 nm (Figure 2.1e).

It is unclear whether the sphere-to-rod

morphological transition results from interruptions on the local Coulombic interactions
within the nanostructures, a hydrophilicity change in the shell domain, or a combination
of these factors.

Detailed studies to better understand the “driving force” of this

uncommon morphological transition are currently underway. In the case of SCKs from
DOTAlysine4-g-PAA56-b-PS140 (SCK6 and SCK14), spheres still remained dominant,
but their particle size distributions were broad (Figure 2.1h).
Interestingly, as the grafting DOTAlysine number continued to increase, the four
SCKs (SCK7, SCK8, SCK16, and SCK17) from DOTAlysine7-g-PAA53-b-PS30(60)
returned to the more thermodynamically favourable spherical morphology.

It is

surprising that, even at this high proportion of modification (i.e., the introduction of ca.
21 additional carboxylic acid groups per hydrophilic chain segment and the concomitant
increased hydrophilic ratio and increased steric effects) along the polymer backbones,
their assembly sizes and shapes remained similar to the control SCKs. Again, the block
35

copolymer having the longest PS block length and coupling of ca. 7 DOTAlysines per
polymer was unusual, in that it experienced poor solubility and could not be assembled
into uniform micelles.
Radiolabelling of these micelles and their corresponding SCKs with

64

Cu were

investigated thoroughly. All the pre-DOTAlysine-SCKs/micelles exhibited high specific
activity (Figure 2.2) compared with the SCKs prepared by coupling the DOTA onto preestablished nanoparticles (post-DOTA-SCKs, Control4 in Figure 2.2).26 The specific
activities of the pre-DOTAlysine-SCKs increased by 10 to 40 fold.

This high

radiolabelling on a per particle basis creates an opportunity for reliable use with
administration of a minimum amount of polymeric nanoparticles for in vivo PET
imaging.
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Figure 2.2. Radiolabelling results for pre-DOTAlysine-SCKs: (a) SCKs from
functionalized PAA60-b-PS30; (b) SCKs from functionalized PAA60-b-PS60; (c) SCKs
from functionalized PAA60-b-PS140. The numbers of effective DOTAlysines/particle
(with ± 5% standard deviation) were obtained from the numbers of effective
DOTAlysines/polymer chain (determined from isotopic dilution experiments, see
Experimental Section) and the calculated particle aggregation number (Table 2.1).
Control4 were post-DOTA-SCKs.26
The specific activity and the number of effective DOTAlysines per SCK did not
follow the expected tendency, which would be an increase in labelling with an increase in
DOTAlysine grafting density.
available for

64

Rather, it appeared that the proportion of DOTAs

Cu chelation reached a “saturation point” after 4 DOTAlysine grafts per

polymer chain. Since not all grafting DOTAlysines were located on the particle surface,
the membrane-like structures within the shell regions of SCKs29 might hinder the
formation of

64

Cu-DOTAlysine complexes due to steric crowding and prevention of the
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DOTAlysine macrocyclic from assuming a configuration amenable to stable

64

Cu

coordination.32 It is uncertain whether morphological differences (sphere vs. rod) also
play a role.
Moreover, for SCKs prepared from a fixed DOTAlysine graft number per
polymer chain (Figure 2.2), it was found that: (i) as the extents of crosslinking increased
(from 0% to 50%), less DOTAlysines were available for coordinating with copper; (ii) as
the proportion of the hydrophilic PAA comprising the entire nanostructure decreased, so
did the number of effective DOTAlysines and the overall specific activity. The lower
permeability within the shell domains of the SCKs having higher extents of crosslinking29
could hinder the diffusion of

64

Cu to approach the DOTAlysine chelators located

throughout the sub-surface and deep-shell areas. For instance, the number of effective
DOTAlysines per DOTAlysine7-g-PAA53-b-PS30 chain determined by isotopic dilution
experiments (see Experimental Section) was ca. 2.8, much lower than 7.0, which was
determined by 1H NMR analysis.

The second trend observed further suggests the

complexities on the self-assembly behaviour of DOTAlysine-g-PAA-b-PS block
copolymers. The lower radiolabelling efficiency on micelles and SCKs established from
the longer hydrophobic PS block (while the DOTAlysine-g-PAA segment was invariable)
could be related with their atypical morphological characteristics (vide supra).
Nevertheless, all micelles and SCKs prepared from DOTAlysine-g-PAA-b-PS exhibited
high radiolabelling results, providing a library of nanoparticles with varying
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characteristic parameters to be employed for PET imaging when a minimum amount of
imaging agent is needed.
It is noteworthy that this grafting strategy affords nanoobjects with remarkably
improved radiolabelling efficiencies, relative to the post-functionalization of preestablished SCKs,26 but also introduces complications with the assembling process,
presenting unusual morphologies in some cases. More efforts are being devoted to
investigate these morphological variations.

Although micelles give the highest

radiolabelling, their stability concerns, i.e., stable architectures exist only above their
critical micelle concentrations, remain challenging for in vivo applications.23 Considering
both the radiolabelling results and the SCK morphological properties, we conclude,
tentatively, that the current optimum sample for in vivo PET imaging are SCKs having
20% shell crosslinking and prepared from PAAn-b-PSp containing ca. 2 DOTAlysine per
polymer chain.

Conclusions
In summary, we have developed a new strategy to construct shell crosslinked
nanoparticles, containing large numbers of DOTAlysines per particle (> 400) that were
accessible for

64

Cu radiolabeling.

These nanoparticles originated from conveniently

prepared DOTAlysine-g-PAA-b-PS block copolymer precursors. The morphology of
these pre-DOTAlysine-SCKs was, however, complicated by the number of DOTAlysine
39

grafts per polymer chain.

Nonetheless, the

64

Cu–complexed pre-DOTAlysine-SCK

nanoparticles showed impressive specific activities (ca. 400 μCi μg-1), which suggest that
these nanoparticles might be used to develop highly sensitive in vivo PET tracers at low
administering doses. This “pre-grafting” strategy may also be employed to couple other
molecules for targeting interested epitopes and/or for improving the in vivo biodistribution of nanoobjects.

Experimental Section
PAA-b-PS Block Copolymer Synthesis. All block copolymers were synthesized by
acidolysis of PtBA-b-PS precursors, which were prepared by sequential polymerization
of tert-butyl acrylate and styrene via nitroxide mediated radical polymerization (NMP),
with trifluoroacetic acid (TFA) as reported in the literature.33
General

Procedure

for

DOTAlysine-g-PAA-b-PS

Synthesis.

Grafting

DOTAlysines onto PAA-b-PS by amidation involved the following: To a round-bottom
flask equipped with a magnetic stir bar, was added a sample of PAA-b-PS block
copolymer and anhydrous N,N-dimethylformamide (DMF). The mixture was stirred for
1 h at room temperature to ensure that a clear and homogeneous solution was obtained.
To

this

solution,

was

added

1-[3’-(dimethylamino)propyl]-3-ethylcarbodiimide

methiodide (EDCI) and 1-hydroxybenzotriazole (HOBt) and the reaction mixture was
allowed to stir for 1 h at rt. Finally, a pre-mixed solution of DOTAlysine·TFA and N,N40

diisopropylethylamine (DIPEA) in anhydrous DMF was added and the reaction mixture
was further stirred for 20 h at rt. The reaction mixture was then transferred to pre-soaked
dialysis tubing (MWCO ca. 6,000 to 8,000 Da) and dialyzed against nano-pure H2O (18.0
MΩ cm, pre-treated with Chelex100®) for 4 d to remove the organic solvent and small
molecule by-products. The aqueous solution was then lyophilized to afford the product
as white solid.
General Procedure for the Micellization of DOTAlysine-g-PAA-b-PS.

To a

round-bottom flask equipped with a magnetic stir bar, was added DOTAlysine-g-PAA-bPS, followed by anhydrous DMF. The mixture was sonicated for 10 min and stirred for 2
h at rt to ensure that a clear and homogeneous solution (final concentration, ca. 1.0
mg/mL) had formed. To this solution, was added dropwise via a syringe pump at a rate
of 15.0 mL/h, an equal volume of nano-pure H2O (18.0 MΩ cm) and the mixture was
further stirred for 16 h at rt. Finally, the solution was transferred to pre-soaked dialysis
tubing (MWCO ca. 6,000 to 8,000 Da) and dialyzed against nano-pure H2O (18.0 MΩ
cm, pre-treated with Chelex100®) for 4 d to afford a clear solution of micelles.
General Procedure for the Preparation of Pre-DOTAlysine-SCKs. To a 250 mL
round-bottom flask equipped with a magnetic stir bar, was added a solution of
DOTAlysine-g-PAA-b-PS micelles in nano-pure H2O (18.0 MΩ cm) (50.0 mL, 0.054
mmol of carboxylic acid residues). To this solution was added dropwise over 10 min, a
solution of 2,2'-(ethylenedioxy)-bis(ethylamine) (0.9 mg, 0.006 mmol for 20%
41

crosslinking extent; or 2.2 mg, 0.015 mmol for 50% crosslinking extent) in nano-pure
H2O (18.0 MΩ cm) (2.0 mL). The reaction mixture was allowed to stir for 2 h at rt. To
this solution was added, dropwise via a syringe pump over 1 h, a solution of EDCI (4.0
mg, 0.014 mmol for 20% crosslinking extent; or 10.0 mg, 0.034 mmol for 50%
crosslinking extent) in nano-pure H2O (18.0 MΩ cm) (2.0 mL) and the reaction mixture
was further stirred for 16 h at rt. Finally, the reaction mixture was transferred to presoaked dialysis tubing (MWCO ca. 6,000 to 8,000 Da) and dialyzed against 5.0 mM PBS
(pH 7.3, with 5.0 mM NaCl, pre-treated with Chelex100®) for 5 d to remove the small
molecule by-products and afford aqueous solutions of pre-DOTAlysine-SCKs.
64

Cu labelling and isotopic dilution experiments of the pre-DOTAlysine-SCKs.

A 100 μL pre-DOTAlysine-SCK solution in 5.0 mM PBS (pH 7.3, with 5.0 mM NaCl,
0.2-0.3 mg/mL) was diluted with 100 μL of 0.1 M ammonium acetate buffer (pH 5.5) and
to this solution,

64

Cu(OAc)2 was added (ca. 1.0 mCi).

The resulting solution was

incubated at 43 °C for 2 h, and then subjected to DTPA challenge. The labelling yield
was determined by radio-TLC on ITLC-SG plates using methanol/CH3CO2NH4 (aq) as
eluent. The number of effective DOTAlysines/polymer chain was determined by isotopic
dilution experiments. A series of known amounts of “hot plus cold” copper (Cu2+
solution spiked with

64

Cu) were added to several 100 μL SCK solutions respectively.

After a 2 h incubation at 43 °C and DTPA challenge, each solution aliquot was analyzed
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by radio-ITLC to determine the number of effective DOTAlysine per polymer chain, as
previously reported.23
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Chapter 3

Facile, Efficient Approach to Accomplish Tunable Chemistries and
Variable Biodistributions for Shell Crosslinked Nanoparticles (SCKs)
[Portions of this work have been published previously as Guorong Sun, Aviv Hagooly,
Jinqi Xu, Andreas M. Nyström, Zicheng Li, Raffaella Rossin, Dennis A. Moore, Karen L.
Wooley and Michael J. Welch Biomacromolecules 2008, 9(7), 1997-2006.]

Abstract
The in vivo behavior of shell crosslinked knedel-like (SCK) nanoparticles is
shown to be tunable, via a straightforward and versatile process that advances SCKs as
attractive nanoscale carriers in the field of nanomedicine.

Tuning of the

pharmacokinetics was accomplished by grafting varied numbers of methoxy-terminated
poly(ethylene glycol) (mPEG) chains to the amphiphilic block copolymer precursors,
together with chelators for the radioactive tracer and/or therapeutic agent 64Cu, followed
by self assembly into block copolymer micelles and chemical crosslinking throughout the
shell regions.

64

Cu-radiolabeling was then performed in order to evaluate the SCKs in

vivo by means of biodistribution experiments and positron emission tomography (PET).
It was found that the blood retention of PEGylated SCKs could be tuned, depending on
the mPEG grafting density and the nanoparticle surface properties. A semi-quantitative
model of the density of mPEG surface coverage as a function of in vivo behavior was
applied to enhance the understanding of this system.
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Introduction
There are many types of nanoparticle platforms that are undergoing investigation
as multi-functional agents for packaging, transport and delivery of imaging and
therapeutic agents in the broad field of nanomedicine.1-6 Many such nanostructures
derive from the supramolecular assembly of small molecule or polymer components. For
any new agent, it is critical that the composition, structure and properties be well-defined
and controlled. The multimolecular association of amphiphilic block copolymers into
core-shell micellar nanoassemblies has received particular attention.7-10

Covalent

crosslinking throughout the shell domains of spherical micelles, which are established
from the self assembly of amphiphilic block copolymers, can afford shell crosslinked
knedel-like (SCK) nanoparticles as discrete nanoscale objects.11, 12 With the benefits of
robust character, offered via the crosslinking, and the amphiphilic core-shell morphology,
imposed by the self assembly process, SCKs, and also internally-crosslinked block
copolymer micelles, have received significant attention as sophisticated hosts for
purposes of diagnosis and therapy toward acute vascular injury, acute lung injury and
cancer.13, 14 In each case, it is important that the nanostructures be able to circulate for a
sufficient period in the bloodstream to increase their probability to target specific tissues.
It is well known that systemically-administered nanoparticles tend to be
sequestrated by the mononuclear phagocyte system (MPS), and accumulate mainly in the
liver and spleen. Clearance from the bloodstream begins with the adsorption of plasma
proteins onto the nanoparticle surface (opsonization), which triggers complement
activation and macrophage recognition, and depends on particle size, surface chemistry
and other factors.15, 16 Surface modification with polyethylene glycol (PEG) based units
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is one of the most successful techniques to avoid nanoparticle opsonization and,
therefore, to slow down macrophage recognition.15-17 PEG is water-soluble, non-toxic,
and gives low immunogenic response.18,

19

It can be adsorbed onto or chemically

conjugated with bioactive agents, leading to improvement of their in vivo stability and
enhancement of their pharmacokinetic profiles.20,

21

Also, surface PEGylation of

polymeric nanoparticles was shown to decrease aggregation and to prolong blood
circulation times.1, 7, 8, 10, 15-17 Although the mechanism is still controversial, many studies
have suggested that the presence of PEG on the surface of a nanoparticle can exert
entropic and steric repulsions to resist and minimize the adsorption of plasma proteins
and the subsequent macrophage recognition.7,

8, 15-17

For each new nanostructured

material under development, the chemical composition, together with size,22 shape,23, 24
and flexibility,25 are believed to require tuning in order to determine their interactions
with biomacromolecules and, therefore, their fate in vivo. In general, entire “coverage”
of the nanoparticle surface with PEG is considered to be vital to achieve “stealth”
characteristics.26-36 Therefore, it is critical that chemical methodologies are available to
control and confirm the number of PEG chains and density of PEGylation. It is also
important that the chemistry allows for the incorporation of probes that can track the
nanoparticles and be used for imaging purposes.

In this work, we employ

64

Cu-

radiolabeling for biodistribution evaluation and positron emission tomography (PET), as
a highly sensitive and non-invasive imaging technique,37,
PEGylation on blood retention and MPS uptake.39-41
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to assess the effect of

Experimental Section
Materials.

All reagents and solvents were obtained from commercial sources

(Sigma-Aldrich, Acrose, and Fluka) and used without further purification unless
otherwise noted.

64

Cu was prepared on the Washington University Medical School CS-

15 Cyclotron by the

64

Ni(p,n)64Cu nuclear reaction at a specific activity of 50–200

mCi/μg at the end of bombardment. The buffers used for dialysis after SCK preparation
and during

64

Cu-labeling were treated overnight with Chelex-100® resin (Bio-Rad

Laboratories, Hercules, CA) before use.
Measurements. 1H NMR spectra were recorded in solutions on a Varian Mogli 500
spectrometer with the residual solvent signal as an internal standard. Gel permeation
chromatography

(GPC)

was

conducted

on

a

Waters

1515

HPLC

(Waters

Chromatography, Inc.) equipped with a Waters 2414 differential refractometer, a PD2020
dual-angle (15° and 90°) light scattering detector (Precision Detectors, Inc.), and a
three-column series PL gel 5μm Mixed C, 500 Å, and 104 Å, 300 × 7.5 mm columns
(Polymer Laboratories Inc.).

The system was equilibrated at 35 °C in anhydrous

tetrahydrofuran (THF), which served as the polymer solvent and eluent with a flow rate
of 1.0 mL/min.

Polymer solutions were prepared at a known concentration (ca. 3

mg/mL) and an injection volume of 200 μL was used. Data collection and analysis were
performed, respectively, with Precision Acquire software and Discovery 32 software
(Precision Detectors, Inc.). Interdetector delay volume and the light scattering detector
calibration constant were determined by calibration using a nearly monodispersed
polystyrene standard (Pressure Chemical Co., Mp = 90 kDa, Mw/Mn < 1.04).

The

differential refractometer was calibrated with standard polystyrene reference material
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(SRM 706 NIST), of known specific refractive index increment dn/dc (0.184 mL/g). The
dn/dc values of the analyzed polymers were then determined from the differential
refractometer response.
Samples for transmission electron microscopy (TEM) measurements were diluted
with 1 wt% of phosphotungstic acid (PTA) stain solution (v/v, 1:1). Carbon grids were
exposed to oxygen plasma treatment to increase the surface hydrophilicity. Micrographs
were collected at 100,000× magnification and calibrated using a 41 nm polyacrylamide
bead from NIST. The number average particle diameters (Dav) and standard deviations
were generated from the analysis of a minimum of 150 particles from at least three
different micrographs.
Hydrodynamic diameters (Dh) and size distributions for the SCKs in aqueous
solutions were determined by dynamic light scattering (DLS). The DLS instrumentation
consisted of a Brookhaven Instruments Limited (Worcestershire, U.K.) system, including
a model BI-200SM goniometer, a model BI-9000AT digital correlator, a model EMI9865 photomultiplier, and a model 95-2 Ar ion laser (Lexel, Corp.; Farmindale, NY)
operated at 514.5 nm. Measurements were made at 20 ± 1 °C. Prior to analysis, solutions
were filtered through a 0.22 μm Millex®-GV PVDF membrane filter (Millipore Corp.,
Medford, MA) and then centrifuged in a model 5414 microfuge (Brinkman Instruments,
Inc.; Westbury, NY) for 10 minutes to remove dust particles.

Scattered light was

collected at a fixed angle of 90°. The digital correlator was operated with 522 ratio
spaced channels, and initial delay of 5 μs, a final delay of 100 ms, and a duration of 10
minutes. A photomulitplier aperture of 400 μm was used, and the incident laser intensity
was adjusted to obtain a photon counting of between 200 and 300 kcps.
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Only

measurements in which the measured and calculated baselines of the intensity
autocorrelation function agreed to within 0.1 % were used to calculate particle size. The
calculations of the particle size distributions and distribution averages were performed
with the ISDA software package (Brookhaven Instruments Company), which employed
single-exponential fitting, cumulants analysis, non-negatively constrained least-squares
(NNLS) and CONTIN particle size distribution analysis routines. All determinations
were made in triplicate and the data were presented as mean values ± standard deviations
between runs.
Zeta potential (ζ) values for the nanoparticle solution samples in 5 mM phosphate
buffered saline (PBS) were determined with a Brookhaven Instrument Co. (Holtsville,
NY) model Zeta Plus zeta potential analyzer. Data were acquired in the phase analysis
light scattering (PALS) mode following solution equilibration at 25 °C. Calculation of ζ
from the measured nanoparticle electrophoretic mobility (μ) employed the Smoluchowski
equation: μ = εζ/η, where ε and η are the dielectric constant and the absolute viscosity of
the medium, respectively. Measurements of ζ were reproducible to within ± 2 mV of the
mean value given by 16 determinations of 10 data accumulations.
The aggregation number was calculated based upon the diameter measured from
TEM by using the following equation:
4 3
πr ρ
3
Naggr =
× NA
Mn

where r is the radius of the SCK, ρ is the density of polystyrene, Mn is the numberaverage molecular weight of polystyrene block segment, and NA is the Avogadro
constant.
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A Bioscan 200 scanner (Bioscan, Washington, DC) was used to read the instant thin
layer chromatography (ITLC) plates (Pall ITLC-SG plates, VWR International, Batavia,
IL). Fast protein liquid chromatography (FPLC) and radio-FPLC were performed using
an ÄKTA FPLC system (GE Healthcare Biosciences) equipped with a Beckman 170
Radioisotope Detector (Beckman Instruments, Fullerton, CA). The radioactivity was
measured in a Beckman gamma-counter 8000 (Beckman instrument, Irvine, CA)
The imaging studies were carried out using the MicroPET® Focus (Siemens Medical
Solutions Inc., Knoxville, TN) and the MicroCAT II (CTI-Imtek, Knoxville, TN)
scanners.
Preparation of mPEG2000-g-PAA-b-PS Block Copolymers.

The poly(acrylic

acid)-b-polystyrene (PAA-b-PS, PAA60-b-PS60 for this work) block copolymer was
prepared as previously published (for the PAA60-b-PS60 block copolymer precursor,
poly(tert-butyl acrylate)-b-polysteyrene, PtBA60-b-PS60, Mn,GPC = 13,500 Da, Mw/Mn =
1.2).42 Grafting mPEG2000 onto PAA-b-PS involved the following: to a solution of
PAA60-b-PS60 block copolymer in anhydrous N,N-dimethylformamide (DMF), 1-[3’(dimethylamino)propyl]-3-ethylcarbodiimide

methiodide

(EDCI)

and

1-

hydroxybenzotriazole (HOBt) were added and the reaction mixture was allowed to stir
for 1 h at room temperature (rt). Then, a solution of mono-amine terminated mPEG2000
in anhydrous DMF was added and the reaction mixture was further stirred for 30 h at rt.
The relative ratios of PAA60-b-PS60 block copolymer:EDCI:HOBt:mPEG-NH2 were
varied to alter the grafting densities, whereby to achieve grafting densities of 1, 2.5 and
5.5 mPEGs per macromolecule, the stoichiometries were 1.0:1.3:1.3:1.3, 1.0:3.5:3.5:3.5,
and 1.0:7.0:7.0:7.0, respectively. The final grafted block copolymers were isolated by

54

transferring the reaction mixtures to pre-soaked dialysis tubing (MWCO 6,000 to 8,000
Da) and dialyzing against nano-pure H2O (18.0 MΩ cm) for 4 d to remove the organic
solvent and the small molecule by-products.

The aqueous solutions were then

lyophilized to afford the products as a white solid. 1H-NMR (500 MHz, CD2Cl2, ppm): δ
1.20-2.40 (br, -CH2- and -CH- of the polymer backbone), 3.34 (s, mPEG terminal CH3OHs), 3.42-3.80 (br, mPEG backbone -OCH2CH2O- Hs), 6.16-7.11 (br, aromatic Hs).
mPEG20001-g-PAA59-b-PS60 PAA60-b-PS60 (110.0 mg, 10.4 μmol), EDCI (4.0 mg,
13.5 μmol), HOBt (1.8 mg, 13.5 μmol), and mono-amine terminated mPEG2000 (27.0
mg, 13.5 μmol) in anhydrous DMF (15.0 mL). Yield: 72%.
mPEG20002.5-g-PAA57.5-b-PS60 PAA60-b-PS60 (120.0 mg, 11.3 μmol), EDCI (11.8
mg, 39.6 μmol), HOBt (5.4 mg, 40.0 μmol), and mono-amine terminated mPEG2000
(79.2 mg, 39.6 μmol) in anhydrous DMF (15.0 mL). Yield: 75%.
mPEG20005.5-g-PAA54.5-b-PS60 PAA60-b-PS60 (110.0 mg, 10.4 μmol), EDCI (21.6
mg, 72.8 μmol), HOBt (9.9 mg, 73.3 μmol), and mono-amine terminated mPEG2000
(145.6 mg, 72.8 μmol) in anhydrous DMF (15.0 mL). Yield: 75%.
Preparation of mPEG2000-g-DOTAlysine-g-PAA-b-PS Block Copolymers. The
DOTAlysine (a lysine derivative for 1,4,7,10-tetraazocyclododecane-N,N′,N″,N′″tetraacetic acid, DOTA) was grafted onto mPEG2000-g-PAA-b-PS by following a
procedure similar to that used to graft mPEG2000 (described above). To a solution of
mPEG2000-g-PAA-b-PS block copolymer (10.3 μmol) in anhydrous DMF (10.0 mL),
EDCI (11.6 mg, 39.1 μmol) and HOBt (5.3 mg, 39.3 μmol) were added and the reaction
mixture was allowed to stir for 1 h at rt. Then, a solution of DOTAlysine (trifluoroacetic
acid (TFA) salt, 23.1 mg, 39.2 μmol) and N,N-diisopropylethylamine (DIPEA, 25.4 mg,
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19.6 mmol) in anhydrous DMF (2.0 mL) was added and the reaction mixture was further
stirred for 30 h at rt. The final grafted block copolymers were isolated by transferring the
reaction mixtures to pre-soaked dialysis tubing (MWCO 6,000 to 8,000 Da) and dialyzing
against nano-pure H2O (18.0 MΩ cm) for 5 d to remove the organic solvent and the small
molecule by-products.

The aqueous solutions were then lyophilized to afford the

products as a white solid. Yield: 65%.

1

H-NMR (500 MHz, CD2Cl2 with 2 drops of

CF3CO2D, ppm): δ 1.20-2.40 (br, -CH2- and -CH- of the polymer backbone, overlap with
DOTAlysine Hs), 2.40-2.70 (br, DOTAlysine macrocyclic Hs), 3.34 (s, mPEG terminal
CH3O- Hs), 3.42-3.80 (br, mPEG backbone -OCH2CH2O- Hs), 6.16-7.11 (br, aromatic
Hs).
Micellization of mPEG2000-g-DOTAlysine-g-PAA-b-PS.

To a solution of

mPEG2000-g-DOTAlysine-g-PAA-b-PS in anhydrous DMF (ca. 1.0 mg/mL), was added
dropwise an equal volume of nano-pure H2O via a syringe pump at a rate of 15.0 mL/h,
and the mixture was further stirred for 16 h at rt. The solution was then transferred to
pre-soaked dialysis tubing (MWCO ca. 6,000 to 8,000 Da) and dialyzed against nanopure H2O for 4 d to afford a clear solution of micelles.
Construction of mPEGylated DOTA-SCKs.

To a solution of mPEG2000-g-

DOTAlysine-g-PAA-b-PS micelles in nano-pure H2O was added a solution of 2,2'(ethylenedioxy)-bis(ethylamine) in nano-pure H2O dropwise over 10 min. The reaction
mixture was allowed to stir for 2 h at rt. EDCI in nano-pure H2O was then added to the
resulting solution, dropwise via a syringe pump over 1 h. The general stoichiometry
employed to achieve 20% nominal crosslinking was 9:2.2:1 for carboxylic acid
units:EDCI:crosslinker, and to achieve 50% nominal crosslinking, the stoichiometry was

56

3.6:2.2:1. The reaction mixture was further stirred for 16 h at rt. Finally, the mixture was
transferred to pre-soaked dialysis tubing (MWCO ca. 6,000 to 8,000 Da) and dialyzed
against 5.0 mM PBS (pH 7.3, with 5.0 mM NaCl) for 5 d to remove the small molecule
by-products and afford aqueous solutions of mPEGylated DOTA-SCKs.
Preparation of SCK6.
Synthesis of mPEG50003-g-PAA57-b-PS60 Block Copolymer A similar procedure
as grafting mPEG2000 described above was followed with a relative ratio of PAA60-bPS60 block copolymer:EDCI:HOBt:mPEG5000-NH2 = 1.0:4.0:4.0:4.0.
Synthesis of mPEG50003-g-DOTAlysine2-g-PAA55-b-PS60 Block Copolymer A
similar protocol as the preparation of mPEG2000-g-DOTAlysine-g-PAA-b-PS block
copolymers described above was followed.
Micellization and crosslinking throughout the shell domain of the micelle to afford
SCK6 were carried out following the same protocol as described above.
Preparation of SCK7. Monomethoxy poly(ethylene glycol) hydroxyl terminated
(mPEG5000-OH), nominal molecular weight 5000 Da, was purified by flash column
chromatography on silica gel eluted with methanol/DCM 5:95 (v/v). Styrene and tertbutyl acrylate (t-BA) were distilled over calcium hydride prior to use.
Synthesis of Poly(ethylene glycol) Macroinitiator (mPEG5000Ini) A dry 250 mL
round bottom flask equipped with a stir bar was charged with mPEG5000-OH (16.5 g,
3.30 mmol), triethylamine (TEA, 0.70 g, 6.93 mmol), 4-dimethylaminopyridine (DMAP,
0.20 g, 1.64 mmol), and 200 mL of dichloromethane (DCM). The solution was stirred at
0 °C for 30 min after which 2-bromoisobutyryl bromide (1.52 g, 6.60 mmol) was added
drop-wise to the reaction mixture with the aid of a dropping funnel. The reaction was left
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to proceed for 24 h after which the solution was filtered and the filtrate concentrated
under vacuum. The crude reaction mixture was redissolved in 300 mL of DCM and
washed with a 10 w/w % sodium hydrogen sulfate solution (3 x 150 mL), followed by a
10 w/w % sodium bisulfate solution (3 x 150 mL). The organic phase was dried over
magnesium sulfate (MgSO4), filtered, and concentrated in vacuum. The crude product
was purified by repeated precipitation in diethyl ether from DCM. The product was
collected by filtration and dried under vacuum to give mPEG5000Ini as a white solid
(12.1 g, 71%).

1

H NMR (CDCl3, ppm): δ 1.93 (s, 6H, -CO(CH3)2-Br), 3.38 (s, 3H,

mPEG terminal CH3O- Hs), 3.42-3.80 (br, mPEG backbone-OCH2CH2O- Hs).
Synthesis of mPEG5000-b-PtBA100 Block Copolymer A dry 25 mL Schlenk flask
equipped with a stir bar was charged with t-BA (8.36 g, 65.2 mmol), mPEG5000Ini (1.0
g, 0.22 mmol), Cu(I)Br (62.0 mg, 0.43 mmol), anisole (5.0 g, 46.2 mmol), and THF (1.0
g, 13.9 mmol). After the reaction mixture was frozen in liquid nitrogen N,N,N′,N″,N″pentamethyldiethylenetriamine (PMDETA, 7.0 mg, 0.43 mmol) was added via a gas-tight
syringe. Three freeze-pump-thaw cycles were performed, and the mixture was backfilled with nitrogen and brought to rt. The flask was heated to 50 °C, and the reaction
was let to proceed for 28 h (28 % conversion), and after which it was quenched by
immersion of the reaction flask in liquid nitrogen.

The reaction mixture was then

dissolved in THF, passed through a neutral aluminium oxide column, and concentrated
under vacuum. The reaction mixture was then dissolved in THF and transferred to presoaked dialysis tubing (MWCO 6,000–8,000 Da) and dialyzed against a methanol/H2O
mixture (30:70 by volume) for 4 d to remove the residual monomer. The aqueous
solution was then lyophilized to afford the product mPEG5000-b-PtBA100 as white solid
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(2.0 g, 60 %). Mn = 20.0 kDa, Mw/Mn = 1.20. 1H-NMR (CDCl3, ppm): δ 1.20-1.70 (br,
meso and racemo -CH2- of the polymer backbone), 1.30-1.60 (br, (CH3)3C- of the tertbutyl ester), 2.11-2.40 (br, -CH- of the polymer backbone), 3.38 (s, 3H, mPEG terminal
CH3O- Hs), 3.42-3.80 (br, mPEG backbone -OCH2CH2O- Hs).
Synthesis of mPEG5000-b-PtBA100-b-PS50 Block Copolymer

A dry 25 mL

Schlenk flask equipped with a stir bar was charged with styrene (1.52 g, 14.6 mmol),
mPEG5000-b-PtBA100 (1.0 g, 0.049 mmol), Cu(I)Br (20.9 mg, 0.15 mmol), and anisole
(1.8 g, 16.7 mmol). After the reaction mixture was frozen in liquid nitrogen PMDETA
(25.0 mg, 0.15 mmol) was added via a gas-tight syringe. Three freeze-pump-thaw cycles
were performed, and the mixture was back-filled with nitrogen and brought to rt. The
flask was heated to 60 °C, and the reaction was allowed to proceed for 31 h (16.5 %
conversion), and after which it was quenched by immersion of the reaction flask in liquid
nitrogen. The reaction mixture was then dissolved in THF, passed through a neutral
aluminium oxide column, and concentrated under vacuum. The reaction mixture was
then dissolved in THF and transferred to pre-soaked dialysis tubing (MWCO 6,000–
8,000 Da) and dialyzed against a methanol/H2O mixture (30:70 by volume) for 4 d to
remove the residual monomers. The aqueous solution was then lyophilized to afford the
product mPEG5000-b-PtBA100-b-PS50 as white solid (0.88 g, 71 %). Mn = 24.0 kDa,
Mw/Mn = 1.20. 1H-NMR (CDCl3, ppm): δ 1.15-1.65 (br, meso and racemo -CH2- of the
polymer backbone), 1.30-1.60 (br, (CH3)3C- of the tert-butyl ester), 2.11-2.40 (br, -CHof the polymer backbone), 3.39 (s, 3H, mPEG terminal CH3O- Hs), 3.40-3.80 (br, mPEG
backbone -OCH2CH2O- Hs), 6.15-6.83 (br, o-Ar), 6.85-7.11 (br, m,p-Ar).

59

Synthesis of mPEG5000-b-PAA100-b-PS50 Block Copolymer A 25 mL round
bottom flask equipped with a stir bar was charged with mPEG5000-b-PtBA100-b-PS50
(250 mg, 0.010 mmol), 5 mL of DCM and 5 mL of TFA. The reaction was left to
proceed at rt for 24 h after which it was concentrated under vacuum. The crude product
was then dissolved in THF and transferred to pre-soaked dialysis tubing (MWCO 6,000–
8,000 Da) and dialyzed against nano-pure H2O (18.0 MΩ cm) for 4 d to remove small
molecule impurities. The aqueous solution was then lyophilized to afford the product
mPEG5000-b-PAA100-b-PS50 as white solid (0.18 g, 95 %). 1H-NMR (DMSO-d6, ppm):
δ 1.10-2.05 (br, meso and racemo -CH2- of the polymer backbone), 2.11-2.21 (br, -CHof the polymer backbone), 3.30 (s, 3H, mPEG terminal CH3O- Hs), 3.42-3.90 (br, mPEG
backbone -OCH2CH2O- Hs), 6.12-6.80 (br, o-Ar), 6.90-7.20 (br, m,p-Ar), 11.0-14.0 (br, COOH).
Synthesis of mPEG-b-(DOTAlysine7-g-PAA93)-b-PS50 Block Copolymer Grafting
of the DOTAlysines onto mPEG5000-b-PAA100-b-PS50 by amidation was achieved by
the same procedure as described above.
Micellization and crosslinking throughout the shell domain of the micelle to afford
SCK7 were carried out following the same protocol as described above.
General Method for
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Cu Labeling. A solution of mPEGylated DOTA-SCK (ca.

0.2–0.3 mg/mL) in 5.0 mM PBS (pH 7.3, with 5.0 mM NaCl) was diluted with an equal
volume of 0.1 M ammonium acetate buffer (pH 5.5) and
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Cu-acetate (ca.30–500 μCi)

was added. A Tween-20 solution in PBS was added to prevent non specific adsorption of
the labeled nanoparticles on the labeling vials and other laboratory glassware (0.1%
Tween-20, v/v, in the final solution). The labeling mixtures were incubated at 43 °C for
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1 h, and then 5 μL of a 10 mM aqueous diethylenetriaminepentaacetic acid (DTPA)
solution was added. The sample was allowed to incubate for 10 min at rt. The purity of
the labeled samples was monitored by radio-ITLC using a 1:1 mixture (v/v) of 10 wt%
ammonium acetate and methanol as developing solvent. The samples were filtered
through 0.45 μm PVDF filters (Millipore Corp., Medford, MA). Samples with < 95 %
radiochemical purity (RCP) were purified by using size exclusion cartridges (Zeba spin
desalting column 2 mL, Pierce). Using 10 mM PBS (pH 7.4) as elute (up to 500 μL total
volume of sample and PBS). The Zeba column has > 95% retention of salts and other
small molecules (MW < 1000 Da) and tends to retain excess of DTPA. Tween-20 with
MW around 1,200 Da may also retain under this conditions. Since the eluted sample was
diluted for at least five times the reaction volume no more than 0.02% of Tween-20 was
injected. FPLC analysis was used to determinate the purity of the injected samples. The
purified samples were diluted with 10 mM PBS (pH 7.4) to prepare appropriate doses for
bidistribution and imaging studies.
General Method for FPLC Analysis.

A 50–100 μL of the labeled SCK was

injected into a Superose 12 gel filtration column (GE Healthcare Biosciences) and eluted
with 20 mM 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) with 150 mM
NaCl (pH 7.3) at 0.8 mL/min. The UV wavelength was preset to 280 nm and the
radioactivity was monitored by an in-line radio-detector. Under these conditions, the
retention times of the native and radiolabeled SCKs were 10 min while the retention
times of free
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Cu and

64

Cu-DTPA were 20–22 min. Samples with RCP > 95% were

used for animal studies.
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General Method for Specific Activity Measurement. A 100 μL of mPEGylated
DOTA-SCK solution (ca. 0.2–0.3 mg/mL) in 5.0 mM PBS (pH 7.3, with 5.0 mM NaCl)
was diluted with 100 μL of 0.1 M ammonium acetate buffer (pH 5.5) and to this solution,
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Cu-acetate was added (ca. 1 mCi). The resulting solution was incubated at 43 °C for 2

h, and then subjected to DTPA challenge. The labeling yield was determined by radioTLC on ITLC-SG plates using methanol/CH3CO2NH4 (aq) as eluent. The number of
effective DOTAlysines/polymer chain was determined by isotopic dilution experiments.
A series of known amounts of “hot plus cold” copper (Cu2+ solution spiked with
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Cu)

were added to 100 μL SCK solution aliquots. After 2 h incubation at 43 °C and DTPA
challenge, each solution was analyzed by radio-ITLC to determine the number of
effective DOTAlysine per polymer chain, as previously reported.39
Biodistribution and small animal PET imaging studies of PEGylated SCKs. All
animal studies were performed in compliance with guidelines set by the Washington
University Animal Studies Committee. Normal female Sprague-Dawley rats (180–200 g,
n = 4 per time point) were anesthetized with 1–2% vaporized isoflurane and injected with
ca. 30 μCi of activity in 200 μL via the tail vein (ca. 20–25 μg/kg rat body weight). At
specific time points post injection, organs and tissues of interest were harvested, blotted
dry, and the radioactivity was measured in a Beckman gamma-counter 8000 (Beckman
instrument, Irvine, CA). For blood and muscle, total activity was calculated assuming
that these tissues constitute 6 and 41% of the total body weight, respectively. Diluted
standard doses (1:100) were prepared and counted along with the samples. All the data
were corrected for 64Cu decay. The percent injected dose per gram tissue (%ID/g) values
were calculated using the following equation:
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%ID/g =

(cpm in sample − background ) × 10 2
(decay correction factor ) × (sample weight ) × (cpm in standard )

One-way analysis of variance (ANOVA) and post-hoc multiple comparison
(Bonferroni’s t-test) on the biodistribution data were performed by using Prism v. 4.00
(Graphpad, San Diego, CA).

Groups with P < 0.05 were considered significantly

different.
Normal female Balb/c mice (n = 2) weighing 20–30 g were injected with ca. 100–200
μCi of
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Cu-labeled SCK (0.15–0.3 mg/kg mouse body weight) in 150 μL via tail vein

and anesthetized with 1–2% vaporized isoflurane for data collection at specific time
points.

MicroPET and microCT image co-registration was accomplished using a

landmark registration technique (by using fiducial markers directly attached to the animal
bed) and AMIRA image display software (TGS Inc., Richmond, TX). Data analysis of
microPET images was performed using the manufacturer software (ASIPRO, Siemens
Medical Solutions). Data were calculated in terms of standardized uptake values (SUVs)
in 3D regions of interests (ROIs) using the following equation:
SUV =

Radioactiv ity Concen tration in ROI [ μCi/cc]
Injected D ose [ μCi]/Animal Weight [g ]

Results and Discussion
Previous in vivo evaluation of SCKs led to the hypothesis that both size and core
composition played a synergistic role in influencing the blood circulation times, while
surface chemistry (i.e., PEGylation) was shown to have little effect on particle
biodistribution.39 However, the synthetic route for the introduction of PEG onto preestablished particles allowed for neither reliable reproducibility, because of the
63

complexity of aqueous amidation chemistry,43 nor accurate quantification of the degree of
PEGylation, unless chromophore-functionalized PEG was used.44 In more recent studies,
we have developed a new “pre-grafting” strategy, which couples the desired
functionalities (metal chelators) onto block copolymer precursors from which SCKs are
assembled.42

This methodology was shown to provide functionalized SCKs with

enhanced labeling for potential application in molecular imaging. Herein, the “pregrafting” strategy is applied to attach an accurate number of PEG chains onto the SCKs.
The stealth properties of these nanoparticles were evaluated in vivo by means of
biodistribution experiments and small animal PET imaging, focusing our attention on
blood retention and accumulation in the main MPS organs (liver and spleen). The results
indicate that “pre-grafting” is a facile and practical method to obtain various degrees of
PEGylated SCKs, making it feasible to retain the SCKs in blood up to 48 h after
intravenous administration. At the same time, pre-conjugation of chelators for 64Cu (t1/2
= 12.7 h; β+ = 17.8%, Emax = 0.653 MeV), such as DOTA, followed by radiolabeling
affords SCKs with high specific activity (greater than 100 μCi/µg polymer), which can be
useful for PET imaging when signal intensity is of concern (i.e., when targeting low
abundance molecular targets).
Construction of mPEGylated DOTA-SCKs with High 64Cu Specific Activity.
Mono-amine terminated methoxyPEG (mPEG-NH2, Mn = 2,000 Da, PDI = 1.06) and
DOTAlysine (a lysine derivative of DOTA for
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Cu chelation),42,

43, 45

were grafted

sequentially onto PAA60-b-PS60 block copolymer through conventional amidation
chemistry in organic solvent (Figure 3.1, and see Experimental Section) with ca. 75% and
65% isolated yield, respectively. The numbers of mPEG grafts per block copolymer
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chain were varied by the stoichiometry of mPEG-NH2 vs. PAA60-b-PS60, and were
determined by 1H NMR spectroscopy for three samples as 1.0 (16 wt %), 2.5 (32 wt %),
and 5.5 (51 wt %), respectively, using the proton resonances at 3.6-3.8 ppm (mPEG
ethylene oxide backbone Hs) and 3.34 ppm (terminal methoxy Hs). The number of
DOTAlysines (ca. 2 per polymer chain, determined by comparison of the integration area
of the aliphatic proton resonances at δ 1.20 – 2.70 ppm vs. the polystyrene aromatic
protons resonating at 6.16-7.11 ppm, before and after DOTAlysine grafting) was held
constant for all samples, as confirmed by 1H NMR spectroscopy.

Such extents of

DOTAlysine grafting was shown to be sufficiently high for effective 64Cu complexation,
while also being sufficiently low to allow polymer assembly into a globular morphology
during the block copolymer micellization process.42

Figure 3.1. Schematic drawing of the synthetic route for the construction of
mPEGylated SCKs.
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The preparation of mPEGylated SCKs from these mPEG2000-g-DOTAlysine-gPAA-b-PS block copolymers was conducted by following an established standard
protocol (Figure 1, and see Experimental Section).42, 43 These SCKs were characterized
by DLS, TEM, and zeta potential measurements (Figure 3.2 and Table 3.1). Compared
with the non-mPEGylated SCK1, mPEGylated SCK2-5 showed similar particle sizes and
nearly spherical morphology with relatively narrow polydispersity, which allowed for
estimation of nanoparticle surface PEG density (vide infra).
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Cu-labeled SCK1-5 were

obtained with high specific activities (> 100 μCi/μg polymer), which enabled the
administration of low doses to normal rodents (ca. 5 μg per animal) for the in vivo
studies.

Figure 3.2. TEM characterization of PEGylated SCKs. a) TEM micrograph of SCK1
(after negative stain with PTA). b) TEM micrograph of SCK2 (after negative stain with
PTA). c) TEM micrograph of SCK3 (after negative stain with PTA). d) TEM
micrograph of SCK4 (after negative stain with PTA).
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Table 3.1. Physical properties of mPEGylated DOTA-SCKs. SCK1-6 originated from
mPEGx-g-DOTAlysine2-g-PAA58-x-b-PS60 block copolymer precursors, according to
Scheme 1. SCK7 originated from a triblock copolymer of mPEG-b-(DOTAlysine7-gPAA93)-b-PS50.

SCK1

mPEG2000
/Chain, x
0

DOTA
/Chain
2.0

Crosslinking
Extentsb
20%

(Dh)nc
(DLS, nm)
21 ± 3

Davd
(TEM, nm)
16 ± 2

Zeta Potential
(mV)
-38.5 ± 0.8

SCK2

1.0

2.0

20%

20 ± 4

16 ± 2

-40.9 ± 0.6

0.20

SCK3

2.5

2.0

20%

19 ± 4

14 ± 3

-31.9 ± 1.3

0.21

SCK4

5.5

2.0

20%

20 ± 4

14 ± 2

-30.2 ± 0.5

0.20

SCK5

5.5

2.0

50%

20 ± 4

15 ± 2

-20.8 ± 0.5

0.20

SCK6

3.0f

2.0

20%

21 ± 4

16 ± 2

-14.6 ± 0.6

0.19

SCK7

1.0

7.0

20%

22 ± 2

18 ± 2

-14.1 ± 1.3

0.09

Samplea

Polydispersity
0.14

a

Sample concentrations were 0.20-0.30 mg/mL in 5 mM PBS buffer (pH 7.2 with 5 mM
NaCl). b These values are based on the stoichiometry used during the crosslinking
reaction. c Number-average hydrodynamic diameters. e Dav were measured for the SCK
core domains, for at least 150 particles. f mPEG5000 was used instead of mPEG2000.
Semi-Quantitative Model for Estimation of mPEGylated SCK Surface
Coverage. Although quantitative values can be obtained for self-assembled monolayers
from grafted polymers on flat substrates,46-56 the actual density of coverage for a
nanostructure with a high degree of surface curvature is an unknown parameter. Given
the radius of gyration (Rg) of mPEG2000 (about 1.8 nm57), and the shell thickness of the
nanoparticles (ca. 2.0 to 3.0 nm, based upon the DLS and TEM measurements), a
hypothesis could be made that almost all of the terminal portions of the mPEG chains
were exposed around the periphery of the mPEGylated SCKs, due to the fact that the
thickness of the shell domain is less than 2×Rg. The glassy PS block, which forms the
hydrophobic core domain during the micellization process, was selected based upon the
results from previous investigations39, 43, 58 that found the nanostructures to exist as rigid
spheres that underwent little structural deformation, even upon adsorption onto a solid
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substrate.58 Therefore, the PS-core SCKs should experience low degrees of structural
deformation in rapidly flowing capillaries in vivo, so that they can be modeled as spheres.
The surface coverage could be expressed via the average distance (D, see Figure 3.1
insertion for illustration) between the exposed mPEG molecules,47 which was calculated
through the following equation:

D=

π ( Dh) 2
N

nm

where N denotes the number of mPEGs per SCK nanoparticle (obtained from the number
of mPEGs per polymer chain and the aggregation number of polymer chains estimated to
be within each SCK nanoparticle), and Dh is the hydrodynamic diameter of the
corresponding SCK.
The results calculated based upon this hypothesis, summarized in Table 3.2, were
consistent with zeta potential measurement data (Table 3.1). As expected, a decrease in ζ
value (SCK3 vs. SCK2) was observed as the mPEG surface coverage increased
(decreased D values), indicating that both the surface negative charges and the mobility
decreased.59 The similar ζ values for SCK4 and SCK3, in spite of a two-fold increase in
mPEG grafts for SCK4 with respect to SCK3, might be associated with near complete
surface coverage and/or reduced mPEG conformational degrees of freedom after a certain
number of mPEG2000 grafts per polymer chain. As expected, the consumption of a
higher number of carboxylic acid groups during the crosslinking process resulted in a
dramatic decrease of surface charge for SCK5 compared to SCK4.
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Table 3.2. Calculation of mPEG2000 surface coverage of mPEGylated SCK1-4, which
originated from mPEG2000x-g-DOTAlysine2-g-PAA58-x-b-PS60 block copolymer
precursors, according to Figure 3.1.
Sample

a

SCK1
SCK2
SCK3
SCK4

mPEGa
/Chain
0
1.0
2.5
5.5

Dav
(nm)
16 ± 2
16 ± 2
14 ± 3
14 ± 2

Nagg
240
240
200
200

mPEGa
/SCK
0
240
500
1100

Dh
(nm)
21 ± 3
20 ± 4
19 ± 4
20 ± 4

Stb
(nm2)
1390 ± 130
1260 ± 160
1140 ± 140
1260 ± 160

(St/mPEG)c
(nm2)
0
5.3 ± 0.7
2.3 ± 0.3
1.2 ± 0.2

Dd
(nm)
0
2.3 ± 0.2
1.5 ± 0.1
1.1 ± 0.1

mPEG2000. b Surface area of mPEGylated SCKs. c Surface area per mPEG chain at
the periphery of the SCK. d Average distance between mPEG chains at the periphery of
the SCK.
Stealth Property of mPEGylated SCKs.

Although the influence of

mPEGylation on SCK biodistribution cannot be predicted by simply evaluating the SCK
surface PEG coverage, these calculations provided the rationale to explain the dramatic
differences observed in vivo. From the calculations performed by de Gennes and coworkers,47, 48 the value of D should be ca. 1 nm to oppose the adsorption of small proteins
(diameter ca. 2 nm) and ca. 1.5 nm for larger proteins (diameter ca. 6-8 nm). Therefore,
no or low PEG surface coverage would result in no resistance to opsonization, which can
explain the rapid disappearance of SCK1 (no PEG) and SCK2 (D = 2.3 ± 0.2 nm) from
the blood circulation (< 0.5 percent injected dose per gram (%ID/gram) at 10 min post
injection) and their rapid uptake in the liver and spleen (Figure 3.3A). The mPEG
surface coverage of SCK3 (D = 1.5 ± 0.1 nm) is, theoretically, effective in limiting the
adsorption of large proteins but not that of small ones. In fact, SCK3 exhibited a slightly
longer blood retention (1.2 ± 0.2 %ID/gram at 10 min post injection) compared to SCK1
and SCK2 but was eliminated within one hour from the administration, and accumulated
in the liver and spleen. To maintain the SCKs in circulation, an exceptionally high
amount of PEG is required, as confirmed by the in vivo behavior of SCK4 (D = 1.1 ± 0.1
nm).
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Figure 3.3. Biodistribution data for 64Cu-labeled mPEGylated SCKs (which originated
from mPEG2000x-g-DOTAlysine2-g-PAA58-x-b-PS60 block copolymer precursors,
according to Scheme 1) in Sprague-Dawley rats (ca. 25 μg/kg rat body weight). Data are
expressed as percent injected dose per gram (%ID/gram) ± one standard deviation (n = 4;
ANOVA, p < 0.0001; *: p < 0.05, compared to SCK5). (A) Biodistribution of SCK1-4
at 10 min and 1 h post injection. (B) Biodistribution of SCK4 up to 48 h post injection.
(C) Biodistribution of SCK5 up to 48 h post injection.

In fact, the presence of approximately 1100 mPEG2000 grafts per nanoparticle
led to a nearly full surface coverage for SCK4, and gave a high retention in blood over
the first few hours after administration (2.3 ± 0.1 %ID/gram at 4 h) and an effective
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clearance thereafter (0.2 ± 0.1 %ID/gram at 48 h post injection, Figure 3.3B). The
prolonged circulation is the result of a low MPS uptake, reasonably due to slow
opsonization and recognition by the macrophages of liver and spleen (up to 75% less
dose in liver and spleen with respect to SCK1 at 48 h post injection). As a note, the
nonspecific binding of nanoscale objects with large vascular carrier proteins and red
blood cells60 might also play important roles for the in vivo fate of the SCKs. However,
the latter issue could also be reduced because of the sufficient surface PEG coverage,
which also directly related with their charge characteristics. No significant uptake in
lung, muscle and kidney was detected.
mPEG Length Effect on Biodistribution. Besides surface graft density, the

length of the mPEG grafts has been reported to be of paramount importance in order to
maintain nanoparticles in the blood stream.28, 30, 35, 41, 47, 61 Therefore, to assess whether
PEG length effects also apply to SCKs, mPEGylated SCKs (SCK6) from mPEG50003-gDOTAlysine2-g-PAA55-b-PS60 block copolymer precursors were prepared,
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Cu-labeled

and tested in normal rodents (Figure 3.4). The use of mPEG5000 grafts produced a
longer nanoparticle blood circulation time and a lower liver uptake compared to the
mPEG2000-containing analog with similar grafting density (SCK3). However, relative
to SCK3, higher splenic accumulation was observed for SCK6 at both considered time
points. Noticeably, at 1 h, a nearly two-fold increase in spleen uptake was observed.
Furthermore, clearance of SCK6 from the bloodstream was faster than that observed for
the SCKs with higher surface density of mPEG2000 grafts (SCK4 and SCK5). The
observation that PEG grafting density is more important than PEG length is supported by
a recently report from Li and coworkers62 on long circulating core crosslinked
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nanoparticles (t1/2,β = 46.2 h) with hydrophilic shell domains constructed from very short
PEG chains (nine ethylene oxide repeating units)

Figure 3.4. Biodistribution data of 64Cu-labeled SCK3, 4, (from mPEG2000-gDOTAlysine-g-PAA-b-PS block copolymer precursors) and 6 (from mPEG5000-gDOTAlysine-g-PAA-b-PS block copolymer precursors) in Sprague-Dawley rats (ca. 25
μg/kg rat body weight) at 10 min and 1 h post injection. Data are expressed as percent
injected dose per gram (%ID/gram) ± one standard deviation (n = 4).
mPEG Location: Block Copolymer Structural Backbone vs. Pendent Grafts.

A different approach for constructing PEGylated nanoparticles from triblock copolymers
containing one PEG chain as the terminal unit (SCK7, Figure 3.5) could not achieve the
prolonged blood circulation time obtained for SCK4-6 (Figure 3.5C). From the intrinsic
properties of PEG and the SCK PS core domain, as reported by Caldwell et al.,63 a
portion of the PEG chains may adsorb onto the PS core and not extend to the nanoparticle
surface. The multiple PEG grafts in SCK4-6 provides an excess for PEG coverage of the
surface. Moreover, a combination of short and long PEG segments can be expected to
extend from the surface of SCK4-6, based upon the chemical methodology used for the
preparation of these particles which involved the introduction of mPEG along the block
copolymer hydrophilic chain segment prior to nanoparticle assembly. In fact, a mixture
of mPEG lengths have been found to provide a more effective steric barrier against
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protein adsorption compared to a homogeneous population of longer chains.64, 65 Further
studies are needed in order to correlate the improved biodistribution for the SCKs, with
the combination of effects such as the variation in mPEG chain length, decreased
negative charge, increased nanoparticle rigidity, decreased mobility, and conformational
degrees of freedom66 for the mPEG grafts.

Figure 3.5. Preparation, TEM characterization, and in vivo evaluation of SCK7. (A)
Schematic drawing of the preparation of SCK7 from DOTA7-g-PEG5000-b-PAA93-bPS50. (B) TEM micrograph of SCK7 (after negative stain with PTA). (C)
Biodistribution of 64Cu-labeled SCK7 in Sprague-Dawley rats (ca. 25 μg/kg rat body
weight; data are expressed as percent injected dose per gram (%ID/gram) ± one standard
deviation, n = 4).
Crosslinking Extents (Surface Property) Effects.

The influence of shell

crosslinking extents on SCK bioavailability was also investigated. In general, increasing
the crosslinking extent provides a more robust nanostructure with fewer negative charges
(carboxylates) remaining on the surface. A slightly anionic surface was found to exert
beneficial effects on nanoparticle blood circulation and MPS sequestration due to a
reduction of non-specific binding of plasma opsonins.67 However, high surface charge
was found to have negative impact on the biodistribution, and several studies have
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concluded that neutral particles exhibit lower rates of opsonization.15, 16, 68 SCK5 having
ca. 50% surface charge reduction relative to SCK4, exhibited significantly higher
retention in blood and lower accumulation in liver and spleen compared to SCK4 at each
time point evaluated (Figure 3.3C).
Small Animal PET Imaging Evaluation. Except for the spleen uptake, the

results of small animal PET imaging (Figure 3.6A-3.6F and Table 3.3) showed a general
concordance with the biodistribution findings. Little activity was detected in the heart of
normal mice injected with 64Cu-labeled SCK1 at 4 and 24 h post injection (Figure 3.6A3.6B), suggesting that no significant amounts of particles were circulating in blood at
these time points. On the contrary, when imaging mice injected with 64Cu-labeled SCK4
(Figure 3.6C-3.6D) and SCK5 (Figure 3.6E-3.6F), the heart of the mice was clearly
visible up to 4 and 24 h post injection, respectively, as a consequence of the long blood
retention. No significant activity was detected in kidneys and bladder of all the mice
used for the imaging study, due to the lack of urinary excretion, while the presence of
diffuse signal in the abdominal area suggested slow elimination through the intestine.
Interestingly, SCK5 exhibited the highest splene standardized uptake value (SUV)
among the evaluated particles, suggesting high splenic uptake. This contradictory result
between biodistribution and PET data is possibly due to a different interaction between
nanoparticles and macrophage receptor populations in different animal species (rat vs.
mouse).16
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Figure 3.6. Co-registered small animal PET/CT images (coronal slices) of Balb/C mice
(n = 2) injected with 64Cu-labeled, mPEGylated SCKs (ca. 100 – 200 μCi of 64Cu-labeled
SCKs (0.15 – 0.3 mg/kg mouse body weight in 150 μL via tail vein). (A-B) SCK1 at 4
and 24 h post injection, respectively. (C-D) SCK4 at 4 and 24 h post injection,
respectively. (E-F) SCK5 at 4 and 24 h post injection, respectively. The image intensity
is decay corrected and scaled by max/min frame. White arrows indicate heart, liver and
spleen.
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Table 3.3. Comparative organ-by-organ standardized uptake values (SUVs) for the 64Curadiolabeled SCKs from the quantitation of small animal PET images in normal Balb/c
mice.
SUVa
Heart
Liver
Spleen
Sample
b
4 h p.i
24 h p.i
4 h p.i
24 h p.i
4 h p.i
24 h p.i

0.5 ± 0.1
8.3 ± 1.5
5.4 ± 0.8
1.9 ± 0.4
1.8 ± 0.4
SCK1 0.3 ± 0.1
1.7 ± 0.3
4.9 ± 0.3
5.1 ± 0.1
2.6 ± 0.1
2.3 ± 0.2
SCK4 4.2 ± 0.9
2.5 ± 0.5
5.3 ± 0.2
4.7 ± 0.1
4.0± 0.4
4.5 ± 0.5
SCK5 4.6 ± 0.1
a
Data were obtained from 3D regions of interest in the selected organs, and are presented
as mean SUV ± standard deviation. b Post injection.
Conclusions

In summary, we have employed a facile “pre-grafting” strategy to attach mPEG
chains and DOTA chelators onto SCKs and their in vivo behaviors have been studied
after
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Cu radiolabeling.

It is clear that mPEGylated SCKs exhibited longer blood

circulation, in comparison to non-mPEGylated analogs. More importantly, the blood
retention of these nanoparticles correlated well with the densities of mPEG grafts on the
particle surfaces, which were controlled by the stoichiometry during the chemical
modifications of the diblock copolymer precursors used for the construction of these
nanoparticles. The study of in vitro interaction of plasma protein with mPEGylated
SCKs and the development of mPEGylated SCKs bearing radionuclides and further
labeled with high affinity targeting ligands and filled with therapeutic agents, as multifunctional devices for PET imaging-based diagnosis and monitoring of various disease
states and their regression, are in progress.
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Chapter 4

A Fundamental Investigation of Cross-linking Ffficiencies within
Discrete Nanostructures: Using the Cross-linker as a Reporting
Molecule
[Portions of this work have been previously published as Guorong Sun, Nam S. Lee,
William L. Neumann, John N. Freskos, Jeng J. Shieh, Richard B. Dorshow and Karen L.
Wooley Soft Matter 2009, accepted.]

Abstract
Various bi-functional pyrazine-based chromophores were used as cross-linkers to
probe directly the efficiencies of their incorporation into the shell of block copolymer
micelles. In addition, the block copolymer micelles were made to carry pre-installed
reactive functionalities along the central block of an amphiphilic triblock copolymer.
Unique photo-physical characteristics were observed, depending upon the type of
pyrazine cross-linker, the conditions used for cross-linking and the stoichiometries
applied.
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Introduction
During the past decade, nano-scale micelles assembled from amphiphilic block
copolymer precursors have attracted much attention due to their promising applications in
the field of nanomedicine,1-12 ranging from controlled delivery of diagnostic and
therapeutic agents, to targeting of specific diseases and reporting of biological
mechanisms via introduction of various functionalities.6, 13 However, the thermodynamic
stability of such nano-assemblies is only achieved above the critical micelle
concentration and their stability in vivo is, therefore, of concern. To overcome this
potential limitation, covalent cross-linking throughout the shell/core domain of micelles14,
15

has been developed and demonstrated as an effective methodology for creating robust

nanoscale objects that are capable of sustaining dilution.
The advantage of cross-linking is highlighted also through recent reports that core
cross-linking could enhance the cargo “holding” ability of nanostructures16 and the
observation that increasing shell cross-linking extents prolonged the blood retention time
of nanoparticles.17 Moreover, the cross-linker can bring diverse functionality to the
nanostructure, in addition to its structural role.18,

19

While utilization of cross-linking

technology grows rapidly in nano science,20-26 the factors associated with their
incorporation require detailed studies to provide fundamental insights for quantification
and optimization. Herein, we report our investigations of the reaction efficiency during
the shell cross-linking process by varying the cross-linker structures and properties.
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Results and Discussion
In this current work, we were interested in building on previous studies, which
have revealed that the surface chemistry, cross-linking extent and internal composition of
nanoparticles are important parameters for their ultimate properties and potential
biological utility. We also intended to advance the chemical methodologies and improve
the efficiencies involved in the self assembly and cross-linking of amphiphilic block
copolymers that lead to the preparation of well-defined nanoscale objects. Among the
cross-linked nanostructures, shell cross-linked knedel-like (SCK) nanoparticles
constructed from shell cross-linking with diamino cross-linkers throughout the
poly(acrylic acid)-block-polystyrene (PAA-b-PS) micellar PAA shell domain (corona),
via carbodiimide-mediated amidation, is one of the earliest and most highly-studied
examples.17,

27-31

While this strategy has been highly successful under controlled

conditions, we felt that the activation efficiency of AA residues with the carbodiimide
reagents under aqueous conditions could be a point for refinement. Therefore, the acrylic
acid residues were replaced with pre-activated N-acryloxysuccinimide (NAS) groups.
Because the NAS units are of lower hydrophilicity than are AA groups, the addition of a
terminal hydrophilic block segment was required to create an amphiphilic block
copolymer structure and allow for facile aqueous-phase assembly. This design led to a
triblock copolymer structure, poly(ethylene oxide)-block-poly(N-acryloxysuccinimide)block-polystyrene (PEO-b-PNAS-b-PS), containing terminal PEO and PS blocks as
89

hydrophilic and hydrophobic segments, respectively, to drive the assembly, and a central
block segment having building blocks from AA active ester monomers (NAS) as preinstalled and pre-activated amidation sites. This triblock copolymer was established and
exploited for the construction of functionalizable cross-linked nanoparticles (Figure 4.1).
Three pyrazine-based cross-linkers with pendant functionalized amines (Figure 4.1
insertion) were designed as unique UV-vis active probes to report the extent of their
incorporation during the cross-linking reactions.

Figure 4.1. Schematic drawing of the synthetic route for the construction of SCK
nanoparticles, having a PEO corona, an internal shell cross-linked via the UV-active
pyrazine cross-linkers, and a hydrophobic PS core.
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The triblock copolymer was synthesized by two sequential reversible additionfragmentation chain transfer (RAFT) polymerizations6,

7,

32

from a PEO-based

macromolecular chain transfer agent (macro-CTA). Beginning from a mono-methoxyterminated PEO45-macro-CTA, chain extension with the NAS monomer was conducted
using azobisisobutyronitrile (AIBN) as initiator in 1,4-dioxane ([NAS]0 = 1 M,
[macro-CTA]0:[AIBN]0:[NAS]0 = 1:0.05:100) at 60 ˚C. This procedure was a slightly
modified protocol from the reported RAFT polymerization of NAS.33-35 The rate of NAS
polymerization was still found to be rapid (ca. 90% conversion after 1.5 h).

Gel

permeation chromatography (GPC) analysis (Figure 4.2a, upper chromatogram) of the
isolated diblock copolymer (after precipitation in diethyl ether) exhibited a mono-modal
molecular weight distribution with a polydispersity index (PDI) of 1.3. Successful chain
extension of the PNAS block (resonances at 1.78 to 2.20, 2.78, and 3.17 ppm) and
maintenance of the RAFT agent chain-end group (resonances at 0.80, 1.10, 1.20, and 1.30
ppm) were confirmed by

1

H NMR spectroscopy (Figure 4.2b).

The controlled

polymerization was supported further by the experimental molecular weight, as measured
by NMR spectroscopy (Mn,NMR = 18,400 Da), being consistent with the theoretical
molecular weight (Mn,theo = 17,600 Da). Chain extension by styrene polymerization to
afford the triblock copolymer also proceeded with control, indicating the retention of the
chain end activity. The fact that no residual diblock PEO-b-PNAS macro-CTA was
observed along the GPC profile of the triblock copolymer with PS as the third block
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(Figure 4.2a, lower chromatogram, and Figure 4.2c, Mn,NMR = 24,700 Da and PDI = 1.2)
demonstrated its well-defined structure.

Figure 4.2. Characterizations of PEO45-b-PNAS95 and PEO45-b-PNAS95-b-PS60 block
copolymer precursors. a): DMF-GPC profiles of PEO45-b-PNAS95 (top) and PEO45-bPNAS95-b-PS60 (bottom) block copolymers. b): 1H NMR spectrum of PEO45-b-PNAS95.
c): 1H NMR spectrum of PEO45-b-PNAS95-b-PS60.

Micellization of the PEO45-b-PNAS95-b-PS60 triblock copolymer was conducted
by adding water (selective solvent for PEO) to the block copolymer precursor solution in
N,N-dimethylformamide (DMF, common solvent for all three blocks, ca. 1.0 mg/mL).
Water was added to initialize micellization until 50 wt% of water content was achieved
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within 2 h.

The micelles were then directly characterized through dynamic light

scattering (DLS), transmission electron microscopy (TEM), and atomic force microscopy
(AFM). The results from DLS measurements showed that these micelles had narrow size
distributions (Figure 4.3a-c) with a number-averaged hydrodynamic diameter of 74 ± 12
nm. By TEM (Figure 4.3d), the micelles were observed to have uniform diameters (Dav =
25 ± 1 nm), and they also had uniform heights (Hav = 20 ± 2 nm), as observed by AFM
imaging (Figure 4.3e).

Figure 4.3. DLS, TEM and AFM data for the PEO45-b-PNAS95-b-PS60 micelles in
DMF/H2O (v/v = 1:1). DLS (a-c): histograms of micelle intensity-averaged, volumeaveraged, and number-averaged hydrodynamic diameter size distributions, respectively.
TEM (d): stained negatively with phosphotungstic acid. AFM (e): cast onto mica by
spin-coating.
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Pseudo in situ cross-linking experiments were performed after the micelle
formation (see Experimental Section for details), although some amount of hydrolysis of
NAS had already been occurring during the micellization process. Three nominal crosslinking extents (20%, 50%, and 100%, based upon the stoichiometric ratios of crosslinker vs. initial theoretical NAS residues, i.e., 0.1 eq, 0.25 eq, and 0.5 eq, respectively)
were studied. After incubating the micelle with the cross-linker at room temperature for
48 h, the un-reacted cross-linker, DMF, and small molecule by-products were removed
through extensive dialysis against pH 7.2 PBS buffer (5 mM with 5 mM NaCl). As a
note, a different work-up protocol was applied for the SCK nanoparticles prepared from
cross-linker 3, which involved multiple steps of dialysis due to its cationic character and
electrostatic attraction to the nanostructures (see Experimental Section for details and
vide infra).
Unusual photophysical effects were observed upon coupling of the UV-active
cross-linkers into the micellar nanostructure framework. As depicted in Figure 4.4, for
all three systems, the UV-vis maximum absorbance peaks of the pyrazine units within the
SCKs at nominal 20% cross-linking extents clearly showed blue shifts of ~ 30 nm (from
433 nm to 400 nm) for SCKs derived from 1 and 2 vs. the small molecule cross-linkers or
the small molecule cross-linkers mixed with PEO-b-PAA-b-PS micelles. For 3, the blue
shift was increased to ~ 45 nm (from 441 nm to 395 nm). These phenomena were
observed also for the SCKs prepared from 1 and 2 with nominally 50% cross-linking, in
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which the blue shifts were reduced to ~ 10 nm. For SCK3 and SCK7 at nominally 100%
cross-linking and SCK8 (prepared from 3 at nominally 50% cross-linking), no obvious
peak shifts were noticed.
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Figure 4.4. UV-vis absorbance and fluorescence emission profiles of SCKs constructed
from cross-linking of PEO45-b-PNAS95-b-PS60 micelles with cross-linkers 1-3 at nominal
20%, 50%, and 100% cross-linking extents. a): UV-vis (left) and fluorescence (right)
spectra of SCKs prepared from cross-linking with 1 at nominal 20% (solid), 50%
(dashed), and 100% (dotted) cross-linking extents, respectively. b): UV-vis (left) and
fluorescence (right) spectra of SCKs prepared from cross-linking with 2 at nominal 20%
(solid), 50% (dashed), and 100% (dotted) cross-linking extents, respectively. c): UV-vis
(left) and fluorescence (right) spectra of SCKs prepared from cross-linking with 3 at
nominal 20% (solid), 50% (dashed), and 100% (dotted) cross-linking extents,
respectively.
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We hypothesized that the blue shift might be related to functional group
transformations of the aromatic amines on the pyrazine moiety, if they were to participate
in reactions with the NAS units. While heteroaryl amines are very weakly basic and
correspondingly weak nucleophiles, they may participate in coupling reactions due to
effects of the nanoenvironment (e.g. proximity and potential desolvation of partially
coupled linker arms within the shell structure). Once the amides form with the aryl
amines, the energy gap between the ground and excited states would be increased due to
the excess stabilization effect applied to the ground state, caused by the decrease in
electron density on the pyrazine ring with the appearance of electron-withdrawing
amides.

This hypothesis was partially supported by the cross-linker incorporation

efficiency results (vide infra) since the blue shift was only observed for SCKs in which
less than 30% of the total NAS residues were consumed by the aliphatic amino groups
(over 50% of NAS groups remaining) during the cross-linking process. By contrast, the
control SCK nanoparticle (SCK10), cross-linked at 20% with 3 through our
“conventional” synthetic approach,17,

19, 27-30

did not exhibit the blue shift of the

maximum absorbance peak (Figure 4.5a). This result serves as additional evidence for
our hypothesis, since the carbodiimide-mediated amidation was carried out under
conditions

in

which

the

coupling

reagent

(1-[3’-(dimethylamino)propyl]-3-

ethylcarbodiimide methiodide, EDCI) was limited to 20 mol% of the AA residues.
Therefore, the formed intermediates would be dominantly consumed by the cross-linker
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terminal aliphatic amines while the aromatic amines remained intact. For SCK9, a minor
red shift of ~ 5 nm was observed; the origin of which was not clear.

Figure 4.5. UV-vis profiles of control experiment I. a): UV-vis spectra of SCK10
(solid, nominal 20% of cross-linking) and SCK11 (dashed, nominal 50% of crosslinking), prepared through conventional carbodiimide-mediated amidation with crosslinker 3. UV-vis profiles of control experiment II. b): UV-vis spectra of physical
mixtures of PEO45-b-PAA95-b-PS60 micelles and 3 before dialysis and at stoichiometries
of 0.1 eq. (solid) and 0.5 eq. (dashed) of 3, relative to the AA residues, respectively.
After dialysis against high salt buffers (pH 7.2 5 mM PBS buffer with 150 mM of NaCl)
both physical mixture samples gave no signal from 3, with their UV-vis traces
overlapping (dotted).

From a structural viewpoint, cross-linkers 1 and 2 were distinguishable only
through the spacer lengths and hydrophilicities, which further was revealed by their
similar extinction coefficients (ε = 5,150 M-1cm-1 and 5,750 M-1cm-1 at pH 7.2,
respectively). In contrast to earlier studies with coupling of large negatively-charged
macrocycles into the nanoparticle shells,30 the spacer length was unimportant in this
study. No obvious incorporation efficiency differences were observed between 1 and 2 at
each of the experimental cross-linking extents (Table 4.1). While the total amount of
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cross-linkers increased from 0.1 eq to 0.25 eq (relative to NAS residues), the actual
incorporation efficiency decreased from 60% to 40%. A plateau of the incorporation
efficiency occurred with further increase of the cross-linker feeding ratio. These results
might be associated with the unique core-shell structure of the PEO-b-PNAS-b-PS
micelles. As soon as the micellization was initialized after water addition, the hydrolysis
of NAS residues started simultaneously. However, the rate of hydrolysis was much
slower compared with the rate of phase segregation-based micellar assembly. Therefore,
it is expected that most of the NAS residues were “trapped” into the hydrophobic core
domain while a “sub-shell” domain consisted of NAS and AA residues formed at the
interface of PEO shell and PNAS/PS core domains. It was speculated that the crosslinking reaction dominantly occurred within this sub-shell region first because of the
intrinsic hydrophilicity of the cross-linker, although the hydrophilicity increased from 1
to 3, and also because of the mode of administration/transport of the cross-linker from the
exterior inward

As the reaction proceeded and more sub-shell NAS residues were

converted into amides and hydrolyzed to AA carboxylates, the sub-shell domain would
become increasingly hydrophilic and gradually merge into the “final” shell domain of the
nanoparticle.28 The framework structure would then reduce the permeability of the shell
domain31 and restrict further access of cross-linker to the “refurbished” sub-shell domain.
And finally, the “deep onion” PNAS/PAA sub-shell would become un-reachable for the
cross-linkers after incorporating over ca. 40% of 1 or 2.
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Improvement of incorporation efficiency (Table 4.1) at each nominal extent was
achieved while using 3 (ε = 3,470 M-1cm-1 at pH 7.2), a cross-linker bearing positive
charge. This improvement could be attributed to strong electrostatic interactions between
the guanidine moieties of the bifunctional bis-arginyl-pyrazine 3, and copolymer NASderived carboxylates, generated by partial hydrolysis of active esters during the
micellization process. The electrostatic interactions could act as “driving force” for
“pulling” 3 through the formed shell frameworks. Thus, pre-coordination of 3 with each
“onion-like” sub-shell of the micelles via guanidine-carboxylate complexes resulted in a
vast enhancement of inter-strand amide cross-linking reaction efficiency.
Table 4.1. Incorporation efficiency and maximum cross-linking extents upon varying the
cross-linker structures and stoichiometries.
SCKsa

Cross-linker

SCK1
SCK2
SCK3
SCK4
SCK5
SCK6
SCK7
SCK8
SCK9
SCK10f
SCK11f

1
1
1
2
2
2
3
3
3
3
3

Cross-linking
extentsb
20 %
50 %
100 %
20 %
50 %
100 %
20 %
50 %
100 %
20 %
50 %

a

Incorporation
efficiencyc
62 %
45 %
44 %d
60 %
40 %
40 %d
98 %
69 %
56 %
58 %
57 %

Maximum
cross-linking extentse
13 %
23 %
44 %
12 %
20 %
40 %
20 %
35 %
56 %
12 %
29 %

Sample concentrations were 0.20-0.30 mg/mL in 5 mM PBS buffer (pH 7.2 with 5 mM
NaCl). b Nominal cross-linking extents, based upon stoichiometry. c Calculated by the
UV-vis absorption values at 433 nm (for cross-linker 1 and 2) and 441 nm (for crosslinker 3). d The number was not accurate as the Abs value was over 1.0. e See reference
29. f Prepared from “conventional” carbodiimide-mediated amidation by using PEO45-bPAA95-b-PS60 micelles.
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To confirm the existence of the electrostatic interactions between 3 and AA
carboxylates, the PEO45-b-PAA95-b-PS60 micelles (prepared from micellization of the
block copolymer precursor, which was synthesized from hydrolysis of PEO45-b-PNAS95b-PS60, see Experimental Section for details) were simply mixed physically with 3 under
the identical reaction conditions as had been used for the cross-linking reactions (but,
without covalent cross-linking being possible). After 5 days of dialysis against pH 7.2
PBS buffer (5 mM with 5 mM of NaCl), the UV-vis spectra of the mixtures (Figure 4.5b,
solid and dashed) surprisingly indicated that 78% and 73% of the coordination
efficiencies were achieved for 20% and 100% non-covalent cross-linking, respectively.
After further dialyzing against 5 mM PBS buffer with much higher salt concentration
(150 mM NaCl), which is a common protocol for breaking electrostatic interactions, the
UV-vis spectra showed that there was no 3 remaining (Fig 4.5b, overlapping dotted
lines). In fact, when SCK7-9 were exposed to the same work-up process, the difference
of SCK7-9 (especially SCK9) UV-vis profiles before and after the high salt dialysis
process (Figure 4.6) also supported that 3 could be incorporated into the SCKs through
electrostatic interactions. The physical mixing of 3 with the PEO45-b-PAA95-b-PS60
micelles at the special stoichiometry (0.1 eq. of 3, relative to the NAS/AA residues) did
not affect the photo-physical properties of 3. No maximum absorbance peak shift was
found, which serves as additional evidence for our hypothesis that the blue shift was
caused by the covalent modifications onto the pyrazine aryl amines.
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Another control experiment with 3 was then followed, which involved
construction of SCKs from the PEO45-b-PAA95-b-PS60 micelles with 3 through our
“conventional” carbodiimide-mediated amidation strategy.

Compared with the pre-

installed active ester-mediated approach, relatively lower incorporation efficiencies (ca.
60%) were achieved at both 20% and 50% nominal cross-linking extents (SCK10 and
SCK11 in Table 1, respectively). Moreover, attempts at 100% cross-linking failed from
this approach, due to the fact that significant visual precipitation was observed. It is
uncertain why the traditional methodology experienced this problem, while it did not
occur with the new polymer system.

Figure 4.6. UV-vis profiles of SCK7 (green), SCK8 (blue), and SCK9 (red) before
(solid line) and after (dashed line) dialysis against pH 7.2 5 mM PBS (with 150 mM of
NaCl).
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To identify if the nanoparticle morphology changed after the cross-linking,
SCK1-12 were characterized by DLS and TEM; the results are summarized in Table 4.2,
Figure 4.7 (the DLS histogram of particle size distribution by number-averaged Dh), and
Figure 4.8 (TEM micrographs).

From the DLS and TEM characterizations, SCKs

prepared from 1 and 2 at lower cross-linking extents (< 30%) showed no morphological
variations (Figure 4.8a-b and Fig4.8d-e), compared with the micelle (Figure 4.2d). A
clear trend of hydrodynamic diameter decrease was observed with the increase of actual
cross-linking extents from 0% to ca. 20%, suggesting that the nanostructures underwent
“shrinking” after the cross-linking. Further increase of cross-linking extents caused
nanostructure morphological changes, as verified by TEM imaging (Figure 4.8c and
4.8f), although the final nanostructures still displayed relatively narrow size distributions
(Figure 4.7c and 4.7f, respectively).
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Table 4.2. DLS and TEM characterization results for SCK1-12.
SCKsa
SCK1
SCK2
SCK3
SCK4
SCK5
SCK6
SCK7
SCK8
SCK9
SCK10
SCK11
SCK12

Cross-linker
1
1
1
2
2
2
3
3
3
3
3
4

Cross-linking extentsb
13 %
23 %
44 %
12 %
20 %
40 %
20 %
37 %
69 %
12 %
29 %
100 %f

Dh,number (nm)c
62 ± 7
39 ± 2
56 ± 5
64 ± 4
50 ± 2
56 ± 8
104 ± 8
69 ± 5
91 ± 9
85 ± 6
53 ± 4
61 ± 3

Dav (nm)d
22 ± 2
27 ± 1
NAe
22 ± 2
30 ± 1
NAe
20 ± 1
28 ± 2
NAe
20 ± 1
28 ± 2
28 ± 1

a

Sample concentrations were 0.20-0.30 mg/mL in 5 mM PBS buffer (pH 7.2 with 5 mM
NaCl). b Maximum cross-linking extents, based upon incorporation efficiency. c
Number-averaged hydrodynamic diameter with standard deviation between 5 runs. d Dav
were measured by TEM for the SCK nanoparticle core domains, for at least 150 particles.
e
Not available due to the irregular shape of the nanostructures. f Nominal 100% of crosslinking; maximum cross-linking extent could not be determined due to the lack of a
chromophore on 4.

For cross-linker 3, the situation became more complicated: 1) For SCK8 and
SCK11 at nominally 50% cross-linking, spherical morphologies were maintained (Figure
4.8h and 4.8k) and their particle sizes were consistent with the hydrodynamic sizes; 2)
For SCK7 and SCK10 at lower cross-linking extents, the obviously increased Dh (ca.
100 nm) and the observed inter-particle association behaviour reflected by the TEM
micrograph indicated the existence of strong inter-particle interactions; 3) For SCK9
with the highest cross-linking extent (ca. 70%), “island-like” irregular morphology was
noticed. As a note, this kind of morphological alteration caused by high extents of crosslinking was not limited to complicated cross-linkers. For example, SCK12, prepared
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from a simple molecule 2,2´-(ethylene-dioxy)bis(ethylamine) as cross-linker under
similar stoichiometry (0.5 eq, relative to the NAS residues), still displayed atypical
morphology (Figure 4.8l).

Figure 4.7. Histograms of number-averaged hydrodynamic diameter distributions for
SCK1-12 (a-l, respectively).
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Figure 4.8. TEM micrographs of SCK nanoparticles at nominal 20%, 50%, and 100%
cross-linking extents (stained negatively with PTA). a-c): TEM micrographs of SCK1-3
prepared from cross-linker 1 at nominal 20%, 50%, and 100% cross-linking extents,
respectively. d-f): TEM micrographs of SCK4-6 prepared from cross-linker 2 at nominal
20%, 50%, and 100% cross-linking extents, respectively. g-i): TEM micrographs of
SCK7-9 prepared from cross-linker 3 at nominal 20%, 50%, and 100% cross-linking
extents, respectively. j-k): TEM micrographs of SCK10-11 prepared from cross-linker 3
at nominal 20% and 50% cross-linking extents, respectively. l): TEM micrograph of
SCK12 prepared from cross-linker 4 at nominal 100% cross-linking extent.
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Finally, the fluorescence emission properties of SCK1-9 were studied (Figure
4.4). The fluorescence emission intensities of these SCKs decreased as more pyrazine
units were incorporated, which could be attributed to an amplified self-quenching effect
between fluorophores. Interestingly, compared with SCK1, SCK4 displayed enhanced
fluorescence (ca. 50% of intensity increase) although they shared almost identical
characteristic parameters (size, concentration, the amount of chromophore per
nanoparticle, and the closely intrinsic photophysical-property of the cross-linkers 1 and
2). This enhancement might be related to the fact that the longer spacer of 2 enabled the
pyrazine moiety to adapt suitable conformations within the relatively loose shell domain
and avoid self-quenching.

Conclusions
In summary, the amphiphilic and reactive triblock copolymer, PEO-b-PNAS-bPS, having a well-defined structure was synthesized through RAFT polymerization and
was then utilized for the construction of shell cross-linked nanoparticles using unique
photo-active cross-linkers. Three pyrazine-derived bisamino cross-linkers with different
spacer lengths and charges were incorporated into the nanostructures to study the factors
associated with the reaction efficiency, employing the pyrazine to act as the reporting
probe.

It was found that the introduction of positive charges onto the cross-linker

improved significantly the incorporation efficiency, while the length of the spacer had
107

little effect. The photo-physical properties of these cross-linked nanostructures were also
investigated and a blue shift of over 30 nm was observed for the maximum absorbance
peak, for all cross-linkers at lower incorporation levels (< 20%) within the nanoscale
frameworks. Further studies on their pH-responsive photo-physical properties and their
potential applications for optical imaging and monitoring, are currently underway.

Experimental Section
Materials.

The mono-methoxy terminated mono-hydroxy poly(ethylene glycol)

(mPEG2k, MW = 2,000 Da, PDI = 1.06) was purchased from Intezyne Technologies
(Tampa, FL) and was used for the synthesis of macro-CTA36 without further purification.
The cross-linker 1-3 were synthesized according to the previous report.37

Other

chemicals were purchased from Aldrich and Acrose were used without further
purification unless otherwise noted. Prior to use, styrene (99%), purchased from Aldrich,
were distilled over calcium hydride and stored under N2. The Supor 25 mm 0.1 μm
Spectra/Por Membrane tubes (molecular weight cut-off (MWCO) 6-8 kDa), used for
dialysis, were purchased from Spectrum Medical Industries Inc.. Nanopure water (18
mΩ•cm) was acquired by means of a Milli-Q water filtration system (Millipore Corp.;
Bedford, MA).
Measurements.

1

H and

13

C NMR spectra were recorded on a Varian 600 MHz

spectrometer interfaced to a UNIX computer using Mercury software. Chemical shifts
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are referred to the solvent proton resonance. Infrared spectra were obtained on a PerkinElmer Spectrum BX FT-IR system using diffuse reflectance sampling accessories with
FT-IR Spectrum v2.00 software.
The

molecular

weight

distribution

was

determined

by

Gel

Permeation

Chromatography (GPC). The N,N-dimethylformamide (DMF) GPC was conducted on a
Waters Chromatography, Inc. (Milford, MA) system equipped with an isocratic pump
model 1515, a differential refractometer model 2414, and a two-column set of Styragel
HR 4 and HR 4E 5 µm DMF 7.8 × 300 mm columns. The system was equilibrated at 70
°C in pre-filtered DMF containing 0.05 M LiBr, which served as polymer solvent and
eluent (flow rate set to 1.00 mL/min).

Polymer solutions were prepared at a

concentration of ca. 3 mg/mL and an injection volume of 200 µL was used. Data
collection and analysis was performed with Empower Pro software (Waters, Inc.). The
system was calibrated with poly(ethylene glycol) standards (Polymer Laboratories,
Amherst, MA) ranging from 615 to 442,800 Da.
The atomic force microscopy (AFM) characterization of micelles was performed by
tapping-mode AFM under ambient conditions in air. The AFM instrumentation consisted
of a Nanoscope III BioScope system (Digital Instruments, Veeco Metrology Group;
Santa Barbara, CA) and standard silicon tips (type, OTESPA-70; L, 160 μm; normal
spring constant, 50 N/m; resonance frequency, 246-282 kHz). Samples for AFM imaging
analysis were prepared through spin-coating ca. 1.0 μL of the micelle solution (0.5
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mg/mL) onto freshly cleaved mica plates (Ruby clear mica, New York Mica Co.) and
allowed to dry freely in air.
Samples for Transmission Electron Microscopy (TEM) measurements were diluted
with a 1 % phosphotungstic acid (PTA) stain (v/v, 1:1). Carbon grids were exposed to
oxygen plasma treatment to increase the surface hydrophilicity.

Micrographs were

collected at 100,000× magnification and calibrated using a 41 nm polyacrylamide bead
from NIST. The number average particle diameters (Dav) and standard deviations were
generated from the analysis of a minimum of 150 particles from at least three different
micrographs.
Hydrodynamic diameters (Dh) and size distributions for the vesicles in aqueous
solutions were determined by dynamic light scattering (DLS). The DLS instrumentation
consisted of a Brookhaven Instruments Limited (Worcestershire, U.K.) system, including
a model BI-200SM goniometer, a model BI-9000AT digital correlator, a model EMI9865 photomultiplier, and a model 95-2 Ar ion laser (Lexel Corp.) operated at 514.5 nm.
Measurements were made at 25 ± 1 °C. Scattered light was collected at a fixed angle of
90°. The digital correlator was operated with 522 ratio spaced channels, and initial delay
of 5 μs, a final delay of 100 ms, and a duration of 6 minutes. A photomulitplier aperture
of 100 μm was used, and the incident laser intensity was adjusted to obtain a photon
counting of between, 200 and 300 kcps. Only measurements in which the measured and
calculated baselines of the intensity autocorrelation function agreed to within 0.1 % were
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used to calculate particle size. The calculations of the particle size distributions and
distribution averages were performed with the ISDA software package (Brookhaven
Instruments Company), which employed single-exponential fitting, cumulants analysis,
and CONTIN particle size distribution analysis routines.

All determinations were

repeated 5 times.
The UV-vis absorption spectra of SCKs were collected at room temperature using a
Varian Cary 100 Bio UV-visible spectrophotometer and plastic cuvettes with 10 mm of
light path. For each SCK absorption spectroscopy measurement, the pH 7.2 PBS (5 mM
with 5 mM of NaCl) buffer solution outside the dialysis tubing was used as control.
The fluorescence spectra of SCKs were obtained at room temperature using a Varian
Cary Eclipse fluorescence spectrophotometer.

All fluorescence spectra from SCK

solutions were measured at optical densities at the excitation wavelength. If not specially
mentioned otherwise, an excitation wavelength of the observed maximum absorption
peak was used. Each fluorescence spectrum was normalized with respect to the absorbed
light intensity at the excitation wavelength.
Synthesis of PEO45-b-PNAS95. To a 25 mL Schlenk flask equipped with a magnetic
stir bar dried with flame under N2 atmosphere, was added the mPEG2k macro-CTA (0.24
g, 0.10 mmol) and 1,4-dioxane (10 mL). The reaction mixture was stirred 0.5 h at rt to
obtain a homogeneous solution. To this solution was added NAS (1.7 g, 10 mmol) and
AIBN (0.8 mg, 5 μmol). The reaction flask was sealed and stirred 10 min at rt. The
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reaction mixture was degassed through several cycles of freeze-pump-thaw. After the
last cycle, the reaction mixture was stirred for 10 min at rt before being immersed into a
pre-heated oil bath at 60 °C to start the polymerization. After 1.5 h, the monomer
conversion reached ca. 90% by analyzing aliquots collected through

1

H-NMR

spectroscopy. The polymerization was quenched by cooling the reaction flask with liquid
N2. The solution was diluted with 20 mL of DMSO and precipitated into 600 mL of cold
diethyl ether at 0 °C twice. The precipitants were collected, washed with 100 mL of cold
ether, and dried under vacuum overnight to afford the PEO45-b-PNAS95 block copolymer
precursor as a yellow solid (1.2 g, 65% yield based upon monomer conversion).

1

H

NMR (600 MHz, DMSO-d6, ppm): δ 0.81 (t, J = 6 Hz, 3H, dodecyl CH3), 1.09 (br, 5H,
CH3 and dodecyl CH2), 1.20 (br, 19H, CH3 and dodecyl CH2s), 1.30 (br, 2H, dodecyl
CH2), 1.60 (t, J = 6 Hz, 2H, dodecyl CH2), 2.01 (br, PNAS backbone protons), 2.75 (NAS
CH2CH2s), 3.09 (br, PNAS backbone protons), 3.20 (s, mPEG terminal OCH3), 3.47 (m,
OCH2CH2O from the PEG backbone), 4.07 (br, 2H from the PEO backbone terminus
connected to the ester linkage);

13

C NMR (150 MHz, DMSO-d6, ppm): δ 172.8, 69.8,

41.2, 25.2; IR (NaCl, cm-1): 2925, 1811, 1780, 1735, 1361, 1206, 1070, 649.
Synthesis of PEO45-b-PNAS95-b-PS60. To a 10 mL Schlenk flask equipped with a
magnetic stir bar dried with flame under N2 atmosphere, was added the PEO45-b-PNAS95
macro-CTA (0.55 g, 30 μmol), 1,4-dioxane (2.2 mL), and DMF (2.2 mL). The reaction
mixture was stirred 0.5 h at rt to obtain a homogeneous solution. To this solution was
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added styrene (0.94 g, 9.0 mmol) and AIBN (0.24 mg, 1.5 μmol). The reaction flask was
sealed and stirred 10 min at rt. The reaction mixture was degassed through several cycles
of freeze-pump-thaw. After the last cycle, the reaction mixture was stirred for 10 min at
rt before being immersed into a pre-heated oil bath at 60 °C to start the polymerization.
After 16.5 h, the monomer conversion reached ca. 19% by analyzing aliquots collected
through 1H-NMR spectroscopy.

The polymerization was quenched by cooling the

reaction flask with liquid N2. The polymer was purified by precipitation into 250 mL of
cold diethyl ether at 0 °C twice. The precipitants were collected and dried under vacuum
overnight to afford the block copolymer precursor as a yellow solid (0.58 g, 77% yield
based upon monomer conversion).

1

H NMR (600 MHz, CD2Cl2, ppm): δ 0.81 (br,

dodecyl CH3), 1.10-2.40 (br, dodecyl Hs, PNAS, and PS backbone protons), 2.75 (NAS
CH2CH2s), 3.15 (br, PNAS backbone protons), 3.28 (s, mPEG terminal OCH3), 3.60 (m,
OCH2CH2O from the PEG backbone), 6.20-7.30 (br, Ar Hs);

13

C NMR (150 MHz,

DMSO-d6, ppm): δ 172.8, 145.2, 128.0, 125.7, 69.8, 41.6, 25.2; IR (NaCl, cm-1): 2925,
1810, 1779, 1732, 1452, 1362, 1208, 1070, 813, 699, 648.
General Procedure for Micellization of PEO45-b-PNAS95-b-PS60. To a solution of
PEO45-b-PNAS95-b-PS60 block copolymer in DMF (ca. 1.0 mg/mL), was added dropwise
an equal volume of nano-pure H2O via a syringe pump at a rate of 15.0 mL/h, and the
mixture was further stirred for 1 h at rt before using for characterizations and crosslinking reactions.
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General Procedure for Cross-linking of PEO45-b-PNAS95-b-PS60 Micelles. To a
solution of PEO45-b-PNAS95-b-PS60 micelles (15.0 mg of block copolymer precursor,
57.7 μmol of NAS residues) in 30.0 mL of DMF/H2O (v:v = 1:1) at rt, was added
dropwise over 10 min, a solution of cross-linker (5.8 μmol for nominal 20% of crosslinking, 14.5 μmol for nominal 50% of cross-linking, and 29.0 μmol for nominal 100% of
cross-linking, respectively) in nano-pure H2O. The reaction mixture was allowed to stir
for 48 h at rt. For reactions involving cross-linker 1, 2, and 4, the mixture was transferred
to pre-soaked dialysis tubing (MWCO 6,000-8,000 Da) and dialyzed against 5.0 mM
PBS (pH 7.2, with 5.0 mM NaCl) for 7 days to remove DMF, un-reacted cross-linker,
and the small molecule by-products and afford an aqueous solution of cross-linked
nanoparticles. For reactions involving cross-linker 3, the mixture was transferred to presoaked dialysis tubing (MWCO 6,000-8,000 Da) and sequentially dialyzed against 5.0
mM PBS (pH 7.2, with 5.0 mM NaCl) for 3 days, 5.0 mM PBS (pH 7.2, with 150 mM
NaCl) for 2 days, and 5.0 mM PBS (pH 7.2, with 5.0 mM NaCl) for 2 days to remove
DMF, un-reacted cross-linker, and the small molecule by-products and afford an aqueous
solution of cross-linked nanoparticles.
Synthesis of PEO45-b-PAA95-b-PS60. A 25 mL round bottom flask equipped with a
stir bar was charged with PEO45-b-PNAS95-b-PS60 (100 mg, 4.05 μmol), 10 mL of
CH2Cl2 and 1 mL of trifluoroacetic acid (TFA). After adding 0.1 mL of water, the
reaction mixture was stirred vigorously for 24 h at rt and then, was concentrated under
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vacuum. The crude product was dissolved into 10 mL of DMF, transferred into presoaked dialysis tubing (MWCO 6,000–8,000 Da) and dialyzed against nano-pure H2O
(18.0 MΩ cm) for 4 days to remove small molecule impurities. The aqueous solution
was lyophilized to afford the product as slightly yellow solid (60 mg, 95 % yield). 1HNMR (600 MHz, DMSO-d6, ppm): δ 0.81-2.40 (br, docecyl Hs and polymer backbone
Hs), 3.37 (s, 3H, mPEG terminal OCH3), 3.42-3.82 (br, mPEG backbone -OCH2CH2OHs), 6.22-7.30 (br, Ar Hs), 12.25 (br, -COOH); 13C NMR (150 MHz, DMSO-d6, ppm): δ
175.8, 145.2, 128.0, 125.7, 69.8, 41.6; IR (NaCl, cm-1): 3450-2900, 2925, 1718, 1458,
1258, 1183, 1103, 954, 794, 699.
Micellization of PEO45-b-PAA95-b-PS60. To a solution of PEO45-b-PAA95-b-PS60
(30 mg) in 30 mL of DMF, was added dropwise 30 mL of nano-pure H2O via a syringe
pump at a rate of 15.0 mL/h, and the mixture was further stirred for 16 h at rt. Finally,
the mixture was transferred into pre-soaked dialysis tubing (MWCO 6,000-8,000 Da) and
dialyzed against nano-pure water for 5 days to afford the micelle solution.
Cross-linking of PEO45-b-PAA95-b-PS60 Micelle with 3 through “Conventional”
Amidation. To a solution of PEO45-b-PAA95-b-PS60 micelle (10 mg of PEO45-b-PAA95b-PS60 block copolymer precursor, 62 μmol of AA residues) in 40 mL of nano-pure
water, was added dropwise over 30 min, a solution of 3 (3.7 mg, 6.2 μmol for SCK10
and 9.2 mg, 15 μmol for SCK11, respectively) in nano-pure water. The mixture was
stirred 2 h at rt and a freshly prepared EDCI solution (3.8 mg, 13 μmol for SCK10 and
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9.2 mg, 31 μmol for SCK11, respectively) in nano-pure water was then added over 1 h.
The reaction mixture was further stirred 48 h at rt before transferring into a pre-soaked
dialysis tubing (MWCO 6,000-8,000 Da) and sequentially dialyzing against 5 mM pH 7.2
PBS (with 5 mM NaCl) for 3 days, 5 mM pH 7.2 PBS (with 150 mM NaCl) for 2 days,
and 5 mM pH 7.2 PBS (with 5 mM NaCl) for 2 days to afford an aqueous solution of the
cross-linked nanoparticles.
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Chapter 5

Reversible Addition Fragmentation Chain Transfer (RAFT)
Polymerization of 4-Vinylbenzaldehyde
[Portions of this work have been published previously as Guorong Sun, Chong Cheng
and Karen L. Wooley Macromolecules 2007, 40(4), 793-795.]

Abstract
The

direct

reversible

addition-fragmentation

chain

transfer

(RAFT)

polymerization of 4-vinylbenzaldehyde (VBA) was established as a new synthetic
method for the preparation of well-defined poly(vinylbenzaldehyde) (PVBA), a polymer
having reactive aldehyde side chain substiuents. RAFT polymerization of VBA was
investigated using S-1-dodecyl-S΄-(α,α´-dimethyl-α´´-acetic acid)trithiocarbonate as chain
transfer agent and 2,2'-azobis(isobutyronitrile) as initiator in 1,4-dioxane or 2-butanone at
70-75 °C for 7.5-22.5 h. With 45-76% of monomer conversion, the resulting PVBA had
well controlled number-average molecular weight (Mn) and low polydispersity (PDI <
1.17). The living characteristic of the RAFT polymerization process was confirmed by
the linearity between the Mn values of PVBA and monomer conversions. Well-defined
PVBA was further used as a macromolecular chain transfer agent in RAFT
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polymerization of styrene (St), and a block copolymer PVBA-b-PSt with relatively low
polydispersity (PDI = 1.20) was successfully synthesized.

123

Introduction
Construction of polymers with highly reactive functionalities that allow for
further diverse functional group transformation (FGT) is an emerging research area in
modern polymer chemistry.1

Among these polymers, polymers bearing aldehyde

functionalities are attractive because aldehydes are among the most reactive substrates for
FGT under mild reaction conditions.2 Conventional radical polymerization of aldehydefunctionalized monomers has been studied since 1950s,3 however, the resulting polymers
lacked well-defined structures, due to the non-living nature of the polymerization
technique.4-7 Anionic polymerization provided an alternative synthetic pathway for the
preparation of aldehyde-functionalized polymers,8-13 but the stringent polymerization
conditions and tedious preparation procedures (protection of monomer, polymerization,
and deprotection of the resulting polymers were required) significantly restrict the
applicability of this synthetic route.
To efficiently prepare well-defined aldehyde-functionalized polymers, we
investigated living radical polymerization of aldehyde-functionalized monomers. In the
past decade, reversible addition fragmentation chain transfer (RAFT) polymerization has
been developed and demonstrated as a powerful tool in living radical polymerization.14,15
Relative to other living radical polymerization techniques, one important advantage of
RAFT is that it provides facile and homogenous living polymerization systems applicable
for a wide variety of monomers under relatively mild reaction conditions.
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In this

communication, we report our recent work of RAFT polymerization of 4vinylbenzaldahyde (VBA), as a new methodology for the construction of well-defined
aldehyde-functionalized polymers

Results and Discussion
Several synthetic pathways for the synthesis of VBA have been reported in the
literature, including transition metal-catalyzed cross-coupling of 4-bromobenzaldehyde
with ethylene or vinyl reagents, Grignard addition to N,N-dimethyl formamide (DMF)
followed by acid hydrolysis, and Wittig olefination.5-7 We prepared VBA by Wittig
olefination of 4-(diethoxymethyl)benzaldehyde, a commercially available monoprotected benzene-1,4-dicarboxaldehyde, followed by deprotection (Scheme 5.1, a slight
modification from Dhal’s method6), because this reliable synthetic pathway had
satisfactory yield (82% over 2-steps) with feasible scale-up and simple work-up
protocols. As demonstrated by Dhal et al.,6 radical polymerization of the intermediate
monomer (diethyl acetal-protected styrene) followed by deprotection can also yield
PVBA. However, we prefer to directly introduce aldehyde functionalities by using VBA
as a (co)monomer because of our intention to avoid deprotection of polymers and also the
key concern that the post-polymerization deprotection step may result in deconstruction
of useful functionalities presented on the polymers, including the terminal RAFT
functionalities.
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Scheme 5.1. RAFT polymerization of VBA.

RAFT polymerization of VBA was then conducted, and as a result, well-defined
PVBA was synthesized (Table 5.1). Relative to other chain transfer agents (CTAs) for
RAFT

polymerization

systems,

S-1-dodecyl-S΄-(α,α´-dimethyl-α´´-acetic

acid)trithiocarbonate (DDMAT)16 can be prepared readily and has less unfavorable odor
and therefore, it was used as the CTA in our study ([VBA]0/[CTA]0 = 100/1.0). A typical
thermal

initiator

2,2'-azobis(isobutyronitrile)

(AIBN)

was

used

as

initiator

([CTA]0/[AIBN]0 = 1.0/0.1-0.2), and the polymerization temperature was chosen at 70-75
°C to maintain a suitable decomposition rate of AIBN to provide initiating radicals.
Because of the poor solubility of PVBA in its monomer, either 1,4-dioxane or 2-butanone
was used as the polymerization solvent, and 2-butanone was further found as a better
solvent than 1,4-dioxane for PVBA.17 For each trial, the monomer conversion was
determined by

1

H-NMR analysis of the final polymerization solution based on

comparison of the integration area of resonances of aldehyde protons of PVBA at 9.8
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ppm and the integration area of resonances of aldehyde protons of VBA at 10.0 ppm
corresponding to the aldehyde proton signals from both polymer and monomer,
respectively. PVBA was obtained by precipitation of the final polymerization solution
twice into cold pentane and drying under vacuum.18

Table 5.1. Reversible addition fragmentation chain transfer polymerization of 4vinylbenzaldehyde (VBA).
Entry

[VBA]0:[DDMAT]0:[AIBN]0

1

100:1.0:0.1

2

100:1.0:0.1

3

100:1.0:0.2

4

100:1.0:0.1

5

100:1.0:0.1

Solvent
1,4-dioxane
(71 vol %)
1,4-dioxane
(71 vol %)
1,4-dioxane
(50 vol %)
2-butanone
(50 vol %)
2-butanone
(50 vol %)

T
(°C)

t
(h)

Conversiona

Mn, calcd
(Da)

Mn, GPC
(Da)

PDIb

70

11

56%

7,800

8,800

1.14

70

22.5

76%

10,400

10,300

1.17

70

7.5

45%

6,300

7,900

1.09

75

10

62%

8,500

9,100

1.07

75

17.5

73%

10,000

10,500

1.06

Mn, calcd: Calculated number-average molecular weight based upon monomer conversion.
Mn, GPC: Number-average molecular weight measured by Gel Permeation
Chromatography (GPC). PDI: Polydispersity index. a By 1H-NMR. b By GPC.

The well-defined structure of PVBA was verified by

1

H NMR and Gel

Permeation Chromatography (GPC) analyses (Figure 5.1). As shown in Figure 5.1(a),
the integration area ratio of aldehyde protons vs. aromatic protons in PVBA was
1.00:2.12:2.03, illustrating the essential absence of side reactions on the aldehyde
functionality of VBA during the RAFT process and the quantitative presence of aldehyde
functionalities in PVBA. The presence of the ω-trithiocarbonate RAFT functionality in
PVBA was indicated by its 1H NMR resonances at 0.88 and 3.22 ppm (for CH3 and
SCH2, respectively), and the 1H NMR resonances of the benzylic proton of the terminal
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VBA unit at 4.84 ppm with an integration area ratio of 1.00:1.93 with the SCH2 at 3.22
ppm.

The number-average degree of polymerization was obtained by 1H NMR

spectroscopy (DPNMR), by comparing the intensity of the benzylic proton of the terminal
VBA unit at 4.84 ppm with that of the aldehydic proton signal at 9.8 ppm, and was found
to agree with the number-average degree of polymerization obtained by GPC (DPGPC)
within the error range (for example for sample entry 5 (Table 5.1), the DPNMR and DPGPC
values were 78 and 75, respectively).

Molecular weight and molecular weight

distribution data for the PVBA samples were determined by GPC using THF as eluent
(Figure 5.1(b)). All PVBA samples have not only excellent agreements between the GPC
and calculated (based on monomer conversion) molecular weights but also monomodal
molecular weight distributions with low polydispersties (PDI = 1.06-1.17), indicating
well-controlled chain growth and very high chain transfer efficiency of the
trithiocarbonate RAFT functionality in the polymerization process.

Figure 5.1. RAFT polymerization of 4-vinylbenaldehyde: (a) 1H-NMR spectrum of
PVBA (500 MHz, CD2Cl2; Table 5.1 entry 5). (b) GPC curve for PVBA (Table 5.1 entry
5). (c) GPC curve for PVBA (Table 5.1 entry 2) and PVBA-b-PSt (polymerization
conditions: [Styrene]0/[macro-CTA]0/[Initiator]0 = 150/1.0/0.1, 70 vol % of 2-butanone,
60 °C, 12 h).
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To confirm the living characteristic of this RAFT polymerization system, the
relationships between polymer molecular weights and monomer conversions were
studied and the polymerization kinetics was also investigated (Figure 5.2).

During

polymerization, aliquots were withdrawn from the reaction vessel at predetermined times
and analyzed by 1H-NMR spectroscopy for determination of the monomer conversions
and by GPC for determination of the polymer molecular weights and polydispersities.

Figure 5.2. Kinetic plots for RAFT polymerization of 4-vinylbenzaldehyde: (a)
relationship of number-average molecular weight (Mn, ■) and polydispersity index (PDI,
□) versus monomer conversion; (b) time dependence of monomer conversion [M] and
ln([M]0/[M]t). (polymerization conditions: [VBA]0/[Chain Transfer Agent]0/[Initiator]0 =
100/1.0/0.1, 50 vol % of 2-butanone, 75 °C).
As shown in Figure 5.2(a), excellent linear agreement (R2 = 0.9976) between
polymer molecular weight and monomer conversion was obtained, and the resulting
polymers also maintained narrow molecular weight distributions (PDI = 1.07 to 1.11).
Such results verified the living characteristics of the RAFT polymerization process. As
shown in Table 5.1, similar to conventional radical polymerization of VBA,4,5,7a RAFT
polymerization of VBA proceeded relatively slowly. Figure 5.2(b) depicts the kinetic
plot of the polymerization. Pseudo first-order kinetics were maintained at the initial
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polymerization stage (~4 h), and then the kinetics deviated from linearity. Because
AIBN has a short half-life of ca. 3 h at 75 °C, such retardation in polymerization might
essentially be the result of the decreased radical concentration due to the depletion of
AIBN.
The living characteristics of RAFT polymerization has allowed ready preparation
of a broad variety of block copolymers.19 We also investigated the chain extension of the
well-defined PVBA having terminal RAFT functionality by RAFT polymerization as a
synthetic method for the preparation of aldehyde-functionalized block copolymers.
Although copolymerizations of vinylbenzaldehydes with styrene have already been
extensively studied,5,7 so far there is no literature report on the synthesis of block
copolymers bearing pendant aldehyde functionalities by radical polymerization. Using
PVBA (Mn, GPC = 10,300 Da, PDI = 1.17) as macro-CTA and AIBN as initiator, RAFT
polymerization of styrene ([St]0/[macro-CTA]0/[AIBN]0 = 150/1.0/0.1) was conducted at
60 °C in 2-butanone (70 vol%). The polymerization was allowed to proceed for 12 h,
and 17% conversion of styrene was obtained, as measured by 1H NMR spectroscopy. As
shown in Figure 5.1(c), the formation of diblock copolymer PVBA-b-PSt (Mn,GPC =
12,500 Da, PDI = 1.19) by chain extension from the PVBA-based macro-CTA was
verified by GPC analysis. Moreover, the good agreement between the experimental and
calculated molecular weights (Mn,calcd = 12,900 Da) and the mono-modal molecular
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weight distribution of the PVBA-b-PSt illustrates the quantitative chain transfer
efficiency of the PVBA-based macro-CTA.

Conclusions
In

summary,

we

have

established

RAFT

homopolymerization

of

4-

vinylbenzaldehyde as a new and facile synthetic method for the preparation of PVBAs
with predictable molecular weights and low polydispersities. The chain extension from
PVBA for the preparation of block copolymers also has been explored and PVBA-b-PSt
has been constructed. To our knowledge, this is the first example of block copolymer
bearing multiple aldehydes by direct polymerization without protected monomer, which
was possible by applying radical polymerization. We believe that these homo- and block
(co)polymers can serve as templates for feasible access of polymers with more complex
architectures or conjugates with bio-active substrates for biological and medicinal
applications via well-developed carbonyl chemistry.

Experimental Section
All chemicals were purchased from Aldrich or Acros and were used as received
without further purifications unless noted. THF was distilled over sodium and stored
under N2. Styrene was distilled over CaH2 and stored under N2. AIBN was recrystallized
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from methanol and stored at 0 °C before use. The chain-transfer agent DDMAT was
synthesized as reported in the literature16 and stored at room temperature.
1

H NMR and

13

C NMR spectra were recorded on solutions in CDCl3 on a Varian

Mercury 300 spectrometer with the residual solvent signal as an internal standard. Gel
permeation chromatography (GPC) was conducted on a Waters 1515 HPLC (Waters
Chromatography, Inc.) equipped with a Waters 2414 differential refractometer, a PD2020
dual-angle (15° and 90°) light scattering detector (Precision Detectors, Inc.), and a
three-column series PL gel 5μm Mixed C, 500 Å, and 104 Å, 300 × 7.5 mm columns
(Polymer Laboratories Inc.). The system was equilibrated at 35 °C in anhydrous THF,
which served as the polymer solvent and eluent with a flow rate of 1.0 mL/min. Polymer
solutions were prepared at a known concentration (ca. 3 mg/mL) and an injection volume
of 200 μL was used. Data collection and analysis were performed, respectively, with
Precision Acquire software and Discovery 32 software (Precision Detectors, Inc.).
Interdetector delay volume and the light scattering detector calibration constant were
determined by calibration using a nearly monodispersed polystyrene standard (Pressure
Chemical Co., Mp = 90 kDa, Mw/Mn < 1.04).

The differential refractometer was

calibrated with standard polystyrene reference material (SRM 706 NIST), of known
specific refractive index increment dn/dc (0.184 mL/g). The dn/dc values of the analyzed
polymers were then determined from the differential refractometer response.
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Synthesis of 4-Vinylbenzaldehyde.

To a 250 mL RB flask equipped with a

magnetic stir bar dried with flame under N2 atmosphere at room temperature, was added
methyltriphenylphosphonium bromide (10.8 g, 30.0 mmol) and 75.0 mL of dried THF.
The reaction flask was cooled to -78 °C. To this suspension, was added dropwise a
solution of n-BuLi (1.6 M in hexane, 18.3 mL, 29.2 mmol) over 20 min. The reaction
mixture was stirred 30 min at -78 °C, then slowly was allowed to warm to room
temperature and stirred for an additional 10 min at room temperature.
The orange-red solution was cooled to -78 °C. To this solution, a solution of the
terephthaldehyde monodiethylacetal (5.0 g, 24 mmol) in 15.0 mL of dry THF was added
dropwise over 1 h. The reaction mixture was stirred 30 min at -78 °C, 3 h at 0 °C, and
allowed to warm to room temperature over 2 h.
The reaction was quenched by adding 10.0 mL of saturated NaHCO3 solution. Water
(100 mL) was added, the organic layer was collected and the aqueous layer was extracted
with diethyl ether (20.0 mL × 3). The combined organic layers were washed with brine,
dried with anhydrous Na2SO4, and concentrated in vacuo. The residue was used directly
in the next reaction step without purification.
To a solution of the residue in 70.0 mL of THF at 0 °C, was added dropwise, 15.0 mL
of 0.1 N HCl solution over 15 min. The reaction mixture was stirred for 1 h at 0 °C,
slowly allowed to warm to room temperature, and then stirred for an additional 3 h at
room temperature.
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The THF was removed in vacuo, CH2Cl2 (50 mL) was added, and the aqueous layer
was extracted three times with 15.0 mL of CH2Cl2. The combined organic layers were
washed with brine, dried over anhydrous Na2SO4, and concentrated. Purification by
column chromatography afforded the final product as a colorless oil (1:20 Et2O/hexane,
v/v). Yield 2.7 g, 82%. 1H-NMR (300 MHz, CDCl3, ppm): δ 5.45 (dd, J = 11.0 Hz, 0.6
Hz, 1H), 5.92 (dd, J = 17.4 Hz, 0.6 Hz, 1H), 6.78 (dd, J = 11.0 Hz, 17.4 Hz, 1H), 7.56
(½ABq, J = 6.8 Hz, 1.8 Hz, 2H), 7.85(½ABq, J = 6.8 Hz, 1.8 Hz, 2H), 10.00 (s, 1H); 13CNMR (75 MHz, CDCl3, ppm): δ 117.6, 126.9, 130.3, 135.8, 136.1, 143.6, 191.9.
Polymerization

of

4-Vinylbenzaldehyde.

A

general

procedure

of

homopolymerization of 4-vinylbenzaldehyde under optimized reaction conditions was
performed as follows.
To a 25 mL Schlenk flask equipped with a magnetic stir bar dried with flame under
N2 atmosphere, was added sequentially the DDMAT (45.8 mg, 0.125 mmol), 4vinylbenzaldehyde (1.7 g, 13 mmol), 2-butanone (2.5 mL), and AIBN (2.1 mg, 0.013
mmol). The reaction flask was sealed and stirred 10 min at room temperature. The
reaction mixture was degassed through several cycles of freeze-pump-thaw. After the
last cycle, the reaction mixture was recovered back to room temperature and stirred for
10 min before immersing into a pre-heated oil bath at 75 °C to start the polymerization.
The polymerization was monitored by analyzing aliquots collected at pre-determined
times by 1H-NMR spectroscopy. As the expected monomer conversion was reached, the
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polymerization was quenched by quick immersion of the reaction flask into liquid N2.
THF (5.0 mL) was added to the reaction flask and the polymer was purified by
precipitation into 150 mL of cold pentane at 0 °C twice. The precipitants were collected,
washed with another 50 mL of cold pentane, and dried under vacuum overnight to afford
the PVBA as yellow solid. 1H-NMR (300 MHz, CDCl3, ppm): δ 0.88 – 1.24 (br, dodecyl
Hs), 1.52 – 2.06 (br, polymer backbone Hs), 3.22 (br, SCH2 of the chain terminus), 4.84
(br, 1H from the polymer backbone benzylic terminus connected to trithiocarbonate),
6.58 – 6.85 (br ½ABq, aromatic Hs), 7.33 – 7.62 (br ½ABq, aromatic Hs), 9.88 (br,
aldehyde Hs);

13

C-NMR (75 MHz, CDCl3, ppm): δ 41.1, 128.2, 130.0, 135.1, 151.1,

191.8.
Synthesis of PVBA-b-PS. To a 10 mL Schlenk flask equipped with a magnetic stir
bar dried with flame under N2 atmosphere, was added the PVBA as macro-CTA (1.02 g,
0.1 mmol) and 2-butanone (4.0 mL). The reaction mixture was stirred 1 h at room
temperature to obtain a homogeneous solution. To this solution was added styrene (1.56
g, 15.0 mmol) and AIBN (1.6 mg, 0.01 mmol). The reaction flask was sealed and stirred
10 min at room temperature. The reaction mixture was degassed through several cycles
of freeze-pump-thaw. After the last cycle, the reaction mixture was recovered back to
room temperature and stirred for 10 min before immersing into a pre-heated oil bath at 60
°C to start the polymerization. The polymerization was monitored by analyzing aliquots
collected at pre-determined times by 1H-NMR spectroscopy. As the expected monomer
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conversion was reached, the polymerization was quenched by quick immersion of the
reaction flask into liquid N2. THF (5.0 mL) was added to the reaction flask and the
polymer was purified by precipitation into 150 mL of cold pentane at 0 °C twice. The
precipitants were collected, washed with another 50 mL of cold pentane, and dried under
vacuum overnight to afford the PVBA-b-PS as yellow solid.
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Chapter 6

Benzaldehyde-functionalized Polymer Vesicles
[Portions of this work have been published previously as Guorong Sun, Huafeng Fang,
Chong Cheng, Peng Lu, Ke Zhang, Amy V. Walker, John-Stephen Taylor and Karen L.
Wooley ACS Nano 2009, 3(3), 673-681.]

Abstract
Polymer vesicles with diameters of ca. 100-600 nm and bearing benzaldehyde
functionalities within the vesicular walls were constructed through self assembly of an
amphiphilic block copolymer PEO45-b-PVBA26 in water.

The reactivity of the

benzaldehyde functionalities was verified by crosslinking the polymersomes, and also by
a one-pot crosslinking and functionalization approach to further render the vesicles
fluorescent, each via reductive amination.
nanostructures to undergo cell association.
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In vitro studies found these labelled

Introduction
Polymer vesicles, also known as “polymersomes”,1-6 are supramolecular
assemblies of amphiphilic block copolymers7-14 or complementary random copolymers15
with sizes ranging from tens of nanometers to several hundreds of microns (“giant
vesicles”).

Similar to liposomes, polymersomes are composed of closed bilayer

membranes with hollow cavities and, therefore, have tremendous potential for
encapsulation and controlled delivery.16-20 Moreover, their structures can be manipulated
on both polymeric and supramolecular levels to afford tunability of their properties,
including size control over nanoscale to microscale dimensions,21-24 external stimulus
responses,25-32 mechanical properties,33-35 membrane permeability,36-39 and in vivo fate.40,
41

Starting from the middle of the 1990s, a variety of polymer vesicles have been
developed and studied as efficient and promising candidates for the delivery of both
hydrophilic (encapsulated inside the hollow cavity) and hydrophobic (loaded within the
bilayer membrane wall) molecules. However, most of them consisted of amphiphilic
block copolymers with limited functionalities for chemical transformations after vesicle
construction. While polymersome surface functionalizations have been reported through
reactions with the functionalities installed at the chain ends of the hydrophilic
segments,42, 43 there are limited literature reports associated with modifications of wall
domains of polymersomes. Up to date, only radical polymerization,33, 44 photo-induced
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[2+2] cyclo-addition,15, 45-47 base-catalyzed self condensation of siloxanes,28, 48 and ringopening of epoxides49 have been employed to crosslink the walls of polymer vesicles.
With the increasing interests in potential biomedical applications that utilize the
membrane of polymersomes as a functional unit,18, 41, 50-53 introduction of highly reactive
functionalities into polymer vesicles is being explored to expand the scope of chemistries
that can be incorporated within such nanostructures. Herein, we report our approach for
constructing size-tunable polymersomes with benzaldehyde functionalities (a diverse
electrophile that undergoes reaction under mild conditions), as well as their crosslinking
and fluorophore-functionalization via reductive amination (Scheme 6.1).

Scheme 6.1. Construction and functionalization of PEO45-b-PVBA26 vesicles through
reductive amination.
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Results and Discussion
Synthesis of Amphiphilic Block Copolymer Precursor. Poly(ethylene oxide)b-poly(4-vinyl benzaldehyde) (PEO45-b-PVBA26), the amphiphilic diblock copolymer
precursor for benzaldehyde-functionalized polymersomes, was prepared following our
previously established method of reversible addition-fragmentation chain transfer
(RAFT) polymerization of VBA.54 The synthesis was conducted by using a monomethoxy terminated PEO-based macro-chain transfer agent (macro-CTA, Mn = 2,360 Da,
Figure 6.1a) and azobisisobutyronitrile (AIBN) in dry DMF heated at 75 °C for 3 h (
[VBA]0:[CTA]0:[AIBN]0 = 55:1:0.25; 55% conversion of VBA). 1H NMR spectroscopic
analysis of the isolated block copolymer (Figure 6.1b) confirmed successful chain
extension for the formation of the PVBA block (resonances at 1.5 to 2.5, 4.8, 6.5 to 7.5,
and 9.8 ppm) and maintenance of the RAFT agent chain-end group (resonances at 0.8 to
1.0, 1.3, and 3.2 ppm). The copolymer had a well-defined block structure of PEO45-bPVBA26, which was supported by agreement between the number-average molecular
weights by GPC (6,200 Da) and by 1H NMR spectroscopy (5,800 Da, based upon
comparison of the intensities of the resonances of the aldehyde proton of the VBA units
at 9.8 ppm and methylene protons of EO units at 3.6 ppm with the characteristic
resonances of the methine proton of the terminal monomer unit at 4.8 ppm and the SCH2
protons from the RAFT functionality at 3.2 ppm). GPC analysis further showed that the

143

block copolymer has a narrow and mono-modal molecular weight distribution (Figure
6.1c) with a polydispersity index (PDI) of 1.2.

Figure 6.1. Synthesis of and characterizations of PEO45-b-PVBA26 block copolymer
precursor. a) Schematic drawing of the synthesis of PEO45-b-PVBA26. b) 1H NMR
spectrum of PEO45-b-PVBA26. c) GPC profile of PEO45-b-PVBA26.

Construction and Characterization of PEO-b-PVBA Vesicles.

General

conditions under which amphiphilic block copolymers with a glassy hydrophobic
segment (Tg = 86 ºC for PVBA) can be assembled in aqueous solutions were then
applied.7, 20, 23, 36, 47 The PEO45-b-PVBA26 block copolymer precursor was first dissolved
into N,N-dimethylformamide (DMF, a good solvent for both PEO and PVBA blocks, ca.
1.0 mg/mL), followed by addition of nanopure water (a selective solvent for the PEO
block) until the water content reached 50 wt%. Finally, the DMF was removed by
extensive dialysis against water.
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The vesicles were characterized by transmission electron microscopy (TEM,
Figure 6.2a-b), scanning electron microscopy (SEM, Figure 6.2c-d), and dynamic light
scattering (DLS, Figure 6.2e). The vesicular structure was confirmed by TEM and SEM.
DLS analyses showed the hydrodynamic diameters of these vesicles were in the range of
ca. 100 to 600 nm, with an intensity-average hydrodynamic diameter distribution
centered at 290 nm and number-average hydrodynamic diameter distribution centered at
250 nm.

Figure 6.2. Characterization of polymer vesicles prepared from PEO45-b-PVBA26 block
copolymer. a-b) TEM images of vesicles (stained negatively with PTA). c-d) SEM
images of vesicles. e) DLS histograms of vesicle size distributions (left: intensityaverage hydrodynamic diameter; right: number-average hydrodynamic diameter).
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It is well-known that the formation of polymersomes usually passes through a
morphological transformation of sphere-rod-vesicle.4 To test whether this general trend
also applied to our system, D2O was added to a solution of PEO45-b-PVBA26 in DMF-d7
(2.0 mg/mL) and aliquots were taken at predetermined water contents (9, 17, 23, and 33
wt%, respectively) for 1H NMR and TEM measurements, the results are summarized in
Figure 6.3.

Figure 6.3. Morphological transformation during the self assembly process of PEO45-bPVBA26. a) 1H NMR spectra of aliquots in DMF-d7 with different D2O contents. b-d)
TEM micrographs of particles and vesicles (stained negative with phosphotungstic acid)
at 9, 17, and 23 wt% of water content, respectively.

At a low water content of 9 wt%, the 1H NMR spectrum (Figure 6.3a) showed no
obvious difference with the spectrum of the block copolymer in neat DMF. However, the
TEM image (Figure 6.3b) clearly indicated the formation of nano-sized objects with
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multiple morphologies including spherical particles, semi-closed membranes, and
vesicles, but no rods were observed. As the water content was increased to 17 wt%, the
resonance signals corresponding to PEO backbone at 3.5 ppm became broader and the
intensities of PVBA resonances (0.8-2.5, 6.7-7.6, and 9.9 ppm) decreased, indicating the
reduced flexibility of both structural blocks. TEM imaging (Figure 6.3c) revealed the
formation of small nanoparticles whose morphology could not be unambiguously
distinguished, and large aggregates (> 200 nm, Figure 6.3c insertion), which displayed
large-compound vesicular morphology. Finally, clear vesicular morphology appeared at
23 wt% of water content with varied size ranging from 100 to 600 nm (Figure 6.3d). At
this point, essentially no proton resonances from PVBA blocks were observed in the 1H
NMR spectrum, presumably because they were “tightly” packed into the vesicle walls
without significant mobility. Meanwhile, the resonances of PEO backbone protons were
further broadened, likely due to the restricted mobility of the EO units, especially those in
close proximity to the PVBA-based vesicle walls.
Interestingly, when the “intermediate” sample with a low water content of 9 wt%
was directly dialyzed against water, smaller vesicles with number-average hydrodynamic
diameter of ca. 90 nm were produced (Figure 6.4). These small vesicles were stable over
eight months, with no apparent growth in size. Although such size variation could not be
interpreted quantitatively at this stage, these findings indicated kinetic control of selfassembled nanostructures of block copolymers and might provide new insight for
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adjusting vesicle size without changing the chemical composition of their polymer
precursors.

Figure 6.4. Characterization of small PEO45-b-PVBA26 vesicles. a-b) TEM images of
vesicles (stained negatively with PTA). c) DLS histograms of vesicle size distributions
(number-average hydrodynamic diameter).

Crosslinking of PEO-b-PVBA Vesicles via Reductive Amination.

The

chemical accessibility of the aldehyde functionality in the vesicular wall was verified by
reductive amination-based crosslinking with 2,2´-(ethylene-dioxy)bis(ethylamine) (0.3
eq. relative to the aldehyde residues) and sodium cyanoborohydride (0.6 eq. relative to
the aldehyde residues). No significant aggregation of vesicles was observed, based upon
the DLS analysis (Figure 6.5a) and TEM imaging (Figure 6.5b), suggesting that only
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intra-vesicular crosslinking reactions occurred. It is noteworthy that after crosslinking,
the vesicles required buffer (5 mM pH 7.2 PBS with 5 mM of NaCl was used in our
experiments) to remain suspended in aqueous solution.

The zeta potential (ζ)

measurement showed a dramatic decrease of surface negative charge (-65.3 ± 0.7 mV vs.
-25.7 ± 0.8 mV), which might be associated with protonation of amines that were
incorporated into the vesicles as a result of the reductive amination chemistry. The need
for buffer and the less negative zeta potential value suggested that the structure of vesicle
was chemically changed after crosslinking, which was confirmed by

1

H NMR

spectroscopy (Figure 6.5e). New resonances corresponding to the diamino crosslinker
appeared at 3.3 ppm and the ratio of aldehyde protons vs. aromatic protons was decreased
from 1.0:4.6 to 1.0:6.2, indicating ca. 26% of aldehyde residues were consumed during
the reaction (i.e., 43% incorporation efficiency based upon reaction stoichiometry, which
was close to the results obtained by utilizing chromophores through the same chemistry,
vide infra). Typically, crosslinking leads to shorter relaxation times and broadening and
losses of solution-state NMR signal intensities. The observation of the new diamino
crosslinker resonance may indicate covalent mono-attachment within the vesicles,
providing a relatively low degree of crosslinking.

However, crosslinking indeed

occurred, as was observed by the changes in the robust physical characteristics for the
product vesicles. Of the 26% consumption of aldehydes, only a small fraction would be
required to effectively crosslink an entire vesicle. Crosslinking significantly increased
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the vesicle stability, and no appreciable variations in size or size distribution were found
after lyophilization and re-suspension of these vesicles (Figure 6.5d).

Figure 6.5. Characterization of crosslinked PEO45-b-PVBA26 vesicles through reductive
amination. a) DLS histograms of non-crosslinked (blue) and crosslinked (red) vesicle
distributions. b-c) TEM (b) and SEM (c) images of crosslinked vesicles in 5 mM pH 7.2
PBS. d) TEM image of lyophilized crosslinked vesicles after re-suspension in 5 mM pH
7.2 PBS. e) 1H NMR spectra (DMSO-d6) of lyophilized crosslinked vesicles (red) and
polymer precursor (black). f) IR spectra (KBr) of lyophilized crosslinked vesicles (red)
and polymer precursor (black).

In Vitro Cellular Studies. Amine-derived dyes were then incorporated into the
vesicles either sequentially or coincidentally with the crosslinking reaction via the same
chemistry, to demonstrate multiple couplings within a single nanostructure and to label
the vesicles for biological studies. The vesicles were functionalized with fluorecein and
crosslinked (0.02 eq. of dye, 0.5 eq. of crosslinker, 1 eq. of NaCNBH3 relative to the
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aldehydes, respectively), each via reductive amination in a one-pot approach. UV-vis
spectroscopy (Figure 6.6a) showed an absorption at 488 nm corresponding to the
fluorescein, with an incorporation efficiency of ca. 35 %. And again, no obvious size and
morphological variations were observed for the fluorescein-functionalized noncrosslinked and crosslinked vesicles, as confirmed by TEM (Figure 6.6b).

Figure 6.6. a) UV-vis profile of fluorescein dye-functionalized crosslinked vesicles. b)
TEM images of non-crosslinked (top) and crosslinked (bottom) fluorescent vesicles.

In vitro CHO and HeLa cell experiments were then conducted for crosslinked and
non-crosslinked fluorescein dye-labeled vesicles. By fluorescence confocal microscopy,
the vesicles were observed to undergo association with the cells, in a time-dependent
manner. No apparent fluorescence signal was detected after 1 and 4 h of incubation at 37
ºC. After 24 h, vesicles were visible under confocal microscopy (Figure 6.7e-h) and
quantified by flow cytometry (Figure 6.7i) for both cell lines. Interestingly, an increased
fraction of vesicles was observed to be associated with HeLa cells after the vesicles were
crosslinked, while the opposite trend was noticed for CHO cells, with a greater fraction of
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non-crosslinked vesicles undergoing strong cellular interactions. It is uncertain whether
the vesicles are internalized within the cells. Although flow cytometry data confirmed
that the vesicles remained associated with the cells under demanding conditions, the
confocal microscopy images suggest that the vesicles are localized preferentially near the
cell membrane.

We hypothesize that such behavior may be the result of physical

association or that it could be due to covalent coupling reactions between the aldehydeloaded vesicles and amino-groups on (membrane bound) proteins. Although equimolar
amounts of aldehyde and reducing agent were employed during the preparation of the
fluoroescein-labeled, crosslinked vesicles, a portion of aldehydes still remain, as
indicated by the 1H NMR (Figure 6.5e) and IR data (Figure 6.5f) collected during the
crosslinking experiments (vide supra).
The cytotoxicity of the crosslinked vesicles was also tested, using the cationic
dendrimer polyfect as a positive control. Compared with polyfect, these vesicles had
insignificant cytotoxicity for both cell lines (Figure 6.7j-k), indicating their biocompatibility and making them promising materials for fundamental studies in
biotechnology.
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Figure 6.7. In vitro evaluations of fluorescein-labeled vesicles. a-b) Fluorescent
confocal and bright-field images of CHO cells, respectively, without incubation with
fluorescent vesicles. c-d) Fluorescent confocal and bright-field images of HeLa cells,
respectively, without incubation with fluorescent vesicles. e-f) Overlay of bright field
and fluorescent confocal images of CHO cells incubated with crosslinked and noncrosslinked vesicles, respectively. g-h) Overlay of bright field and fluorescent confocal
images of HeLa cells incubated with crosslinked and non-crosslinked vesicles,
respectively. i) Flow cytometry results. j-k) Cytotoxicity results for CHO and HeLa
cells, respectively.

Conclusions
In summary, we have synthesized polymer vesicles bearing benzaldehyde
functionalities in the vesicular walls from self assembly of the block copolymer PEO45-bPVBA26. The aldehyde functionalities were shown to allow for modifications through
facile and practical chemistry. Further investigations of the chemistry of these synthetic
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and reactive vesicles, including optimizing the reaction efficiency, exploring its scope,
and incorporating other labels and ligands, are ongoing now.

These robust

nanostructures, with their ability to associate with the cell membrane, may find
application as a nanoscopic device for repair or modification of cellular membrane
functions.

Experimental Section
Materials.

Mono-methoxy terminated mono-hydroxy poly(ethylene glycol)

(mPEG2k, MW = 2,000 Da, PDI = 1.06) was purchased from Intezyne Technologies
(Tampa, FL) and was used without further purification. S-1-dodecyl-S΄-(α,α´-dimethylα´´-acetic

acid)trithiocarbonate

(DDMAT),55

4-(Dimethy1amino)pyridinium

4-

Toluenesulfonate (DTPS),56 and VBA54 were synthesized according to literature reports.
Other reagents and solvents were purchased from commercial sources (Sigma-Aldrich,
Acrose, and Fluka) and were used without further purification unless otherwise noted.
Methylene chloride (CH2Cl2) was distilled from calcium hydride and stored under N2
before using.
Cell Culture. Chinese Hamster Ovary cells (CHO-K1) and human cervix carcinoma
(HeLa) cells were cultivated in DMEM containing 10% FBS, streptomycin (100 μg/mL),
and penicillin (100 units/mL) at 37 °C in a humidified atmosphere containing 5% CO2.
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Measurements. 1H NMR spectra were recorded on a Varian 500 MHz spectrometer
interfaced to a UNIX computer using Mercury software. Chemical shifts were referred to
the solvent proton resonance.

Infrared spectra were obtained on a Perkin-Elmer

Spectrum BX FT-IR system using diffuse reflectance sampling accessories with FT-IR
Spectrum v2.00 software.
Absolute molecular weight and molecular weight distribution were determined by Gel
Permeation Chromatography (GPC). GPC was performed on a Waters 1515 HPLC
system (Water Chromatography Inc.), equipped with a Waters 2414 differential
refractometer, a PD2020 dual-angle (15 and 90) light scattering detector (Precision
Detectors Inc.), and a three-column series PL gel 5 μm Mixed columns (Polymer
Laboratories Inc.). The eluent was anhydrous tetrahydrofuran (THF) with a flow rate of
1 mL/min.

All instrumental calibrations were conducted using a series of nearly

monodispersed polystyrene standards. Data were collected upon an injection of a 200 μL
of polymer solution in THF (ca. 5 mg/mL), and then analyzed using Discovery 32
software (Precision Detectors Inc.).
Samples for Transmission electron microscopy (TEM) measurements were diluted
with a 1 % phosphotungstic acid (PTA) stain (v/v, 1:1). Carbon grids were exposed to
oxygen plasma treatment to increase the surface hydrophilicity.

Micrographs were

collected at 10,000, 20,000, 50,000, and 100,000 × magnification and calibrated using a
41 nm polyacrylamide bead from NIST.
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Scanning electron microscopy (SEM) measurements were performed on a Field
Emission Scanning Electron Microscope (Hitachi s-4500), equipped with a NORAN
Instruments energy dispersive x-ray (EDX) microanalysis system, a back scattering
detector and a mechanical straining stage.

SEM samples were prepared with the

following procedure. Silica native oxide wafers (Addison Engineering Inc.) were cleaned
with nitric acid and hydrochloride acid (1:3) and then cut into 5 mm × 5 mm square. For
each sample, 50 μL of aqueous solution was applied directly on the cleaned Si surface,
and the solvent was kept in fume hood to evaporate at ambient temperature (21 ± 2 °C).
The samples were immediately transferred to SEM instrument for measurement after
completely dried.
Hydrodynamic diameters (Dh) and size distributions for the vesicles in aqueous
solutions were determined by dynamic light scattering (DLS). The DLS instrumentation
consisted of a Brookhaven Instruments Limited (Worcestershire, U.K.) system, including
a model BI-200SM goniometer, a model BI-9000AT digital correlator, a model EMI9865 photomultiplier, and a model 95-2 Ar ion laser (Lexel Corp.) operated at 514.5 nm.
Measurements were made at 25 ± 1 °C. Scattered light was collected at a fixed angle of
90°. The digital correlator was operated with 522 ratio spaced channels, and initial delay
of 5 μs, a final delay of 100 ms, and a duration of 6 minutes. A photomulitplier aperture
of 100 μm was used, and the incident laser intensity was adjusted to obtain a photon
counting of between, 200 and 300 kcps. Only measurements in which the measured and
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calculated baselines of the intensity autocorrelation function agreed to within 0.1 % were
used to calculate particle size. The calculations of the particle size distributions and
distribution averages were performed with the ISDA software package (Brookhaven
Instruments Company), which employed single-exponential fitting, cumulants analysis,
and CONTIN particle size distribution analysis routines.

All determinations were

repeated for 5 times.
Zeta potential (ζ) values for the vesicle solution samples in 5 mM phosphate buffered
saline (PBS) were determined with a Brookhaven Instrument Co. (Holtsville, NY) model
Zeta Plus zeta potential analyzer.

Data were acquired in the phase analysis light

scattering (PALS) mode following solution equilibration at 25 °C. Calculation of ζ from
the measured nanoparticle electrophoretic mobility (μ) employed the Smoluchowski
equation: μ = εζ/η, where ε and η are the dielectric constant and the absolute viscosity of
the medium, respectively. Measurements of ζ were reproducible to within ± 2 mV of the
mean value given by 16 determinations of 10 data accumulations.
The confocal microscopy was collected by using a Leica TCS SP2 confocal
microscopy following excitation with an argon laser (488 nm).

5×105 cells were

incubated on 35 mm MatTek glass bottom microwell dishes (MatTek Co.) for 24 h. Then
the medium was replaced with 2 mL of fresh medium containing with non-crosslinked or
crosslinked vesicles (10 μg/mL of polymer) and incubated for another 24 h. Cells were
washed twice with PBS and the live cells were imaged.
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Flow cytometric analysis for the strong association of the vesicles to the cells was
performed using a FACS-calibur (Becton Dickinson) equipped with an argon laser
exciting at a wavelength of 488 nm. The cells were treated same as above. For each
sample, 20,000 events were collected by list-mode data that consisted of side scatter,
forward scatter, and fluorescence emission centered at 530 nm. The fluorescence was
collected at a logarithmic scale with a 1024 channel resolution. CellQuest software
(Becton Dickinson) was applied for the analyses.
The cytotoxicity of crosslinked vesicles was examined by CellTiter-Glo® Luminescent
Cell Viability Assay (Promega Co.). The CHO-K1 cells and HeLa cells were seeded
respectively in the 96-well plate at a density of 1×104 cells/well and cultured for 24 h in
100 µL DMEM containing 10% FBS. Thereafter, the medium was replaced with 100 µL
of fresh medium containing with different concentration particles.
incubation, 100 μL of the CellTiter-Glo® reagent was added.

After 24 h of

Mixed contents and

allowed the plate to incubate at rt for 10 min to stabilize luminescent signal, recorded the
luminescence at Luminoskan Ascent® luminometer (Thermo Scientific) with integration
time 1 second per well. The relative cell viability was calculated as: cell viability (%) =
(luminescence

(sample)/luminescence (control))

× 100, where luminescence

(control)

was

obtained in the absence of particles and luminescence (sample) was obtained in the presence
of particles.
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Synthesis of mPEG2k Macro-CTA. To a solution of mPEG2000 (4.0 g, 2.0 mmol)
in 40 mL of dry CH2Cl2 at room temperature (rt), was added DDMAT (1.2 g, 3.0 mmol)
and dicyclohexylcarbodiimide (0.60 g, 2.9 mmol), the reaction mixture was stirred 10
min. After the additions of 4-di(methylamino)pyridine (36.6 mg, 0.3 mmol) and DPTS
(375.0 mg, 1.2 mmol), the reaction mixture was further stirred 20 h at rt. Then the
reaction mixture was filtered with celite and the filtrate was placed at 4 ºC overnight,
filtered with celite, and concentrated to ca. 15 mL. After the solution was precipitated
into 250 mL of dry ether at 0 ºC twice, the crude product obtained was further purified by
flash column chromatography (2-3% MeOH/CH2Cl2, v/v) to afford mPEG2k macro-CTA
as a yellow solid (3.2 g, 68% yield). 1H NMR (500 MHz, CD2Cl2, δ): 0.88 (t, J = 6.5 Hz,
3H), 1.26 (m, 16H), 1.38 (t, J = 6.5 Hz, 2H), 1.66 (t, J = 7.5 Hz, 2H), 1.68 (s, 6H), 3.27
(t, J = 7.2 Hz, 2H), 3.33 (s, 3H), 3.40-3.80 (m, 166H), 4.21 (t, J = 5.0 Hz, 2H).
Synthesis of PEO45-b-PVBA26. To a 10 mL Schlenk flask equipped with a magnetic
stir bar dried with flame under N2 atmosphere, was added the mPEG2k macro-CTA (0.48
g, 0.20 mmol) and dry DMF (2.5 mL). The reaction mixture was stirred 1 h at rt to
obtain a homogeneous solution. To this solution was added VBA (1.46 g, 11.0 mmol)
and AIBN (8.1 mg, 50 μmol). The reaction flask was sealed and stirred 10 min at rt. The
reaction mixture was degassed through several cycles of freeze-pump-thaw. After the
last cycle, the reaction mixture was stirred for 10 min at rt before immersing into a preheated oil bath at 75 °C to start the polymerization. After 3.5 h, the monomer conversion
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reached ca. 55% by analyzing aliquots collected through 1H-NMR spectroscopy. The
polymerization was quenched by cooling the reaction flask with liquid N2. CH2Cl2 (5.0
mL) was added to the reaction flask and the polymer was purified by precipitation into
300 mL of cold diethyl ether at 0 °C twice. The precipitants were collected, washed with
100 mL of cold ether, and dried under vacuum overnight to afford the block copolymer
precursor as a yellow solid (1.18 g, 90% yield based upon monomer conversion).

1

H

NMR (500 MHz, CD2Cl2, δ): 0.88-1.24 (br, dodecyl Hs), 1.52-2.06 (br, PVBA backbone
protons), 3.22 (br, SCH2 of the chain terminus), 3.33 (s, mPEG terminal OCH3), 3.343.78 (m, OCH2CH2O from the PEG backbone), 4.84 (br, 1H from the PVBA backbone
benzylic terminus connected to trithiocarbonate), 6.58-6.85 (br, Ar H), 7.33-7.62 (br, Ar
H), 9.88 (br, CHO);

13

C NMR (150 MHz, DMSO-d6, δ): 192.3 , 151.3, 134.4, 129.4,

128.0, 69.8, 42.3, 40.4, 29.0; IR (KBr): 3433, 2923, 2856, 2732, 1699, 1604, 1575, 1453,
1425, 1386, 1354, 1306, 1258, 1214, 1171, 1103, 1017, 951, 837, 726, 674, 552.
General Procedure for Construction of PEO45-b-PVBA26 Vesicles. To a solution
of PEO45-b-PVBA26 block copolymer in DMF (ca. 1.0 mg/mL), was added dropwise an
equal volume of nano-pure H2O via a syringe pump at a rate of 15.0 mL/h, and the
mixture was further stirred for 16 h at rt. The solution was then transferred to pre-soaked
dialysis tubing with Molecular Weight Cut Off (MWCO) of ca. 3,500 Da and dialyzed
against nano-pure H2O for 4 d to afford a solution of vesicles.
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Crosslinking of PEO45-b-PVBA26 Vesicles.

To a solution of PEO45-b-PVBA26

vesicles (7.4 mg of polymer, 33 μmol of aldehyde residues) in 30.0 mL of nano-pure
H2O, was added a solution of 2,2'-(ethylenedioxy)-bis(ethylamine) (1.5 mg, 10 μmol) in
1.0 mL of nano-pure H2O dropwise over 10 min. The reaction mixture was allowed to
stir for 24 h at rt. NaBH3CN (1.3 mg, 20 μmol) in 1.3 mL of nano-pure H2O was then
added to the reaction solution and further stirred for 16 h at rt. Finally, the mixture was
transferred to pre-soaked dialysis tubing (MWCO: ca. 3,500 Da) and dialyzed against 5.0
mM PBS (pH 7.2, with 5.0 mM NaCl) for 5 d to remove the small molecule by-products
and afford an aqueous solution of crosslinked vesicles.
One-pot Functionalization and Crosslinking of PEO45-b-PVBA26 Vesicles. To a
solution of PEO45-b-PVBA26 vesicles (3.2 mg of polymer, 14 μmol of aldehyde residues)
in 10.0 mL of nano-pure H2O, was added a solution of fluorescein-5-thiosemicarbazide
(126.3 μg, 0.30 μmol) in 90.0 μL of DMF. The reaction mixture was allowed to stir for 2
h at rt in the absence of light. To this reaction mixture, was added a solution of 2,2'(ethylenedioxy)-bis(ethylamine) (1.1 mg, 7.2 μmol) in 1.6 mL of nano-pure H2O
dropwise over 10 min. The reaction mixture was further stirred for 24 h at rt in the
absence of light. NaBH3CN (907.2 μg, 14.4 μmol) in 0.4 mL of nano-pure H2O was then
added to the reaction solution and further stirred for 16 h at rt in the absence of light.
Finally, the mixture was transferred to pre-soaked dialysis tubing (MWCO ca. 3,500 Da)
and dialyzed against 5.0 mM PBS (pH 7.2, with 5.0 mM NaCl) for 5 d to remove the
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small molecule by-products and afford an aqueous solution of functionalized and
crosslinked vesicles.
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Chapter 7

Optimizations of Quantum Yield of Fluorescent Nanoparticles for
Development of Potential Optical Imaging Contrast Agents

Guorong Sun, Mikhail Y. Berezin, Jinda Fan, Ke Zhang,
Samuel Achilefu, and Karen L. Wooley

Introduction
During the past decades, in vivo fluorescence imaging has experienced a
renaissance with the “opening” of near-infrared (NIR) window (wavelength between 650
and 900 nm) of electromagnetic spectrum.1-7 By utilizing fluorescent probes such as
quantum dots,8-10 fluorescent proteins,11, 12 and organic NIR dyes,13-20 two main problems
(i.e. tissue autofluorescense and attenuation) associated with deep tissue imaging have
been partially overcome, and now, in vivo optical imaging of a few centimeters depth has
been achieved.
Among the organic NIR fluorophores (NIRFs), carbocyanine-based dyes are
particularly of interest due to their high molar extinction coefficients (usually on the
order of 105 M-1 cm-1) and tunability of photo-physical properties.19 These fluorophores
are also facile to be functionalized with bioactive ligands to enable targeted imaging.15, 21171

23

However, the in vivo application of cyanine dyes generally suffers from high

degradation

rate,

short

blood

circulation

times,

non-specific

tissue/organ

accumulations.24-27 One practical and promising approach for prevailing over the above
drawbacks is to encapsulate/couple cyanine dyes within/onto nanoscale platforms, which
can provide protection and “stealth” properties from the blood clearance systems.14, 28-45
The nanoscale platform can further be decorated with multiple homo- or heterogeneous
targeting agents to improve targeting efficiency by taking advantage of the multivalent
interactions with cell-surface receptors. Furthermore, this approach may allow for the
“hybridization” of different probes within a single nanoparticle to enable multimodal
imaging for increased of the diagnostic accuracy.42, 46-50
Spherical nanoparticles (NPs) represent the most widely applied nanostructures in
molecular imaging. To date, cyanine NIRF-functionalized dendrimers,37, 48 silica NPs,30,
34, 35, 39, 44, 51, 52

and natural/engineered viruses29, 33 have been reported from academic and

industrial research groups. It is well-known that fluorescent tags often suffer from the
fluorescence “self quenching” when placed in close proximity.

In order to obtain

maximized fluorescence, the distance between fluorophores should be greater than the
Forster radius to avoid the non-radiative energy transfer of the same fluorophores. In this
work, we investigated the stoichiometry dependence of fluorophores (fluorescein and
cypate, respectively) per nanoparticle by calculating the distance of two adjacent
fluorophores through both steady-state and dynamic emission spectra, in comparison with
172

the Forster radius. We also proposed and examined a semi-quantitative model (vide
infra) for estimating the maximum number of fluorophores per spherical nanoparticle
while retaining satisfactory QY of the fluorophores.

Experimental Section
Materials.

Mono-methoxy terminated mono-hydroxy poly(ethylene glycol)

(mPEG2k and mPEG5k, MW = 2,000 and 5,000 Da, respectively, PDI = 1.06 and 1.07,
respectively) was purchased from Intezyne Technologies (Tampa, FL) and was used
without further purification.
acetic

acid)trithiocarbonate

Cypate,14 HL-800,17 S-1-dodecyl-S΄-(α,α´-dimethyl-α´´(DDMAT),53

4-(Dimethy1amino)pyridinium

4-

Toluenesulfonate (DTPS),54 VBA,55 mPEG2k macro-chain transfer agent (macroCTA),56 and poly(ethylene oxide)-block-poly(N-acryloxysuccinimide)-block-polystyrene
(PEO45-b-PNAS95-b-PS60)57 were synthesized according to literature reports.

Other

reagents and solvents were purchased from commercial sources (Sigma-Aldrich, Acrose,
and Fluka) and were used without further purification unless otherwise noted. Methylene
chloride (CH2Cl2) was distilled from calcium hydride and stored under N2 before using.
Measurements. 1H NMR spectra were recorded on a Varian 500 MHz spectrometer
interfaced to a UNIX computer using Mercury software. Chemical shifts were referred to
the solvent proton resonance.

Infrared spectra were obtained on a Perkin-Elmer
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Spectrum BX FT-IR system using diffuse reflectance sampling accessories with FT-IR
Spectrum v2.00 software.
Absolute molecular weight and molecular weight distribution were determined by Gel
Permeation Chromatography (GPC). GPC was performed on a Waters 1515 HPLC
system (Water Chromatography Inc.), equipped with a Waters 2414 differential
refractometer, a PD2020 dual-angle (15 and 90) light scattering detector (Precision
Detectors Inc.), and a three-column series PL gel 5 μm Mixed columns (Polymer
Laboratories Inc.). The eluent was anhydrous tetrahydrofuran (THF) with a flow rate of
1 mL/min.

All instrumental calibrations were conducted using a series of nearly

monodispersed polystyrene standards. Data were collected upon an injection of a 200 μL
of polymer solution in THF (ca. 5 mg/mL), and then analyzed using Discovery 32
software (Precision Detectors Inc.).
The

N,N-dimethylformamide

(DMF)

GPC

was

conducted

on

a

Waters

Chromatography, Inc. (Milford, MA) system equipped with an isocratic pump model
1515, a differential refractometer model 2414, and a two-column set of Styragel HR 4
and HR 4E 5 µm DMF 7.8 × 300 mm columns. The system was equilibrated at 70 °C in
pre-filtered DMF containing 0.05 M LiBr, which served as polymer solvent and eluent
(flow rate set to 1.00 mL/min). Polymer solutions were prepared at a concentration of ca.
3 mg/mL and an injection volume of 200 µL was used. Data collection and analysis was
performed with Empower Pro software (Waters, Inc.). The system was calibrated with
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poly(ethylene glycol) standards (Polymer Laboratories, Amherst, MA) ranging from 615
to 442,800 Da.
Samples for Transmission electron microscopy (TEM) measurements were diluted
with a 1 % phosphotungstic acid (PTA) stain (v/v, 1:1). Carbon grids were exposed to
oxygen plasma treatment to increase the surface hydrophilicity.

Micrographs were

collected at 100,000 × magnification and calibrated using a 41 nm polyacrylamide bead
from NIST. The number average particle diameters (Dav) and standard deviations were
generated from the analysis of a minimum of 150 particles from at least three different
micrographs. The aggregation number (Naggr) was calculated based upon the diameter
measured from TEM by using the following equation:

4 3
πr ρ
× NA
Naggr = 3
Mn

(1)

where r is the radius of the NP core domain, ρ is the density of poly(4-vinyl
benzaldehyde) (PVBA), Mn is the number-average molecular weight of PVBA block
segment, and NA is the Avogadro constant.
Hydrodynamic diameters (Dh) and size distributions for the nanoparticles in aqueous
solutions were determined by dynamic light scattering (DLS). The DLS instrument
consisted of a Brookhaven Instruments Limited (Worcestershire, U.K.) system, including
a model BI-200SM goniometer, a model BI-9000AT digital correlator, a model EMI9865 photomultiplier, and a model 95-2 Ar ion laser (Lexel Corp.) operated at 514.5 nm.
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Measurements were made at 25 ± 1 °C. Scattered light was collected at a fixed angle of
90°. The digital correlator was operated with 522 ratio spaced channels, and initial delay
of 5 μs, a final delay of 100 ms, and a duration of 8 minutes. A photomulitplier aperture
of 400 μm was used, and the incident laser intensity was adjusted to obtain a photon
counting of between, 150 and 200 kcps. Only measurements in which the measured and
calculated baselines of the intensity autocorrelation function agreed to within 0.1 % were
used to calculate particle size. The calculations of the particle size distributions and
distribution averages were performed with the ISDA software package (Brookhaven
Instruments Company), which employed single-exponential fitting, cumulants analysis,
and CONTIN particle size distribution analysis routines.

All determinations were

repeated for 5 times and the data were represented as mean values ± standard deviations
between runs.
For optical measurements, the fluorescein-based NPs were diluted with 0.1 M NaOH
solution. Cypate-based nanoparticles were measured in PBS buffer at pH 7.2 (5 mM with
5 mM of NaCl). Both samples were diluted to a concentration where the absorbance
value at maximum absorption peak was less than 0.1 to avoid self-quenching between
nanoparticles and photon re-absorption.
The UV-vis absorption spectra of NPs were collected at room temperature using
Varian Cary 500 Bio UV-visible spectrophotometer and quartz cuvette with 10 mm of
light path.
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The fluorescence spectra of NPs were obtained at room temperature using a Varian
Cary Eclipse and Fluorolog III fluorescence spectrophotometer. Fluorescence lifetime
was measured using TCSPS method as described previously.

For NPs bearing

fluoresceins, the fluorescence decays were measured in aqueous media using excitation
source Nanoled® 460 nm, monitored emission at 570 nm with bandpass 20 nm. For NPs
bearing cypate, the fluorescence lifetimes were determined in aqueous media using
excitation source Nanoled® 773 nm, monitored emission 820 nm with bandpass 20 nm.
In both measurements, a two-exponential decay analysis was applied.
The Foster radius of a homoFRET pair (R0) was calculated using previously
developed FRET calculator from steady-state absorption and emission spectra using
known equations:
0

0.211

2 -4

/
D

Å

(2)

where n is the refraction index typically assumed to be 1.4 for biomolecules in aqueous
solutions; k2 is the orientation factor typically equal to 2/3 for random distributed
fluorophores; QD is the quantum yield of the donor;

is the spectral overlap integral,

which is calculated by the following equation:
∞

M-1 cm-1 nm4

represents the normalized fluorescence

where λ represents the wavelength in nm;
intensity at wavelength λ;

(3)

represents molar absorptivity of the acceptor at given

wavelength.
177

Synthesis of cypate-diamine. To a DMF solution of Cypate (12.5 mg, 17.7 μmol)
and 1-hydroxybenzotriazole (HOBt, 9.6 mg, 70.8 μmol) was added N,N´diisopropylcarbodiimide (DIC) (11.0 μL, 70.8 μmol), the resulting mixture was stirred for
10 min. Boc-ethylene diamine (6.7 μL, 42.3 μmol) was then added and the mixture was
stirred overnight at room temperature (rt). After removing the DMF in vacuo, a solution
of trifluoroacetic acid (TFA), H2O, phenol, and thioanisole (85:5:5:5, v/v) was added and
stirred for 1 h at rt. The volatiles were removed under reduced pressure and the crude
product was washed with diethyl ether (3 × 5mL) and purified by medium pressure
chromatography with a C-18 reverse phase column (acetonitrile/water as eluent). A
green solid was obtained as pure product (10.9 mg, 60.6% yield). MS (EI): 709.0 (M +
1)+.
Synthesis of HL-800-amine. To a solution of HL-800 (10.4 mg, 11.2 μmol) and 2(1H-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl

uronium

hexafluorophosphate

methanaminium (HATU, 6.4 mg, 16.8 μmol) in DMF, was added diisopropylethyl amine
(DIEA, 2.9 μL, 16.8 μmol), the resulting mixture was stirred at rt for 10 min. Bocethylene diamine (2.1 μL, 20.1 μmol) was added and the mixture was stirred overnight at
rt. The reaction mixture was then poured into 150 mL of diethyl ether. Collect the solid
precipitated out and a solution of TFA, H2O, phenol, and thioanisole (85:5:5:5, v/v) was
added following by stirring for 1 h at rt. The crude product was precipitated out by
diethyl ether, washed with diethyl ether (3×5 mL) and purified by medium pressure
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chromatography with a C-18 reverse phase column (acetonitrile/water as eluent). The
solvents were evaporated to give HL-800-amine (3.18mg, 29.2% yield) as a green solid.
MS (EI): 955.2 (M + 1)+.
Synthesis of mPEG5k macro-CTA. To a solution of mPEG5000 (1.80 g, 0.36
mmol) in 20 mL of dry CH2Cl2 at rt, was added DDMAT (0.20 g, 0.54 mmol) and
dicyclohexylcarbodiimide (0.12 g, 0.54 mmol), the reaction mixture was stirred 10 min.
After the additions of 4-di(methylamino)pyridine (13.2 mg, 0.11 mmol) and DPTS (68.6
mg, 0.22 mmol), the reaction mixture was further stirred 20 h at rt. Then the reaction
mixture was filtered with celite and the filtrate was placed at 4 ºC overnight, filtered with
celite, and concentrated to ca. 8 mL. After the solution was precipitated into 150 mL of
dry ether at 0 ºC twice, the crude product obtained was further purified by flash column
chromatography (2-3% MeOH/CH2Cl2, v/v) to afford mPEG5k macro-CTA as a yellow
solid (1.2 g, 60% yield). 1H NMR (500 MHz, CD2Cl2, δ): 0.88 (t, J = 6.5 Hz, 3H), 1.26
(m, 16H), 1.38 (t, J = 6.5 Hz, 2H), 1.66 (t, J = 7.5 Hz, 2H), 1.68 (s, 6H), 3.27 (t, J = 7.2
Hz, 2H), 3.33 (s, 3H), 3.40-3.80 (m, 440H), 4.21 (t, J = 5.0 Hz, 2H).
Synthesis of PEO45-b-PVBA18. To a 10 mL Schlenk flask equipped with a magnetic
stir bar dried with flame under N2 atmosphere, was added the mPEG2k macro-CTA (0.24
g, 0.10 mmol) and dry DMF (2.5 mL). The reaction mixture was stirred 1 h at rt to
obtain a homogeneous solution. To this solution was added VBA (0.66 g, 5.0 mmol) and
AIBN (3.2 mg, 20 μmol). The reaction flask was sealed and stirred 10 min at rt. The
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reaction mixture was degassed through several cycles of freeze-pump-thaw. After the
last cycle, the reaction mixture was stirred for 10 min at rt before immersing into a preheated oil bath at 75 °C to start the polymerization. After 4 h, the monomer conversion
reached ca. 30% by analyzing aliquots collected through 1H-NMR spectroscopy. The
polymerization was quenched by cooling the reaction flask with liquid N2. CH2Cl2 (5.0
mL) was added to the reaction flask and the polymer was purified by precipitation into
300 mL of cold diethyl ether at 0 °C twice. The precipitants were collected, washed with
100 mL of cold ether, and dried under vacuum overnight to afford the block copolymer
precursor as a yellow solid (0.35 g, 80% yield based upon monomer conversion).

1

H

NMR (500 MHz, CD2Cl2, δ): 0.88-1.24 (br, dodecyl Hs), 1.52-2.06 (br, PVBA backbone
protons), 3.22 (br, SCH2 of the chain terminus), 3.33 (s, mPEG terminal OCH3), 3.343.78 (m, OCH2CH2O from the PEG backbone), 4.84 (br, 1H from the PVBA backbone
benzylic terminus connected to trithiocarbonate), 6.58-6.85 (br, Ar H), 7.33-7.62 (br, Ar
H), 9.88 (br, CHO);

13

C NMR (150 MHz, DMSO-d6, δ): 192.3 , 151.3, 134.4, 129.4,

128.0, 69.8, 42.3, 40.4, 29.0; IR (KBr): 3433, 2923, 2856, 2732, 1699, 1604, 1575, 1453,
1425, 1386, 1354, 1306, 1258, 1214, 1171, 1103, 1017, 951, 837, 726, 674, 552.
Synthesis of PEO113-b-PVBA46.

To a 25 mL Schlenk flask equipped with a

magnetic stir bar dried with flame under N2 atmosphere, was added the mPEG5k macroCTA (0.58 g, 0.11 mmol) and dry DMF (7.0 mL). The reaction mixture was stirred 1 h at
rt to obtain a homogeneous solution. To this solution was added VBA (1.5 g, 11.0 mmol)
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and AIBN (3.4 mg, 21 μmol). The reaction flask was sealed and stirred 10 min at rt. The
reaction mixture was degassed through several cycles of freeze-pump-thaw. After the
last cycle, the reaction mixture was stirred for 10 min at rt before immersing into a preheated oil bath at 75 °C to start the polymerization. After 5.5 h, the monomer conversion
reached ca. 47% by analyzing aliquots collected through 1H-NMR spectroscopy. The
polymerization was quenched by cooling the reaction flask with liquid N2. CH2Cl2 (5.0
mL) was added to the reaction flask and the polymer was purified by precipitation into
300 mL of cold diethyl ether at 0 °C twice. The precipitants were collected, washed with
100 mL of cold ether, and dried under vacuum overnight to afford the block copolymer
precursor as a yellow solid (0.92 g, 75% yield based upon monomer conversion).

1

H

NMR (500 MHz, CD2Cl2, δ): 0.88-1.24 (br, dodecyl Hs), 1.52-2.06 (br, PVBA backbone
protons), 3.22 (br, SCH2 of the chain terminus), 3.33 (s, mPEG terminal OCH3), 3.343.78 (m, OCH2CH2O from the PEG backbone), 4.84 (br, 1H from the PVBA backbone
benzylic terminus connected to trithiocarbonate), 6.58-6.85 (br, Ar H), 7.33-7.62 (br, Ar
H), 9.88 (br, CHO);

13

C NMR (150 MHz, DMSO-d6, δ): 192.3 , 151.3, 134.4, 129.4,

128.0, 69.8, 42.3, 40.4, 29.0; IR (KBr): 3433, 2923, 2856, 2732, 1699, 1604, 1575, 1453,
1425, 1386, 1354, 1306, 1258, 1214, 1171, 1103, 1017, 951, 837, 726, 674, 552.
General procedure for construction of PEO-b-PVBA micelles. To a solution of
PEO-b-PVBA block copolymer in DMF (ca. 1.0 mg/mL), was added dropwise an equal
volume of nano-pure H2O via a syringe pump at a rate of 15.0 mL/h, and the mixture was
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further stirred for 16 h at rt. The solution was then transferred to pre-soaked dialysis
tubing with Molecular Weight Cut Off (MWCO) of ca. 3,500 Da and dialyzed against
nano-pure H2O for 4 d to afford a solution of micelles.
General procedure for one-pot functionalization and crosslinking of PEO-bPVBA micelles with fluorescein-5-thiosemicarbazide. To a solution of PEO-b-PVBA
micelles in 10.0 mL of nano-pure H2O, was added a solution of fluorescein-5thiosemicarbazide (20 mol%, 2 mol%, 1 mol%, and 0.5 mol%, relative to the aldehyde
residues, respectively) in DMF. The reaction mixture was allowed to stir for 2 h at rt in
the absence of light.

To this reaction mixture, was added a solution of 2,2'-

(ethylenedioxy)-bis(ethylamine) (150 mol%, relative to the aldehyde residues) in nanopure H2O dropwise over 10 min. The reaction mixture was further stirred for 48 h at rt in
the absence of light. NaBH3CN (200 mol%, relative to the aldehyde residues) in nanopure H2O was then added to the reaction solution and further stirred for 16 h at rt in the
absence of light. Finally, the mixture was transferred to pre-soaked dialysis tubing
(MWCO ca. 3,500 Da) and dialyzed against 5.0 mM PBS (pH 7.2, with 5.0 mM NaCl)
for 7 d to remove the small molecule by-products and afford an aqueous solution of
fluorescein-functionalized crosslinked nanoparticles.
General procedure for one-pot functionalization and crosslinking of PEO113-bPVBA46 micelles with cypate-diamine. To a solution of PEO113-b-PVBA46 micelles
(2.7 mg of polymer, 10.8 μmol of aldehyde residues) in 10.0 mL of nano-pure H2O, was
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added a solution of cypate-diamine (1 mol%, 0.5 mol%, and 0.2 mol%, relative to the
aldehyde residues, respectively) in DMF. The reaction mixture was allowed to stir for 2
h at rt in the absence of light. To this reaction mixture, was added a solution of 2,2'(ethylenedioxy)-bis(ethylamine) (2.4 mg, 16.2 μmol) in nano-pure H2O dropwise over 10
min. The reaction mixture was further stirred for 48 h at rt in the absence of light.
NaBH3CN (1.4 mg, 21.6 μmol) in nano-pure H2O was then added to the reaction solution
and further stirred for 16 h at rt in the absence of light. Finally, the mixture was
transferred to pre-soaked dialysis tubing (MWCO ca. 6,000-8,000 Da) and dialyzed
against 5.0 mM PBS (pH 7.2, with 5.0 mM NaCl) for 7 d to remove the small molecule
by-products and afford an aqueous solution of functionalized and crosslinked
nanoparticles.
Micellization of PEO45-b-PNAS95-b-PS60. To a solution of PEO45-b-PNAS95-b-PS60
block copolymer in DMF (ca. 1.0 mg/mL), was added dropwise an equal volume of
nano-pure H2O via a syringe pump at a rate of 15.0 mL/h, and the mixture was further
stirred for 1 h at rt before using for the following reactions.
Functionalization and crosslinking of PEO45-b-PNAS95-b-PS60 micelles with
cypate-diamine or HL-800 amine. To a solution of PEO45-b-PNAS95-b-PS60 micelles
(4.8 mg of block copolymer precursor, 27.0 μmol of NAS residues) in 10 mL of
DMF/H2O (v:v = 1:1) at rt, was added the solution of cypate-diamine (38.3 μg, 0.054
μmol) or HL-800 amine (51.6 μg, 0.054 μmol) in 50 μL of DMF. The reaction mixture
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was allowed to stir for 2 h at rt in the absence of light. To this reaction mixture, was
added a solution of 2,2'-(ethylenedioxy)-bis(ethylamine) (1.0 mg, 6.8 μmol) in nano-pure
H2O dropwise over 10 min. The reaction mixture was further stirred for 24 h at rt in the
absence of light and transferred to pre-soaked dialysis tubing (MWCO 6,000-8,000 Da)
and dialyzed against 5.0 mM PBS (pH 7.2, with 5.0 mM NaCl) for 7 days to remove
DMF, un-reacted crosslinker, and the small molecule by-products and afford an aqueous
solution of crosslinked nanoparticles.
One-pot functionalization and crosslinking of PEO113-b-PVBA46 micelle with
HL-800-amine. To a solution of PEO113-b-PVBA46 micelles (2.7 mg of polymer, 10.8
μmol of aldehyde residues) in 10.0 mL of nano-pure H2O, was added a solution of HL800-amine (20.7 μg, 0.022 μmol) in DMF. The reaction mixture was allowed to stir for 2
h at rt in the absence of light. To this reaction mixture, was added a solution of 2,2'(ethylenedioxy)-bis(ethylamine) (2.4 mg, 16.2 μmol) in nano-pure H2O dropwise over 10
min. The reaction mixture was further stirred for 48 h at rt in the absence of light.
NaBH3CN (1.4 mg, 21.6 μmol) in nano-pure H2O was then added to the reaction solution
and further stirred for 16 h at rt in the absence of light. Finally, the mixture was
transferred to pre-soaked dialysis tubing (MWCO ca. 6,000-8,000 Da) and dialyzed
against 5.0 mM PBS (pH 7.2, with 5.0 mM NaCl) for 7 d to remove the small molecule
by-products and afford an aqueous solution of functionalized and crosslinked
nanoparticles.
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Results and Discussion
To construct fluorescent NPs, diblock copolymer (poly(ethylene oxide)-blockpoly(4-vinyl benzaldehyde, PEO-b-PVBA) and triblock copolymer (poly(ethylene
oxide)-block-poly(N-acryloxysuccinimide)-block-polystyrene,

PEO-b-PNAS-b-PS)

micelles were functionalized with fluorescein-5-thiosemicarbazide and amine-terminated
carbocyanine dyes through either reductive amination or amidation chemistry. The PEOb-PVBA diblock copolymers I (PEO45-b-PVBA18, Mn, NMR = 4,700 Da, Mn, GPC = 3,900
Da, PDI = 1.2, Figure 7.1A) and II (PEO113-b-PVBA46, Mn, NMR = 12,600 Da, Mn, GPC =
12,400 Da, PDI = 1.4, Figure 7.1B)58 were used for construction of core functionalizable
crosslinked nanoparticles while the PEO-b-PNAS-b-PS triblock copolyper III (PEO45-bPNAS95-b-PS60, Mn, NMR = 18,400 Da, PDI = 1.2, Figure 7.1C) was utilized as precursor
for shell crosslinked nanoparticles.

All block copolymers were prepared through

reversible addition-fragmentation chain transfer (RAFT) polymerization,59-61 based upon
our previous reports.56,

57

The PEO (MW = 2, 000 and 5,000 Da, respectively) was

selected as hydrophilic segment because of its good water solubility, well-known
biocompatibility, and low immunogenic response.62 PVBA was used as the hydrophobic
and reactive segment due to the broad reaction scope and the mild reaction condition of
aldehyde functionality, especially under aqueous conditions. PNAS acted as pre-installed
active ester for reaction with amine-functionalized fluorophores.
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Figure 7.1. Characterizations of PEO45-b-PVBA18 (I), PEO113-b-PVBA46 (II), and
PEO45-b-PNAS95-b-PS60 (III) block copolymer precursors. A): 1H NMR spectrum (left,
500 MHz, CD2Cl2) and THF-GPC profile (right) of PEO45-b-PVBA18 block copolymer.
B): 1H NMR spectrum (left, 500 MHz, CD2Cl2) and THF-GPC profile (right) of PEO45-bPVBA18 block copolymer. C): A): 1H NMR spectrum (left, 600 MHz, CD2Cl2) and
DMF-GPC profile (right) of PEO45-b-PNAS95-b-PS60 block copolymer.
Aqueous assembly of block copolymer I and II followed conventional methods
for micellization of amphiphilic block copolymers with a glassy hydrophobic block
segment. PEO selective solvent, i.e. water, was slowly (ca. 15 mL/h) added to the
solution of PEO-b-PVBA in organic solvent (DMF, ca. 1.0 mg/mL) to induce the
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micellization and further stabilize the formed aggregates. Finally, the organic solvent
was removed through dialysis against water to afford PEO-b-PVBA micelles with PEO
shell and PVBA core domains. The uniformity and narrow size distribution of the
assembled micelles were demonstrated through the combination of DLS and TEM
(Figure 7.2). The DLS measurements showed that these micelles had intensity-averaged
hydrodynamic diameter (Dh, intensity) of 23 ± 2 nm (from PEO45-b-PVBA18) and 26 ± 2 nm
(from PEO113-b-PVBA46), respectively. TEM micrograph revealed their globular shape
with an average core domain diameter (Dav) of 13 ± 1 nm and 19 ± 1 nm, respectively,
depending upon the length of PVBA block segment.

Figure 7.2. Characterization of PEO-b-PVBA micelles. A) Intensity-average weighted
hydrodynamic diameter distribution histogram by DLS (top) and TEM micrograph
(bottom, stained with PTA) of PEO45-b-PVBA18 micelle. B) Intensity-average weighted
hydrodynamic diameter distribution histogram by DLS (top) and TEM micrograph
(bottom, stained with PTA) of PEO113-b-PVBA46 micelle.
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One-pot chemical functionalization with fluorescein-5-thiosemicarbazide and
crosslinking with diamine crosslinker of the PEO45-b-PVBA18 micelles were achieved,
following our previously established reductive amination protocol (Scheme 7.1A).56
Similar to our previous reports,56 buffer solutions with certain ionic strength (pH 7.2 5
mM PBS with 5 mM of NaCl in this study) were found to be required to prevent the
precipitation of the crosslinked nanoparticles. For NP1 (prepared with a feeding ratio of
fluoresceins/aldehydes = 0.2:1), the DLS (Dh, intensity = 21 ± 1 nm) and TEM (Dav = 13 ± 1
nm) characterizations of the functionalized crosslinked NPs showed no obvious
morphology, size, and size distribution variations (Figure 7.3A), compared with the
micelle precursors (Figure 7.2A). UV-Vis measurement of the fluorescein-NP solutions
revealed that a slight red-shift of ca. 8 nm (Figure 7.3E left) occurred for the maximum
absorption peak (λmax, 496 nm for the fluorescein-functionalized NPs v.s. 488 nm for the
unconjugated fluorescein), which might be related to the change of fluorescein local
environment before and after incorporation into the nanostructure.

Although the

thiosemicarbazide is a strong nucleophile, the coupling efficiency of fluorescein into NP
was only ca. 12%. This might be associated with the low accessibility of hydrophilic
fluoresein to the hydrophobic benzaldehyde functionalities (packed inside the
hydrophobic core domain of the micelle).
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Scheme 7.1. Construction of fluorescent nanoparticles through reductive amination (A)
and amidation (B).
Steady state fluorescence spectrum of the diluted NP solution was recorded at the
excitation wavelength of 450 nm over the range of 465-650 nm and shown in Figure
7.3E. Compared with small fluorescein molecule, much lower fluorescence emission
intensity of the NP1 sample (200-fold drop at the same concentration magnitude) was
observed. We attributed the decrease in fluorescence of attached fluorescein moieties to
intra-nanoparticle self-quenching, i.e., the combined effects of homoFRET (non-radiative
energy transfer of the same fluorophores located in close proximity to each other) caused
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by incorporating ca. 150 dyes into a confined space with ca. 13 nm of diameter (vide
infra).
We also conducted the R0 measurement (see Experimental Section for details) and
the result was 4.67 nm, similar to the literature value (4.4 nm). The distance between two
fluorescein moieties on the NPs (r) were calculated from both steady-state and dynamic
emission spectra by using the following equations:
/

⁄
⁄

nm for steady-state emission

(4)

where Fda is the fluorescence intensity of the donor in the presence of acceptor, and Fd is
the fluorescence intensity of the donor in the absence of acceptor, Absda is absorbance of
the donor in the presence of acceptor, Absd is absorbance of the donor in the absence of
acceptor.
and

/

nm for dynamic emission

(5)

where τda represents the relative fluorescence lifetime of the donor in the presence of
acceptor, and τd in the absence of acceptor. The calculated results, together with the
experimentally optical characteristics of the samples, were summarized in Table 7.1.
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Figure 7.3.
Characterizations of NP1-4.
A-D) Intensity-average weighted
hydrodynamic diameter distribution by DLS (top) and TEM micrograph (bottom, stained
with PTA) of NP1-4, respectively. E) UV-Vis (left) and fluorescence emission (middle
and right) spectra of Control1 (Fluorescein, dashed) and NP1 (solid). F) UV-Vis (left)
and fluorescence emission (middle and right) spectra of Control2 (Fluorescein, dashed)
and NP2 (solid). G) UV-Vis (left) and fluorescence emission (middle and right) spectra
of Control3 (Fluorescein, dashed), NP3 (short dashed) and NP4 (solid).
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Table 7.1. Calculated distance between two adjacent fluorescein moieties incorporated
into nanoparticles and the optical characteristics of fluorescent nanoparticles.
Sample
Control1f
NP1
Control2f
NP2
Control3f
NP3
NP4

Dh, intensity
(nm)
─
21 ± 1
─
22 ± 2
─
24 ± 2
24 ± 2

Dav
(nm)
─
13 ± 1
─
13 ± 1
─
19 ± 1
19 ± 1

Nagg

Dyes/NPa

─
350
─
350
─
430
430

─
150
─
15
─
15
30

D
(nm)
─
1.88
─
5.95
─
8.69
6.15

τb
(ns)
3.95
2.07
3.88
2.97
3.92
3.33
3.11

r(τ)c
(nm)
─
4.75
─
5.69
─
6.23
5.84

Φd
0.79
0.005
0.79
0.088
0.79
0.233
0.215

r(Φ)e
(nm)
─
2.0
─
3.3
─
4.04
3.97

a

Calculated based upon ε = 66,000 M-1 cm-1. b Fluorescence average lifetime. c Distance
between two fluorophores based upon lifetime measurement. d Fluorescence quantum
yield. e Distance between two fluorophores based upon quantum yield. f Fluorescein as
control (Control1 for NP1 measurement, Control 2 for NP2 measurement, and
Control3 for NP3 and NP4 measurements, respectively).

We have previously established a semi-quantitative model for evaluation of the
nanoparticle surface coverage density.63 Because only ~ 2.5% of the VBA units were
actually “decorated” with fluorescein, the fluorescein molecules should be attached to the
most accessible VBA units, i.e. benzaldehydes around the periphery of the core domain.
Therefore, the previous model could be easily revised to estimate the distance between
adjacent fluorecein molecules (depicted as D in Scheme 7.1 insertion) through the
following equation:

D=

π ( Dav) 2
N

nm

(6)

where N denotes the number of fluorophores per NP (obtained from the number of
fluorophores per polymer chain and the aggregation number of polymer chains estimated
to be within each NP, see Experimental Section for details), and Dav is the averaged
diameter of the core domain of NP.
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Theoretically, no energy would be transferred and therefore no quenching would
occur if the distance between two fluororeceins exceeds 9 nm. For NP1, the calculated
distances between two fluorescein molecules, both from our model prediction using eq.
(6) (1.88 nm) and from the experimental calculations (2.00 nm from steady state and 4.75
nm from dynamic state, respectively), were far below 9 nm and substantial selfquenching (over 45% of the emission energy was transferred to acceptors) were expected.
The variation of the distance between steady-state and dynamic emission spectra was
attributed to the more complex decay of NP1. In fact, the average lifetime results in
Table 7.1 were the results of deconvolution of decays using two-exponential decay laws
and the multiexponentiality of decays suggested the presence of many distance between
fluorescein moieties.
To reduce the homoFRET effect, the easiest method was to decrease the number
of fluorophores per nanoparticle. Therefore, NP2 with ca. 15 fluoreceins per NP was
prepared from the same block copolymer micelle as NP1, maintaining similar size (Dh,
intensity

= 22 ± 2 nm and Dav = 13 ± 1 nm) and size distribution (Figure 7.3B).64

Significant improvement of QY was observed by a factor of 18 (Table 7.1), due to the
increase of the distance between fluorescein moieties, as calculated from experimental
data and the proposed model (Table 7.1).
However, the QY for NP2 was still below 0.1. Also, ca. 25% of the energy was
non-radiatively transferred to other fluoresceins, based upon the lifetime measurement.
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Further decrease of fluorescein density is expected to enhance QY, but the overall
fluorescence intensity per NP still would not reach a desired level due to the lack of
fluorophores. Theoretical estimation indicated that, for the PEO45-b-PVBA18 system (13
nm diameter core), there can be no more than 5 fluoresceins per particle that are
separated by at least 9 nm. The prediction made this system less attractive for further
optimization because at such a small loading capacity, even the QY for each fluorophore
can be enhanced, the overall fluorescence cannot be indefinitely improved due to the
fewer number of fluorophores per particle.
From equation (6), there exists a linear relationship between D and Dav at fixed
dye loadings, which indicates that the size increase of nanoparticle core domain would
facilitate the enhancement of luminescence efficiency. Therefore, it is desired to use
particles with larger cores for fluorophore functionalization. NP3 and NP4 with larger
core sizes (19 vs. 13 nm, Table 7.1 and Figure 7.3C-D) were then prepared from PEO113b-PVBA46 block copolymer micelles.65
With a core size of 19 nm and 15 fluorescein molecule/NP, the calculated D for
NP3 was 8.69 nm, which was close to the “9 nm requirement”. In fact, only 15.7% of the
absorbed energy was non-radiatively transferred between fluorescein moieties (based
upon lifetime measurement). As a result, QY of NP3 was increased to 0.233, a 2.5-fold
enhancement compared with NP2. For NP4, which bears 30 fluoreceins per particle, a
slight drop of QY (0.215) was observed, likely due to the relative proximity between
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fluorophores (D = 6.15 nm). However, the slightly decreased QY was compensated by
the much increased number of fluorophores, rendering its overall fluorescence intensity
190% as large as than that of NP3 (Figure 7.3G right).
The PEO113-b-PVBA46 micelle system and the optimized stoichiometry of
fluorescein loading (less than 1 mol%, relative to the aldehydes) were then extend to
construct NIR fluorescent nanoparticles. NP5-7 with ca. 70, 45, and 10 cypates per
particle, respectively, were synthesized and subjected to photo-physical studies.
Compared with the coupling yields of fluoresceins at ~ 12% to 15%, the cypate exhibited
~ 36% to 47% incorporation efficiencies. This improvement could to be attributed to the
fact that cypate was much more hydrophobic than fluorescein and had more preference
for the hydrophobic PVBA core.
As shown in Figure 7.4A-C, NP5-7 displayed well-defined globular shape and
narrow size distributions.

Interestingly, although the UV-Vis spectra (Figure 7.4D)

showed that NP5-7 had the identical maximum absorption wavelength at 800 nm, the
fluorescence emission spectrum of NP7 bearing the least number of cypates exhibited a
clear blue-shift of ca. 11 nm (813 nm vs. 824 nm for NP5 and 6, Figure 7.4E). The origin
of this blue-shift was believed to be associated with the increased molecular asymmetry20
of cypate-diamine after incorporation into the nanostructures at lower stoichiometry, i.e.,
some of the cypate-diamines had both amine groups reacted while some only had one
reacted.
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Figure 7.4. A-C) Intensity-average weighted hydrodynamic diameter distribution
histogram by DLS (top) and TEM micrograph (bottom, stained with PTA) of NP5, NP6,
and NP7, respectively. D-E) UV-Vis and fluorescence profiles of NP5 (dashed), NP6
(short dashed), and NP7 (solid), respectively.
Based upon the model prediction equation (eq. (6)), the distance between
neighboring cypate molecules for NP5-7 was 4.0 nm, 5.0 nm, and 10.7 nm, respectively
(Table 7.2). Compared with the general “non-homoFRET criterion” (> 12 nm), it could
speculate that NP5 and NP6 would exhibit very low QYs, which were further confirmed
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through the steady-state (QY = 0.001 and 0.004, respectively) and dynamic (lifetime less
than 0.3 ns) measurements. For NP7, increased QY value was expected due to the
increased D value (over 10 nm). The actual QY value was measured by steady state
fluorescence to be 0.019, very close to free cypate in water (0.021).
Table 7.2. Characterizations and optical characteristics of NIR fluorescent nanoparticles
from PEO113-b-PVBA46 system.
Dh, intensity
(nm)
23 ± 1
NP5
23 ± 1
NP6
22 ± 2
NP7
Calculated based upon ε
Sample

a

Dav
Nagg
(nm)
19 ± 1
430
19 ± 1
430
19 ± 1
430
= 200,000 M-1 cm-1.

Fluorescence average lifetime.

d

D
τc
Φb
(nm)
(ns)
70
4.0
0.001
0.2d
45
5.0
0.004
0.2d
10
10.7
0.019
0.6
Relative to ICG in methanol (QY=0.09).

Dyes/NPa

b

c

Due to the limitation of instrument, the lifetime below 0.3 ns

was not accurate.
The lifetime and quantum yield of carbocyanine dye were also related with the
property of local environment, i.e., the micropolarity of the media.66 For example, the
lifetime of cypate was markedly increased from less than 0.2 ns to 1 ns as the solvent was
switched from water to chloroform. QY could also be affected but was less predictable.
For the core crosslinked PEO-b-PVBA system, since the reactive aldehydes were located
inside the core and the core-shell interfacial domains, the covalently conjugated NIR dyes
were also confined to core periphery and core-shell interface areas and were theoretically
exposed to relatively less polar surroundings, compared with the pure water molecules.
To test whether the QY of cypate-functionalized NPs was affected by fluorophore
location, shell-crosslinked NIR fluorescent nanoparticles (NIR-SCKs, SCK1-2) were
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prepared, in which the carbocyanine molecules (Cypate for SCK1 and HL-800 for
SCK2, respectively) were distributed throughout the shell domain (Scheme 7.1B).
As mentioned earlier, the NIR-SCKs were synthesized through functionalization
and crosslinking the PEO45-b-PNAS95-b-PS60 micelle with pendent NAS functionalities
as pre-installed amidation sites along the polymer backbone for amine-terminated
cyanine dyes and diamine crosslinkers. After the work-up process (extensive dialysis
against PBS buffer), the unreacted NAS residues were hydrolyzed to acrylic acids and
then became components of shell domain of nanoparticles. The cypate incorporation
efficiency (ca. 15%) was lower compared with the PEO-b-PVBA system under similar
cypate-diamine feeding ratio (0.2 mol%, relative to the reactive functionalities). The
particles showed relatively narrow size distributions and globular shape observed through
DLS and TEM (Figure 7.5A-B). The physical characteristics of SCK1 and SCK2 were
summarized in Table 7.3.
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Figure 7.5. Characterizations and photo-physical properties of shell crosslinked NIR
fluorescent nanoparticles. A-B) Intensity-average weighted hydrodynamic diameter
distribution histogram by DLS (top) and TEM micrograph (bottom, stained with PTA) of
SCK1 and SCK2, respectively. C) UV-Vis (left) and fluorescence (right) profiles of
SCK1 (dashed) and SCK2 (solid), respectively.

Table 7.3. Characterizations and optical characteristics of NIR-SCKs from PEO45-bPNAS95-b-PS60 micelles.
Dav
Dh, intensity
Nagg
Dyes/NPa
Φb
(nm)
(nm)
59 ± 3
30 ± 1
1450
40
0.005
SCK1
56 ± 2
30 ± 1
1450
20
0.036
SCK2
a
-1
-1 b
Calculated based upon ε = 200,000 M cm . Relative to ICG in methanol (QY=0.09).
Sample
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Similar to NP7, the fluorescence emission spectrum of SCK1 showed a 10 nm
blue-shift for the maximum emission peak (dashed curve in Figure 7.5D). The blue-shift
could also be attributed to the raise of cypate molecular asymmetry after conjugation.
Although the particle size increased in both core and shell domains (59 nm vs. 23 nm for
hydrodynamic diameter and 30 nm vs. 19 nm for core diameter), and NIR dye loading
was decreased (40 vs. 45), the QY of SCK1 (0.005, Table 7.3) was still low. Based upon
our model prediction, the D value was between the range of 8.41 nm and 15.63 nm,
where 8.41 nm represented the extreme that all dyes were located to the periphery of core
domain and 15.63 nm represented the other extreme that all dyes were placed on the
margin of shell domain. And therefore, it was speculated that the limited enhancement of
luminance efficiency might be originated from the increased environmental micropolarity
after incorporation into the more hydrophilic shell domain.
NIR-SCKs with improved optical characteristics were achieved while the cypate
was replaced by HL-800 at a loading capacity of 20 HL-800s/SCK (SCK2, and the D
value was between the range of 11.89 nm to 22.19 nm). The QY of SCK2 (0.036, Table
7.3) was enhanced by a factor of 7 and the overall fluorescence intensity gained a 2-fold
increase, relative to SCK1. HL-800 was further introduced into the PEO113-b-PVBA46
system for synthesis of NP8 bearing 5 dyes/NP while keeping similar size as NP5-7
(Figure 7.6A, Dh, intensity = 22 ± 1 nm and Dav = 19 ± 1 nm) and comparable D as SCK2
(D = 15.06 nm). Dramatic decrease of QY was observed (0.002 vs. 0.019), even though
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the error of NP8 calculation was high due to the unreliable level of absorption intensity
(Figure 7.6B). These results suggested that the HL-800 might exhibit a reversed solventpolarity response as cypate and the mechanism was not clear now.

Figure 7.6. A) Intensity-average weighted hydrodynamic diameter distribution by DLS
(top) and TEM micrograph (bottom) of NP8. B-C) UV-Vis and fluorescence spectrum of
NP8, respectively.

Conclusions
In summary, we have tested the photo-physical properties of crosslinked
nanoparticles functionalized with fluoresceins or NIR carbocyanine (Cypate and HL-800)
dyes at different stoichiometric loadings.

It is clear that the nanoparticle QY and

fluorescence lifetime was determined by the distance between adjacent fluorophores.
More importantly, the NP maximum dye loading capacity for retaining sufficient QY
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could be predicted through a semi-quantitative model, which correlated well with the
experimental results. These fundamental results could be applied to the development of
nanoparticle-based NIR optical devices for fluorescence imaging.
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Chapter 8
Conclusions

Design and synthesis of discrete and robust polymeric nanostructures bearing the
characteristic of serving as chemoselectively functionalizable platform for biomedical
applications is an area of long-term interest in material science. This desire becomes
emergent as the significantly positive impacts of nanotechnology to traditional healthcare
has been heightened in nearly every medical district, including diagnostics, therapy, and
clinical applications.
The efforts to achieve precise and facile manipulations over the functionalization
of existed shell crosslinked (SCK) nanoparticle platform formed the first portion of this
dissertation (chapter 2 and 3). The general strategy exerted in these works was to design
synthetic pathway of functionalized SCKs from a “more Bottom-up” approach, i.e.,
coupling functionalities to block polymer precursor before assembly into nanostructures.
The efficiency of this approach was confirmed by the construction of DOTA-SCKs, with
high loading capacity of radionuclide

64

Cu (chapter 2, ca. 400 copper per spherical

nanoparticle). Extension of the “pre-grafting” strategy to build PEGylated SCKs (chapter
3) with tunable biodistributions and the following targeting SCKs under developing now
demonstrated the supremacy and versatility of this synthetic methodology. Meanwhile,
in vivo positron emission tomography (PET) imaging at low-dose administration was
realized by the characteristic of enhanced labeling efficiency, provided by the SCKs
prepared through this pathway.
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Fundamental investigations in chapter 4 addressed the utilization of active ester
(N-acryloxysuccinimide, NAS) and probing crosslinkers for better understanding the
chemical and physical factors involved during the shell crosslinking process. In the
meantime, interesting photo-physical properties of pyrazine-based chromophores were
discovered including the blue shift of maximum absorption and dual-emission of
fluorescence, which strictly relied upon the internal nanostructure environment. The preinstallation of NAS as amidation site across the micellar structures not only reduced the
reaction complexity entailed in carbodiimide mediated amidation, but also enabled
selectivity for conjugation of functionalities bearing “critical” activity-related carboxylic
acids, for example, the aspartic acid in RGD peptide motif.
While amidation dominated half portion of this dissertation, the left-over part of
this dissertation (chapter 5 to 7) was focus on one of the most reactive electrophiles,
benzaldehyde, to exploit its controlled polymerization and applications of the form
polymers as building component in supramolecular assembly and functionalization.
Reversible addition-fragmentation chain transfer (RAFT) polymerization of 4vinyl benzaldehyde (VBA) was described in chapter 5. The PVBAs were confirmed with
predictable molecular weight, narrow molecular weight distribution, and well-define
architectures. Successful chain extension from PVBA based macro chain transfer agent
(macro-CTA) afforded well-defined block copolymers with PVBA as reactive block
segments allowing for post-polymerization modifications.

These studies actually

initialized the implements of controlled radical polymerization of carbonyl-bearing
monomers.
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PVBA-based amphiphilic block copolymer systems (poly(ethylene oxide)-blockpoly(4-vinyl benzaldehyde), PEO-b-PVBA) were then established and their aqueous
assemblies were studied (chapter 6 and 7). Dramatic self assembly behavior was noticed
between two block copolymers (PEO45-b-PVBA18 and PEO45-b-PVBA26) having small
structural difference. As characterized through a combination of transmission electron
microscopy (TEM) and dynamic light scattering (DLS), uniform spherical micelles with
narrow size distribution were formed from the PEO45-b-PVBA18 block copolymer
precursor (chapter 7) while polymer vesicles (polymersomes, chapter 6) with tunable
sizes were obtained from the PEO45-b-PVBA26 block copolymer, although the
mechanism behind the difference was not clear at this stage.
The reactivity of the benzaldehyde functionalities was verified by crosslinking the
polymersomes, and also by a one-pot crosslinking and functionalization approach to
further render them fluorescent, each via reductive amination. The mechanic properties
of croslinked vesicles have been significantly improved and the in vitro studies found
these labelled vesicles to undergo cell association (chapter 6).
In chapter 7, the one-pot sequential crosslinking and functionalization protocol
through reductive amination was utilized for installation of fluorescent probes (regular
fluorescein and near-infrared cypate) onto micelles from PEO-b-PVBA block
copolymers. The luminescence effiency of nanoparticles was evaluated and a clear
relationship between quantum yield and the stoichiometry of loaded fluorophores was
established.
As mentioned earlier in the Introduction section, nanomaterials prepared from the
Bottom-up approach have grown dramatically during the past decades. The reason is
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multifactorial but the ultimate goal is very clear, i.e., continuous providing better
nanoscale platforms for variety of applications.
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Appendix
NMR Spectra of Compounds
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